
<html lang="en"     class="pb-page"  data-request-id="e2821358-b1f9-4c13-a054-7fac3cc69db9"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm500480k;issue:issue:10.1021/jmcmar.2015.58.issue-1;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of Type II Inhibitors of TGFβ-Activated Kinase 1 (TAK1) and Mitogen-Activated Protein Kinase Kinase Kinase Kinase 2 (MAP4K2)" /></meta><meta name="dc.Creator" content="Li  Tan" /></meta><meta name="dc.Creator" content="Tyzoon  Nomanbhoy" /></meta><meta name="dc.Creator" content="Deepak  Gurbani" /></meta><meta name="dc.Creator" content="Matthew  Patricelli" /></meta><meta name="dc.Creator" content="John  Hunter" /></meta><meta name="dc.Creator" content="Jiefei  Geng" /></meta><meta name="dc.Creator" content="Lina  Herhaus" /></meta><meta name="dc.Creator" content="Jianming  Zhang" /></meta><meta name="dc.Creator" content="Eduardo  Pauls" /></meta><meta name="dc.Creator" content="Youngjin  Ham" /></meta><meta name="dc.Creator" content="Hwan Geun  Choi" /></meta><meta name="dc.Creator" content="Ting  Xie" /></meta><meta name="dc.Creator" content="Xianming  Deng" /></meta><meta name="dc.Creator" content="Sara J.  Buhrlage" /></meta><meta name="dc.Creator" content="Taebo  Sim" /></meta><meta name="dc.Creator" content="Philip  Cohen" /></meta><meta name="dc.Creator" content="Gopal  Sapkota" /></meta><meta name="dc.Creator" content="Kenneth D.  Westover" /></meta><meta name="dc.Creator" content="Nathanael S.  Gray" /></meta><meta name="dc.Description" content="We developed a pharmacophore model for type II inhibitors that was used to guide the construction of a library of kinase inhibitors. Kinome-wide selectivity profiling of the library resulted in the..." /></meta><meta name="Description" content="We developed a pharmacophore model for type II inhibitors that was used to guide the construction of a library of kinase inhibitors. Kinome-wide selectivity profiling of the library resulted in the..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 30, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm500480k" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm500480k" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm500480k" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm500480k" /></link>
        
    
    

<title>Discovery of Type II Inhibitors of TGFβ-Activated Kinase 1 (TAK1) and Mitogen-Activated Protein Kinase Kinase Kinase Kinase 2 (MAP4K2) | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm500480k" /></meta><meta property="og:title" content="Discovery of Type II Inhibitors of TGFβ-Activated Kinase 1 (TAK1) and Mitogen-Activated Protein Kinase Kinase Kinase Kinase 2 (MAP4K2)" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/large/jm-2014-00480k_0011.jpeg" /></meta><meta property="og:description" content="We developed a pharmacophore model for type II inhibitors that was used to guide the construction of a library of kinase inhibitors. Kinome-wide selectivity profiling of the library resulted in the identification of a series of 4-substituted 1H-pyrrolo[2,3-b]pyridines that exhibited potent inhibitory activity against two mitogen-activated protein kinases (MAPKs), TAK1 (MAP3K7) and MAP4K2, as well as pharmacologically well interrogated kinases such as p38α (MAPK14) and ABL. Further investigation of the structure–activity relationship (SAR) resulted in the identification of potent dual TAK1 and MAP4K2 inhibitors such as 1 (NG25) and 2 as well as MAP4K2 selective inhibitors such as 16 and 17. Some of these inhibitors possess good pharmacokinetic properties that will enable their use in pharmacological studies in vivo. A 2.4 Å cocrystal structure of TAK1 in complex with 1 confirms that the activation loop of TAK1 assumes the DFG-out conformation characteristic of type II inhibitors." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm500480k"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm500480k">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm500480k&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm500480k&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm500480k&amp;href=/doi/10.1021/jm500480k" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 1</span><span class="cit-fg-pageRange">, 183-196</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/1" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm500373x" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm5005144" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Type II Inhibitors of TGFβ-Activated Kinase 1 (TAK1) and Mitogen-Activated Protein Kinase Kinase Kinase Kinase 2 (MAP4K2)</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Li++Tan">Li Tan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tyzoon++Nomanbhoy">Tyzoon Nomanbhoy</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Deepak++Gurbani">Deepak Gurbani</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew++Patricelli">Matthew Patricelli</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Hunter">John Hunter</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jiefei++Geng">Jiefei Geng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lina++Herhaus">Lina Herhaus</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jianming++Zhang">Jianming Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eduardo++Pauls">Eduardo Pauls</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Youngjin++Ham">Youngjin Ham</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hwan+Geun++Choi">Hwan Geun Choi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ting++Xie">Ting Xie</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xianming++Deng">Xianming Deng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sara+J.++Buhrlage">Sara J. Buhrlage</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Taebo++Sim">Taebo Sim</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∞</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Philip++Cohen">Philip Cohen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gopal++Sapkota">Gopal Sapkota</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kenneth+D.++Westover">Kenneth D. Westover</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nathanael+S.++Gray">Nathanael S. Gray</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">ActivX Biosciences, La Jolla, California 92037, United States</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Departments of Biochemistry and Radiation Oncology, The University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390, United States</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, United States</span></div><div class="aff-info" id="aff6"><span class="aff-symbol">#</span> <span class="aff-text">MRC Protein Phosphorylation and Ubiquitylation Unit, College of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, U.K.</span></div><div class="aff-info" id="aff7"><span class="aff-symbol">∞</span> <span class="aff-text">Chemical Kinomics Research Center, Korea Institute of Science and Technology, 39-1, Hawolgok-dong, Seongbuk-gu, Seoul, 136-791, Korea</span></div><div class="corresp-info"><strong>*</strong>Phone: 1-617-582-8590. E-mail: <a href="/cdn-cgi/l/email-protection#6907081d010807080c05360e1b0810290d0f0a004701081b1f081b0d470c0d1c"><span class="__cf_email__" data-cfemail="fe909f8a969f909f9b92a1998c9f87be9a989d97d0969f8c889f8c9ad09b9a8b">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm500480k&amp;href=/doi/10.1021%2Fjm500480k" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 1</span><span class="cit-pageRange">, 183–196</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 17, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>26 March 2014</li><li><span class="item_label"><b>Published</b> online</span>30 July 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 January 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm500480k" title="DOI URL">https://doi.org/10.1021/jm500480k</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice_termsofuse.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm500480k"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">7411</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">45</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm500480k" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Type II Inhibitors of TGFβ-Activated Kinase 1 (TAK1) and Mitogen-Activated Protein Kinase Kinase Kinase Kinase 2 (MAP4K2)&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Li&quot;,&quot;last_name&quot;:&quot;Tan&quot;},{&quot;first_name&quot;:&quot;Tyzoon&quot;,&quot;last_name&quot;:&quot;Nomanbhoy&quot;},{&quot;first_name&quot;:&quot;Deepak&quot;,&quot;last_name&quot;:&quot;Gurbani&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;Patricelli&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Hunter&quot;},{&quot;first_name&quot;:&quot;Jiefei&quot;,&quot;last_name&quot;:&quot;Geng&quot;},{&quot;first_name&quot;:&quot;Lina&quot;,&quot;last_name&quot;:&quot;Herhaus&quot;},{&quot;first_name&quot;:&quot;Jianming&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Eduardo&quot;,&quot;last_name&quot;:&quot;Pauls&quot;},{&quot;first_name&quot;:&quot;Youngjin&quot;,&quot;last_name&quot;:&quot;Ham&quot;},{&quot;first_name&quot;:&quot;Hwan&quot;,&quot;last_name&quot;:&quot;Geun Choi&quot;},{&quot;first_name&quot;:&quot;Ting&quot;,&quot;last_name&quot;:&quot;Xie&quot;},{&quot;first_name&quot;:&quot;Xianming&quot;,&quot;last_name&quot;:&quot;Deng&quot;},{&quot;first_name&quot;:&quot;Sara&quot;,&quot;last_name&quot;:&quot;J. Buhrlage&quot;},{&quot;first_name&quot;:&quot;Taebo&quot;,&quot;last_name&quot;:&quot;Sim&quot;},{&quot;first_name&quot;:&quot;Philip&quot;,&quot;last_name&quot;:&quot;Cohen&quot;},{&quot;first_name&quot;:&quot;Gopal&quot;,&quot;last_name&quot;:&quot;Sapkota&quot;},{&quot;first_name&quot;:&quot;Kenneth&quot;,&quot;last_name&quot;:&quot;D. Westover&quot;},{&quot;first_name&quot;:&quot;Nathanael&quot;,&quot;last_name&quot;:&quot;S. Gray&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;30&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;183-196&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm500480k&quot;},&quot;abstract&quot;:&quot;We developed a pharmacophore model for type II inhibitors that was used to guide the construction of a library of kinase inhibitors. Kinome-wide selectivity profiling of the library resulted in the identification of a series of 4-substituted 1H-pyrrolo[2,3-b]pyridines that exhibited potent inhibitory activity against two mitogen-activated protein kinases (MAPKs), TAK1 (MAP3K7) and MAP4K2, as well as pharmacologically well interrogated kinases such as p38α (MAPK14) and ABL. Further investigation of the structure–activity relationship (SAR) resulted in the identification of potent dual TAK1 and MAP4K2 inhibitors such as 1 (NG25) and 2 as well as MAP4K2 selective inhibitors such as 16 and 17. Some of these inhibitors possess good pharmacokinetic properties that will enable their use in pharmacological studies in vivo. A 2.4 Å cocrystal structure of TAK1 in complex with 1 confirms that the activation loop of TAK1 assumes the DFG-out conformation characteristic of type II inhibitors.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500480k&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500480k" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500480k&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500480k" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500480k&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500480k" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm500480k&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500480k&amp;href=/doi/10.1021/jm500480k" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm500480k" /></input><a href="/doi/pdf/10.1021/jm500480k" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm500480k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm500480k%26sid%3Dliteratum%253Aachs%26pmid%3D25075558%26genre%3Darticle%26aulast%3DTan%26date%3D2015%26atitle%3DDiscovery%2Bof%2BType%2BII%2BInhibitors%2Bof%2BTGF%25CE%25B2-Activated%2BKinase%2B1%2B%2528TAK1%2529%2Band%2BMitogen-Activated%2BProtein%2BKinase%2BKinase%2BKinase%2BKinase%2B2%2B%2528MAP4K2%2529%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D1%26spage%3D183%26epage%3D196%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (6)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290969" title="Cell and molecular biology">Cell and molecular biology</a>,</li><li><a href="/action/doSearch?ConceptID=290682" title="Post-translational modification">Post-translational modification</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/1" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jmcmar.2015.58.issue-1/20150108/jmcmar.2015.58.issue-1.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/medium/jm-2014-00480k_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/large/jm-2014-00480k_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500480k&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">We developed a pharmacophore model for type II inhibitors that was used to guide the construction of a library of kinase inhibitors. Kinome-wide selectivity profiling of the library resulted in the identification of a series of 4-substituted 1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridines that exhibited potent inhibitory activity against two mitogen-activated protein kinases (MAPKs), TAK1 (MAP3K7) and MAP4K2, as well as pharmacologically well interrogated kinases such as p38α (MAPK14) and ABL. Further investigation of the structure–activity relationship (SAR) resulted in the identification of potent dual TAK1 and MAP4K2 inhibitors such as <b>1</b> (NG25) and <b>2</b> as well as MAP4K2 selective inhibitors such as <b>16</b> and <b>17</b>. Some of these inhibitors possess good pharmacokinetic properties that will enable their use in pharmacological studies in vivo. A 2.4 Å cocrystal structure of TAK1 in complex with <b>1</b> confirms that the activation loop of TAK1 assumes the DFG-out conformation characteristic of type II inhibitors.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="specialIssueNotice" class="extra-info-sec articleNote"><h4>SPECIAL ISSUE</h4><p class="last">This article is part of the <a href="/toc/jmcmar/58/1"><issue-title>New Frontiers in Kinases</issue-title></a> special issue.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78443" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78443" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">There are approximately 518 kinases encoded in the human genome, and they have been demonstrated to play pivotal roles in virtually all aspects of cellular physiology. Dysregulation of kinase activity through numerous mechanisms results in many pathologies, but therapeutically relevant kinases have been extensively investigated as anticancer agents. Clinically the most successful kinase inhibitors directly target mutationally activated kinases such as BCR-ABL, EML4-ALK, mutant EGFR, B-RAF, and c-KIT that are bonafide oncogenes in the context of tumors that harbor these lesions. Unfortunately, although genome-wide cancer sequencing efforts have uncovered a large number of kinases that are mutated, very few have been biologically validated as being singularly important to tumor function. One challenge to efficient pharmacological validation of new potential kinase targets is the absence of selective inhibitors for the majority of kinases. We sought to develop efficient kinase inhibitor discovery strategies that will enable the identification of inhibitors with sufficient potency and selectivity that they can be used to interrogate the functional and therapeutic consequences of inhibiting less well characterized kinases.</div><div class="NLM_p">A large majority of known small molecule kinase inhibitors target the ATP binding site with the kinase assuming a conformation otherwise conducive to catalysis (type I inhibitors). A second, broad class of kinase inhibitors (type II) binds to the ATP binding pocket in addition to an adjacent hydrophobic pocket that is created when the activation loop, which contains the conserved DFG motif, is in an “out” conformation. A number of clinically approved inhibitors such as imatinib, nilotinib, and sorafinib have been crystallographically proven to be type II inhibitors of kinases such as ABL, c-KIT, B-RAF, and p38 kinases.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4">(1-4)</a> Upon the basis of these crystal structures, we developed a pharmacophore model that defined the structural features needed to access this type II binding conformation (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>b).<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> The model posits the need for a “head” heterocyclic motif that occupies the adenosine binding pocket typically making one to three hydrogen bonds to the kinase hinge segment, a linker moiety that traverses the region occupied by the “gatekeeper” residue, a hydrogen bond donor/acceptor motif and a hydrophobic “tail” that occupies the pocket created by the flip of the “DFG” motif of the kinase activation loop (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>b). We constructed a library of potential type II inhibitors based upon this model and performed kinome-wide selectivity profiling in an effort to identify new inhibitors and the kinases that might be susceptible to inhibition by type II inhibitors.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> A library of approximately 100 potential type II inhibitors was screened against a panel of over 420 kinases using the KinomeScan approach.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Two compounds to emerge from this effort are <b>1</b> (reported as “NG25” in refs <a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">8</a> and <a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">9</a>) and <b>2</b> which show binding affinity for TAK1 and MAP4K2 (also known as GCK) (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). These compounds possess a 4-substituted 1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine as the hinge-interacting “head” motif, a 1,3-benzoic acid linker motif inspired by imatinib and a 3-trifluormethylbenzamide “tail” motif inspired by sorafinib/nilotinib.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/medium/jm-2014-00480k_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/large/jm-2014-00480k_0013.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. General pharmacophore model for the rational design of type II inhibitors. (a) Examples of known type II inhibitors, which can be divided into a “type I” head (black) attached to a “type II” tail (blue). (b) Schematic representation of the rational design of new type II kinase inhibitors: A, hydrogen bond acceptor; D, hydrogen bond donor; HRB, hinge-region binding; HM, hydrophobic motif.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/large/jm-2014-00480k_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500480k&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/medium/jm-2014-00480k_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/large/jm-2014-00480k_0014.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Chemical structures of “lead” compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/large/jm-2014-00480k_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500480k&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Herein, we report the syntheses and target identification of two novel type II kinase inhibitors <b>1</b> and <b>2</b> of two mitogen activated protein kinases: TAK1 (MAP3K7) and MAP4K2 (GCK). While there have been extensive efforts to target a limited number of MAPKs such as A,B,C-RAF (MAP3Ks), MEK1 (MAP2K1), ERK2 (MAPK1), p38α,β,δ,γ (MAPK14,11,13,12), and JNK1,2,3 (MAPK8,9,10), a majority of other MAPKs have not been subjected to significant inhibitor development efforts. The mitogen activated kinases are typically classified as MAP4Ks (6 members), MAP3Ks (21 members), MAP2Ks (7 members), and MAPKs (14 members) for a total of 49 kinases. TAK1 mediates signaling downstream of multiple cytokine receptors and is functionally important in mitogen, immune, and inflammatory signaling pathways.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a> Recently several inhibitors of TAK1 have been reported and characterized with respect to their anti-inflammatory and anticancer activity.<a onclick="showRef(event, 'ref12 ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14 ref15">(12-15)</a> The biological functions of MAP4K2 are less well elucidated, but it may be a regulator of NF-κB signaling contributing to cancer development for a subset of malignancies,<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> and its pharmacological inhibition has been reported to reduce the viability of colon cancer cells.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> MAP4K2 has also been reported to be required to transduce signals from TGFβ receptor to p38.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Clearly more selective inhibitors of MAP4K2 would be very useful to further elucidate the functions of this kinase. We demonstrate that <b>1</b> and <b>2</b> and other lead compounds (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) can inhibit phosphorylation of proteins predicted to be downstream of TAK1 and MAP4K2 such as IKK, p38, and JNK at concentrations of less than 100 nM. Further modification of <b>1</b> and <b>2</b> resulted in the identification of compounds such as <b>16</b> and <b>17</b> that exhibit selectivity for MAP4K2 relative to TAK1. Broad kinase selectivity profiling using KiNativ, revealed that a subset of the inhibitors could also target additional kinases such as ABL, ARG, p38, SRC, CSK, FER, FES, and EPH-family kinases, suggesting that these kinases are also susceptible to type II inhibition providing a wealth of potential starting points for further elaborating inhibitors of these kinases.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55846" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55846" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthesis of lead compound <b>1</b> is outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. First, pyrrolopyridine <b>27</b> was coupled with 3-hydroxy-4-methylbenzoic acid using K<sub>2</sub>CO<sub>3</sub> as base. The resulting intermediate was subjected to hydrogenolysis using Pd/C to afford the dechlorinated acid <b>28</b> which was then reacted with aniline <b>29</b> using HATU/DIEA to provide the desired amide <b>30</b>. The SEM group of <b>30</b> was deprotected under sequential acid and basic conditions to furnish compound <b>1</b>. This four-step sequence proceeded with high overall yield.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/medium/jm-2014-00480k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/large/jm-2014-00480k_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 3-((1<i>H</i>-Pyrrolo[2,3-<i>b</i>]pyridin-4-yl)oxy)-<i>N</i>-(4-((4-ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-4-methylbenzamide <b>1</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/large/jm-2014-00480k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500480k&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 3-hydroxy-4-methylbenzoic acid, K<sub>2</sub>CO<sub>3</sub>, DMSO, 100 °C; (b) Pd/C, MeOH; (c) <b>29</b>, HATU, DMAP, DIEA, CH<sub>2</sub>Cl<sub>2</sub>; (d) (i) TFA, CH<sub>2</sub>Cl<sub>2</sub>, (ii) LiOH, H<sub>2</sub>O/THF.</p></p></figure><div class="NLM_p">The preparation of compound <b>2</b> is outlined in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. The iodide intermediate <b>32</b> was prepared by reacting aniline <b>29</b> and acid <b>31</b>. Meanwhile, a methoxy group was introduced into aldehyde <b>33</b> using sodium methoxide followed by Wittig olefination to afford the terminal olefin <b>34</b>. The SEM protecting group was replaced with a Boc protecting group to provide compound <b>35</b> which was coupled with iodide <b>32</b> through Heck reaction to furnish compound <b>36</b> in good yield and high trans/cis ratio (>20:1). Deprotection of the Boc protecting group using mildly acidic conditions provided compound <b>2</b> with retention of the high <i>E</i>/<i>Z</i> ratio in good overall yield.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/medium/jm-2014-00480k_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/large/jm-2014-00480k_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of (<i>E</i>)-<i>N</i>-(4-((4-Ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-3-(2-(4-methoxy-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-5-yl)vinyl)-4-methylbenzamide <b>2</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/large/jm-2014-00480k_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500480k&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>29</b>, HATU, DMAP, DIEA, CH<sub>2</sub>Cl<sub>2;</sub> (b) NaOMe, MeOH, 60 °C; (c) MePPh<sub>3</sub>I, <i>n</i>-BuLi, THF, −78 °C to rt; (d) (i) TFA, DCM, (ii) LiOH, H<sub>2</sub>O/THF; (e) Boc<sub>2</sub>O, DMAP, CH<sub>2</sub>Cl<sub>2</sub>; (f) <b>32</b>, Pd<sub>2</sub>(dba)<sub>3</sub>, P(<i>t</i>-Bu)<sub>3</sub>, DIEA, 80 °C; (g) TFA/CH<sub>2</sub>Cl<sub>2</sub>, 0 °C.</p></p></figure><div class="NLM_p">Compounds <b>1</b> and <b>2</b> were screened against a diverse panel of over 420 kinases (DiscoveRX, KinomeScan) using an in vitro ATP-site competition binding assay at a concentration of 10 or 1 μM.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> These two compounds exhibited relatively selective profiles, and for some kinases known to accommodate a type II binding mode, e.g., p38α and ABL, both compounds exhibited potent inhibition. In addition, they also exhibited promising inhibition against several other kinases known to play important roles in cancer-related signaling pathways but whose functions remain uncharacterized because of a lack of highly selective inhibitors, e.g., TAK1, MAP4K2, and EPHA2. To complement the KinomeScan profiling, both compounds were further profiled at 5 and 0.5 μM concentrations on A375 melanoma cells utilizing the KiNativ technology (ActiveX Biosciences).<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19, 20)</a> This live-cell-treatment approach measures the ability of the compounds to protect a subset of kinases in lysates from labeling with a lysine reactive ATP or ADP-biotin probe. Kinases that exhibited moderate or high inhibition of labeling by compounds <b>1</b> and <b>2</b> are listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> (see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for full profiling data). Consistent with the KinomeScan data, at a concentration of 0.5 μM, both compounds inhibited TAK1, MAP4K2, ZAK, p38α, SRC, and LYN while compound <b>1</b> also inhibited FER and compound <b>2</b> inhibited CSK and EPH-family kinases, respectively. To confirm the observed binding of <b>1</b> and <b>2</b> to TAK1 and MAP4K2 by the KiNativ approach, we determined the IC<sub>50</sub> values using biochemical enzyme assays (Invitrogen, SelectScreen).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Compounds <b>1</b> and <b>2</b> inhibited TAK1 with IC<sub>50</sub> values of 149 and 41 nM, respectively, and inhibited MAP4K2 with IC<sub>50</sub> values of 22 and 98 nM respectively. The in vitro IC<sub>50</sub> values of most other targets from KiNativ profiling were also determined and some of them were further confirmed while others were not (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Compound <b>1</b> was also screened at 0.1 μM against another panel of over 100 protein kinases (International Centre for Kinase Profiling, <a href="http://www.kinase-screen.mrc.ac.uk/" class="extLink">http://www.kinase-screen.mrc.ac.uk/</a>) and gave similar results (<a class="ref internalNav" href="#notes-1" aria-label="Figure S1 in Supporting Information">Figure S1 in Supporting Information</a>); the IC<sub>50</sub> values against TAK1 and MAP4K2 were 15 and 17 nM, respectively, in that assay.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Kinase Hits for <b>1</b> and <b>2</b><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/medium/jm-2014-00480k_0007.gif" alt="" id="GRAPHIC-d1910e859-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Footnotes: *ACT = activation loop; Lys1 = conserved Lysine 1; Lys2 = conserved lysine 2; other = labeling of residue outside the protein kinase domain, possibly not in ATP binding site. **A375 live cell were treated with <b>1</b> and <b>2</b> in 5 and 0.5 μM, lysed, and probe-labeled. ***The enzymatic assays were using the SelectScreen kinase profiling service.</p></div></div><div></div></div><div class="NLM_p">To further explore the potential of <b>1</b> and <b>2</b> to be optimized for potency and selectivity against these kinases, we synthesized 24 diverse analogues (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). To approach this optimization in a systematic fashion, this chemotype was divided into three sections: head, linker, and tail. Each of these units was varied sequentially. The head unit was altered from pyrrolopyridin-4-yl in <b>1</b> to pyrrolopyrimidin-4-yl (e.g., <b>3</b>, <b>13</b>) and substituted pyrimidin-4-yls (e.g., <b>6</b>, <b>7</b>); however, analogues of lead compound <b>2</b> contained the original head unit. The linker unit was varied through deletion of the methyl group (e.g., <b>10</b>, <b>24</b>), reversing the amide orientation (<b>11</b>, <b>22</b>) and altering the alkene in compound <b>2</b> via saturation (<b>14</b>) or replacement with an ether linkage (<b>15</b>). The tail unit contained various hydrophilic groups instead of the 4-ethylpiperazin-1-yl moiety, along with variations of the substitution site from the 4-position to the 3-position. These changes resulted in minor variation to the syntheses with most analogues being prepared via similar routes and in high yields.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Structures of All Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/medium/jm-2014-00480k_0008.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">structure</th><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">structure</th><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">structure</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">A-J-S</td><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">A-K-S</td><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">I-M-W</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">I-M-S</td><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">A-L-S</td><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">I-M-X</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">B-J-S</td><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">A-J-T</td><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">I-N-T</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">C-J-S</td><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">B-J-U</td><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">I-P-S</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">D-J-S</td><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">I-N-S</td><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">I-Q-S</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">E-J-S</td><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">I-O-S</td><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">I-R-S</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">F-J-S</td><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">E-J-T</td><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">I-N-Y</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">G-J-S</td><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">E-J-U</td><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">I-M-Z</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">H-J-S</td><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">I-M-V</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div></div><div class="NLM_p">All of the prepared analogues were subjected to KiNativ profiling using HUH7 cell lysates which typically detects approximately 150 protein and lipid kinases of interest. This profiling effort revealed that this class of compounds in general provide good multitargeted scaffolds that can bind to TAK1, MAP4K2, p38α, Abl, ZAK, CSK, FER, FES, and EPHA2 with varying degrees of potency and selectivity. Herein we primarily focus our discussion on how the structural changes affected the ability of the compounds to inhibit TAK1 and MAP4K2 kinases (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). With compound <b>1</b>, we first changed the head from 1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-4-yl to 7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl (<b>3</b>) and 1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-yl (<b>4</b>) and found that the activities against MAP4K2 were maintained while those against TAK1 were clearly improved. However, the addition of a methyl group at the 6-position of the 7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl moiety (<b>5</b>) led to more potent inhibition of MAP4K2 and a decreased potency toward TAK1. We next introduced the monocyclic head units 6-(methylamino)pyrimidin-4-yl (<b>6</b>) and 2-(methylamino)pyrimidin-4-yl (<b>7</b>); <b>6</b> exhibited more potent inhibition of MAP4K2 and decreased potency against TAK1, and <b>7</b> showed slightly decreased activities. To our surprise, the introduction of a 6,7-dimethoxyquinazolin-4-yl head unit (<b>8</b>) yielded potent activity against both kinases while introduction of 4-substituted <i>N</i>-methylpicolinamide (<b>9</b>) eliminated both TAK1 and MAP4K2 potency. We then varied the linker region and found that deletion of the methyl group (<b>10</b>) had little impact on activity while other modifications only led to loss of activity (<b>11</b>). We next investigated the effect of a variety of tail units and found that all changes led to a decrease in activity against both kinases. However, substitution at the 3-position of the aromatic ring in the tail unit with 4-methyl-1<i>H</i>-imidazol-1-yl (<b>12</b>) and 4-methylpiperazin-1-yl (<b>13</b>) led to only a slight decrease in activity against MAP4K2 but almost complete elimination of TAK1 activity. All analogues of compound <b>2</b> generally showed reduced activity against both kinases, with the exception of <b>14</b>, which showed similar activity, and <b>15</b>, which exhibited a slight decrease in activity against TAK1.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR for TAK1 and MAP4K2<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/medium/jm-2014-00480k_0009.gif" alt="" id="GRAPHIC-d1910e1290-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">Footnote: *<b>1</b> and <b>2</b> were profiled at 0.5 μM on A375 live cell, while all others were at 1.0 μM on HUH7 lysate.</p></div></div><div></div></div><div class="NLM_p">These results indicated that modification of the head unit can improve activity against both kinases, although in most cases more dramatically for MAP4K2 with the exception of <b>8</b>. Alteration of the linker unit had little or even negative effect against MAP4K2 and TAK1, while changes in the tail unit always decreased activity against both kinases, although this reduction was small for MAP4K2 but significant for TAK1. These data prompted us to prepare compound <b>16</b>, which combined the head of <b>6</b> and the tail of <b>12</b> and maintained the original linker of <b>1</b> and exhibited similar inhibitory activity for MAP4K2 compared to <b>12</b>. Further modification of the tail of <b>16</b> led to <b>17</b> which exhibited good biochemical selectivity for inhibiting MAP4K2 relative to TAK1 (37 and 2700 nM IC<sub>50</sub> values), along with best KiNativ score for MAP4K2 (85% at 1 μM). The results of KiNativ profiling using HUH7 cell lysates showed that only MAP4K2 and ABL among 220 protein and lipid kinases of interest were inhibited by <b>17</b> (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information Table 3">Supporting Information Table 3</a>), and the inhibition of ABL was rather weak compared with MAP4K2 (49% compared with 85% at 1 μM). Furthermore, the weak inhibition of p38α and ZAK of <b>16</b> was eliminated with <b>17</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). <b>17</b> was also subjected to KiNativ live-cell profiling using HUH7 cells, and strong inhibition of MAP4K2 (88% at 1 μM) labeling was observed suggesting that <b>17</b> is a potent and relatively selective cellular MAP4K2 inhibitor (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information Table 4">Supporting Information Table 4</a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Kinase Selectivity of <b>16</b> and <b>17</b><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/medium/jm-2014-00480k_0010.gif" alt="" id="GRAPHIC-d1910e1370-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">Footnotes: *ACT = activation loop; Lys1 = conserved lysine 1; Lys2 = conserved lysine 2; other = labeling of residue outside the protein kinase domain, possibly not in ATP binding site. **<b>16</b> and <b>17</b> were profiled at 1.0 μM on HUH7 lysate.</p></div></div><div></div></div><div class="NLM_p">To further understand the SAR of TAK1/MAP4K2 inhibitors, we solved cocrystal X-ray structures of TAK1 in complex with <b>1</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O91">4O91</a>). X-ray diffraction extended to 2.4 Å, and the structure was solved using molecular replacement with PDB compound <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2YIY">2YIY</a> as the initial search model. Examination of the active site revealed strong additional electron density into which <b>1</b> was easily modeled (<a class="ref internalNav" href="#notes-1" aria-label="Figure S2A">Figure S2A</a>). Final statistics for diffraction and the model are given in <a class="ref internalNav" href="#notes-1" aria-label="Table S1">Table S1</a>. Interactions with the active site residues are schematically depicted in <a class="ref internalNav" href="#notes-1" aria-label="Figure S2B">Figure S2B</a>. In summary, the nitrogens in the pyrrolopyridine moiety form hydrogen bonds with Ala107 in the hinge binding region. The linker amide is stabilized inside the deeper binding pocket by hydrogen-bonding with Glu77 and the backbone amide of Asp175. These observations further explain why the reversal of the amide (<b>11</b>) resulted in a loss of activity. The nitrogen of the tertiary amine in the piperazinyl tail interacts with carbonyls of Ile153 and His154 on the activation loop (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>c). Compared with the structure of adenosine bound to the active site of TAK1 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2EVA">2EVA</a>) which shows DFG in the active, flipped-in conformation (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>b), binding of <b>1</b> with TAK1 results in an inactive, DFG-out conformation characteristic of type II inhibitors (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>a).</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/medium/jm-2014-00480k_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/large/jm-2014-00480k_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Compound <b>1</b> is a type II inhibitor. (a) Binding of <b>1</b> to the active site of TAK1–TAB1 results in the DFG-out conformation characterized by type II inhibitors. (b) The structure of adenosine bound to the active site of TAK1–TAB1 (PDBID 2EVA) is provided for comparison and shows the DFG-in conformation. The DFG motif is highlighted in red. (c) Key interactions of <b>1</b> with TAK1. (d) Molecular model of the binding mode of MAP4K2 with <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/large/jm-2014-00480k_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500480k&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Simulated docking studies using MAP4K2 as the receptor resulted in a similar overall inhibitor pose relative to the TAK1/<b>1</b> cocomplex structure. However, the long side chain of Gln80 in the C-helix of TAK1 is located very close to the tail of <b>1</b> with only 3.6 Å distance between the carbonyl of Gln80 side chain and the 5-position of 3-trifluormethylphenyl group, whereas the shorter side chain of Ile64 in MAP4K2 is not so proximate in the MAP4K2/<b>1</b> modeling. Substitutions at the 5-position of 3-trifluormethylphenyl group may be too bulky for the side chain of Gln80 of TAK1, whereas they could possibly interact with the side chains of Ile64 and Gln60 of MAP4K2. This potential interaction might compensate for the loss of interactions with the two carbonyls of Ile133 and His134, providing a rationale for why <b>12</b>, <b>16</b>, and <b>17</b> exhibit a preference for binding to MAP4K2 (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>c,d).</div><div class="NLM_p">Many of our compounds also exhibited potent inhibition of p38α; the data from KiNativ and enzymatic assays are shown in <a class="ref internalNav" href="#notes-1" aria-label="Table S2">Table S2</a>. Analogues of <b>1</b> that contained the same linker and tail as <b>1</b> were all active against p38α (<b>3</b>–<b>9</b>), with <b>4</b> being the most potent and <b>9</b> being inactive against TAK1 and MAP4K2. These results indicated that modification of the head unit was tolerated on this scaffold. We were also surprised to find that reversing the amide connectivity of <b>1</b> afforded a very selective p38α inhibitor (<b>11</b>). To prepare analogues of compound <b>2</b>, we first explored different tail units and found several compounds with potent activity against p38α (<b>18</b>–<b>20</b>), with <b>19</b> being the most selective. Modifications of the linker unit, as in compounds <b>14</b> and <b>15</b>, were also tolerated, and these changes sometimes led to potent activity in compounds with tail units that had previously demonstrated poor activity (i.e., <b>21</b>, IC<sub>50</sub> < 10 nM). Similarly, the reversed amide connectivity (<b>22</b>) retained potent activity when the methyl of the linker was deleted. In sharp contrast, its analogues with the original amide connectivity (<b>23</b>, <b>24</b>) were inactive against p38α.</div><div class="NLM_p">Many of the compounds exhibited potent binding activity against ABL kinase which is known to be potently inhibited by type II inhibitors such as imatinib and nilotinib. To evaluate whether these new compounds could inhibit ABL activity in a cellular context, they were evaluated for their antiproliferative activity against BCR-ABL-dependent Ba/F3 cells (<a class="ref internalNav" href="#notes-1" aria-label="Table S3">Table S3</a>). To evaluate their potential for nonspecific cytotoxicity, they were also evaluated against parental Ba/F3 cells grown in the presence of interleukin 3. The results demonstrated that many of our compounds selectively inhibited the proliferation of BCR-ABL-dependent Ba/F3 cells with EC<sub>50</sub> values of less than 400 nM. Several compounds (e.g., <b>2</b>, <b>10</b>) exhibited more than 50% cell growth inhibition at 10 nM, with analogues of <b>2</b> generally being the most active. These compounds exhibited comparable cellular potency to clinically approved second-generation BCR-ABL inhibitors such as nilotinib and dasatinib. Replacement of the (4-ethylpiperazin-1-yl)methyl tail with a 4-ethylpiperazin-1-yl tail (<b>25</b>) provided very selective inhibition against ABL (both enzymatic and cellular); more surprising was that elimination of the trifluoromethyl group afforded a very strong inhibitor with high selectivity (<b>26</b>).</div><div class="NLM_p">Some of our compounds exhibited potent inhibition of a number of additional kinases (<a class="ref internalNav" href="#notes-1" aria-label="Table S4">Table S4</a>). In general, analogues of compound <b>2</b> were more likely to inhibit ZAK, with <b>14</b> being the most active with >96% inhibition at 1 μM (KiNativ) and an IC<sub>50</sub> of 72 nM (SelectScreen). Additionally, compound <b>9</b>, an analogue of <b>1</b>, was very selective against ZAK. Only analogues of <b>2</b> were found to inhibit CSK, with <b>14</b> being the most potent. Compounds <b>2</b> and <b>14</b> exhibited potent activity against EPHA2, although further modification of their scaffolds led to a severe loss of activity. Surprisingly, we found that only analogues of compound <b>1</b> exhibited potency against FES and FER, with the activity of <b>8</b> being very strong (93% and 95% inhibition at 1 μM and IC<sub>50</sub> values of 51 and 36 nM, respectively).</div><div class="NLM_p">To further validate inhibitory activity against TAK1 and MAP4K2 by these inhibitors, we next measured their ability to block the downstream signals induced by different cytokines. First we checked their effect on NF-κB signaling in mouse L929 cells following TNFα stimulation, where we found that most inhibitors with strong TAK1 inhibition in previous assays effectively reduced the phosphorylation level of IKKα/β at 100 nM concentrations. The degradation of IκB-α was also effectively inhibited. The reported irreversible TAK1 inhibitor <b>37</b> (5<i>Z</i>-7-oxozeaenol)<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> was used as positive control, and our lead compounds <b>1</b> and <b>2</b> exhibited comparable cellular potency (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>a). The selective MAP4K2 inhibitors (<b>12</b>, <b>16</b>, and <b>17</b>) and p38α inhibitors <b>11</b>, <b>38</b> (SB203580),<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and <b>39</b> (PH-797804)<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> were also tested and demonstrated no effect at the same concentrations (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>b, <a class="ref internalNav" href="#notes-1" aria-label="Figure S3B">Figure S3B</a>). The most selective MAP4K2 inhibitor <b>17</b> was not very effective even at concentrations up to 1 μM (<a class="ref internalNav" href="#notes-1" aria-label="Figure S3A">Figure S3A</a>), which suggested that MAP4K2 does not contribute much to this pathway under these conditions.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/medium/jm-2014-00480k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/large/jm-2014-00480k_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Evaluation of the ability of compounds to block TNFα-induced phosphorylation of IKKα/β and stabilize IκB-α in L929 cells. L929 cells were pretreated with indicated (a) TAK1/MAP4K2 inhibitors (<b>1</b>, <b>2</b>, <b>3</b>, <b>4</b>, <b>5</b>, <b>7</b>, <b>10</b>) and covalent TAK1 inhibitor (<b>37</b>), (b) more selective MAP4K2 inhibitors (<b>12</b>, <b>16</b>, <b>17</b>, <b>11</b>) and p38 inhibitor (<b>38</b>) at a concentration of 100 nM for 30 min, and then TNFα was added and incubated for 5 min. Samples were collected and subjected to Western blot. Tubulin was used as a loading control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/large/jm-2014-00480k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500480k&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Next we checked the effect of <b>1</b> in MEFs and human 293 IL-1R cells stimulated with IL-1α and found that the phosphorylation levels of downstream p105, p38, and JNK1/2 were all inhibited in a dose-dependent manner (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>a,b). Similar results were obtained in mouse RAW cells following LPS stimulation (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>c). We also discovered that compound <b>1</b> (1 μM) blocked signaling following stimulation of human Gen2.2 cells with the TLR7 agonist CL097; analogue <b>S1</b> (<a class="ref internalNav" href="#notes-1" aria-label="Figure S4">Figure S4</a>) which possessed moderate TAK1 and MAP4K2 inhibitory activity (IC<sub>50</sub> values of 292 and 296 nM, respectively) only partially inhibited signaling. The selective MAP4K2 inhibitor <b>16</b> was not able to block CL097 induced signaling (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>d).</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/medium/jm-2014-00480k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/large/jm-2014-00480k_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Evaluation of the ability of compounds to inhibit IL-1α, LPS, or CL097-induced phosphorylation of p105, p38, and JNK in several cell types. (a–c) 293 IL-1R, MEFs, and RAW cells were pretreated with <b>1</b> at different concentrations for 1 h and then stimulated with IL-1α or LPS for 30 min. Samples were collected and subjected to Western blot for phosphorylation of p105, p38, JNK1/2, and total p38. (d) Gen2.2 cells were pretreated with <b>1</b>, <b>S1</b>, and <b>16</b> at 1 μM for 1 h and then stimulated with CL097 for 30 min. Samples were collected and subjected to Western blot.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/large/jm-2014-00480k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500480k&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">It was more challenging to validate the functional cellular consequences of MAP4K2 inhibition, since the effector pathways of this kinase are less well characterized. TAK1 mediates much of the IL-1-induced phosphorylation of p38,<a onclick="showRef(event, 'ref10 ref25'); return false;" href="javascript:void(0);" class="ref ref10 ref25">(10, 25)</a> although recent reports suggest that TAK1 does not mediate TGFβ-induced phosphorylation of p38 in TAK1-null MEFs and HaCaT cells.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> A siRNA-based screen targeting all MAP3Ks individually in HaCaT cells suggested roles for MAP3K4 and MAP3K10 in mediating TGFβ-induced phosphorylation of p38.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> A similar siRNA screen targeting MAP4Ks in HaCaT cells demonstrated that depletion of MAP4K2 but not MAP4Ks 1, 3, and 5 resulted in substantial inhibition of both IL-1 and TGFβ-induced phosphorylation of p38, while TGFβ-induced phosphorylation of SMAD2 was unaffected (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>a). Cumulatively these studies suggest a possible role for MAP4K2 in IL-1 and TGFβ-induced phosphorylation of p38. We therefore tested the ability of our selective MAP4K2 inhibitors <b>16</b> and <b>17</b> to inhibit IL-1 and TGFβ induced phosphorylation of p38 MAPK in WT and TAK1-deficient MEFs. Both <b>16</b> and <b>17</b> caused a dose-dependent inhibition of IL-1 and TGFβ-induced p38 MAPK phosphorylation but did not inhibit the TGFβ-induced phosphorylation of SMAD2 (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>b). Consistent with the primary role of TAK1 in mediating IL-1 signaling, in WT MEFs, <b>16</b> and <b>17</b> caused ∼50% inhibition in IL-1-induced phosphorylation of p38 at 500 nM (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>b). However, in TAK1-deficient MEFs, both <b>16</b> and <b>17</b> resulted in complete inhibition of IL-1-induced phosphorylation of p38 at 500 nM, suggesting that MAP4K2 may mediate the residual IL-1-dependent but TAK1-independent phosphorylation of p38 (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>b). The dose-dependent inhibition of TGFβ-induced phosphorylation of p38 by <b>16</b> and <b>17</b> was similar in both WT and TAK1-deficient MEFs, consistent with the notion that TAK1 does not mediate TGFβ-induced phosphorylation of p38 in these cells (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>b). Compound <b>1</b>, a dual inhibitor of TAK1 and MAP4K2, exhibited similar potency to <b>16</b> and <b>17</b> while the covalent natural product TAK1 inhibitor <b>37</b> inhibited phosphorylation of both p38 and SMAD2 at very low concentrations regardless of presence of TAK1, consistent with the observation that TAK1 mediates much of the IL-1-induced phosphorylation of p38 and that <b>37</b> has several additional kinase targets including MEK1 (<a class="ref internalNav" href="#notes-1" aria-label="Figure S5">Figure S5</a>).</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/medium/jm-2014-00480k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/large/jm-2014-00480k_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Evaluation of signaling following depletion of MAP4Ks by siRNA and evaluation of the ability of selective MAP4K2 inhibitors <b>16</b> and <b>17</b> to inhibit signaling in wild-type and TAK1-null MEF cells. (a) HaCaT cells were transfected with pools of four different siRNAs targeted against the indicated MAP4Ks. At 48 h after transfection cells were left untreated or treated with TGFβ or IL-1β prior to lysis and Western blot. (b) Wild type and TAK1-null MEFs cells were pretreated with selective MAP4K2 inhibitor compounds <b>16</b> and <b>17</b> for 1 h, followed by stimulation with TGFβ or IL-1α. Samples were collected and subjected to Western blot.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/large/jm-2014-00480k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500480k&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The pharmacokinetic properties of <b>1</b>–<b>5</b> were also evaluated following intravenous and oral delivery in mice, respectively. Compounds <b>1</b> and <b>5</b> demonstrated favorable pharmacokinetic properties, with <i>T</i><sub>1/2</sub> values of 2.0 and 2.9 h, AUC values of 1369 and 2136 following a 10 mg/kg oral dose, and <i>F</i> values of 70.2% and 38.6%, respectively (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). This suggests that these compounds should be useful for murine efficacy studies.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Pharmacokinetic Parameters of <b>1</b>, <b>2</b>, and Analogues</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">route</th><th class="colsep0 rowsep0" align="center">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>max</sub> (h)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center">AUC<sub>last</sub> (h·ng/mL)</th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center">CL (mL min<sup>–1</sup> kg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center"><i>V</i><sub>ss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center"><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">iv</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">396</td><td class="colsep0 rowsep0" align="left">195</td><td class="colsep0 rowsep0" align="left">2.03</td><td class="colsep0 rowsep0" align="left">80.8</td><td class="colsep0 rowsep0" align="left">11.9</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">316</td><td class="colsep0 rowsep0" align="left">1369</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">70.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">iv</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">47.1</td><td class="colsep0 rowsep0" align="left">403</td><td class="colsep0 rowsep0" align="left">4.66</td><td class="colsep0 rowsep0" align="left">55.4</td><td class="colsep0 rowsep0" align="left">14.2</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">4.0</td><td class="colsep0 rowsep0" align="left">163</td><td class="colsep0 rowsep0" align="left">295</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">13.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">iv</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">230.9</td><td class="colsep0 rowsep0" align="left">236.6</td><td class="colsep0 rowsep0" align="left">2.33</td><td class="colsep0 rowsep0" align="left">65.8</td><td class="colsep0 rowsep0" align="left">9.5</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">133.6</td><td class="colsep0 rowsep0" align="left">516.2</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">21.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">iv</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">280.3</td><td class="colsep0 rowsep0" align="left">167.9</td><td class="colsep0 rowsep0" align="left">0.87</td><td class="colsep0 rowsep0" align="left">99.2</td><td class="colsep0 rowsep0" align="left">6.1</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">61.3</td><td class="colsep0 rowsep0" align="left">186.2</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">11.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">iv</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">317</td><td class="colsep0 rowsep0" align="left">554</td><td class="colsep0 rowsep0" align="left">2.94</td><td class="colsep0 rowsep0" align="left">26.5</td><td class="colsep0 rowsep0" align="left">5.42</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">4.0</td><td class="colsep0 rowsep0" align="left">233</td><td class="colsep0 rowsep0" align="left">2136</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">38.6</td></tr></tbody></table></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43676" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43676" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In conclusion, compounds <b>1</b> and <b>2</b>, along with their analogues, represent two novel “type II” kinase inhibitor scaffolds discovered using a kinome-wide profiling approach and exhibit diverse activities against a limited set of kinase targets. Among these compounds, <b>1</b> was especially interesting as a very potent TAK1 inhibitor and has already been used in some studies,<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> and <b>2</b> is also being utilized in cancer studies because of its potent antiproliferative effects against particular tumor types. Profiling of these type II inhibitors reveals that a subset of the compounds also are capable of potently inhibiting LCK, ABL, p38α, etc., and this needs to be considered when using them to interrogate TAK1 and MAP4K2 dependent effects. As for application of TAK1 inhibitors, the most commonly used probe nowadays is <b>37</b>, which is not a selective inhibitor. <b>37</b> strongly inhibits MAP2Ks and MAPKs such as MEK1 (MAP2K1) and ERK1 (MAPK1) and many other targets such as KDR, PDGFR, ZAK, etc. Moreover, the binding to several of these targets is covalent, and it is likely that other reactive cysteines can be targeted by this compound intracellularly.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Compound <b>1</b> provides a complementary pharmacological probe of TAK1 relative to <b>37</b> due to its distinct chemical structure, nonoverlapping off-target pharmacology, and reversible mode of inhibition. The cocrystal structure of TAK1/<b>1</b> has helped in rationalizing the SAR and will be used to design type II TAK1 inhibitors in the future. Meanwhile <b>16</b> and <b>17</b> represent relatively selective MAP4K2 inhibitors; compound <b>17</b> especially exhibits impressive selectivity and excellent potency in cellular assays. <b>11</b> is a selective p38α inhibitor; both <b>25</b> and <b>26</b> are selective ABL inhibitors. By modification of the tail moiety, these inhibitors (<b>11</b>, <b>17</b>, and <b>26</b>, etc.) can specifically interact with the allosteric DFG-pockets, which may provide a means of achieving selectivity among otherwise highly homologous kinases. The cocrystal structure of TAK1/<b>1</b> reveals that Gln80 is proximal (3.6 Å) from the phenyl ring of the benzamide “tail” moiety, which suggests that a unique H-bond may be able to be introduced in this region to gain selectivity for TAK1. Finally, given their wide diversity with respective kinase selectivity, enzymatic and cellular potency, and favorable pharmacokinetic parameters, 4-substituted 1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridines may represent privileged scaffolds for the development of therapeutic agents targeting various kinases.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37078" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37078" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Chemistry</h3><div class="NLM_p last">Unless otherwise noted, reagents and solvents were obtained from commercial suppliers and were used without further purification. <sup>1</sup>H NMR spectra were recorded on a 400 MHz (Varian 7600 AS) or 600 MHz (Varian Inova) instrument, and chemical shifts are reported in parts per million (ppm, δ) downfield from tetramethylsilane (TMS). Coupling constants (<i>J</i>) are reported in Hz. Spin multiplicities are described as s (singlet), brs (broad singlet), t (triplet), q (quartet), and m (multiplet). Mass spectra were obtained on a Waters Micromass ZQ instrument. Preparative HPLC was performed on a Waters Symmetry C18 column (19 mm × 50 mm, 5 μm) using a gradient of 5–95% acetonitrile in water containing 0.05% trifluoroacetic acid (TFA) over 8 min (10 min run time) at a flow rate of 30 mL/min. Purification of compounds was performed with either a Teledyne ISCO CombiFlash Rf system or a Waters Micromass ZQ preparative system. Purities of assayed compounds were in all cases greater than 95%, as determined by reverse-phase HPLC analysis.</div></div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> 4-Methyl-3-((1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)oxy)benzoic Acid (<b>28</b>)</h3><div class="NLM_p last">To a stirred solution of <b>27</b> (570 mg, 2 mmol) and 3-hydroxy-4-methylbenzoic acid (340 mg, 2.2 mmol) in 13 mL of DMSO was added K<sub>2</sub>CO<sub>3</sub> (830 mg, 6 mmol). The reaction mixture was allowed to stand for 5 h at 100 °C and then cooled to room temperature. The mixture was acidified with 1 N HCl solution and extracted with ethyl acetate. The organic phase was washed with brine and dried over Na<sub>2</sub>SO<sub>4</sub>, then filtered and evaporated to give a pale yellow liquid (690 mg, 80%). To a stirred solution of this gained liquid (690 mg, 1.6 mmol) in 10 mL of methanol was added Pd/C (10 wt % loading, 120 mg). The reaction mixture was stirred under hydrogen atmosphere for 2 or 3 days. The reaction was monitored by TLC, and more Pd/C might be needed for complete conversion during the period. Then the reaction solution was filtered, concentrated, and purified with column chromatography (hexane/ethyl acetate = 1:1) to give the title compound as a white solid (510 mg, 80%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.30 (d, <i>J</i> = 5.6 Hz, 1H), 8.02 (d, <i>J</i> = 8.0 Hz, 1H), 7.90 (s, 1H), 7.48 (d, <i>J</i> = 8.0 Hz, 1H), 7.33 (d, <i>J</i> = 3.6 Hz, 1H), 6.52 (d, <i>J</i> = 3.6, 1H), 6.44 (d, <i>J</i> = 5.6, 1H), 5.78 (s, 2H), 3.65 (t, <i>J</i> = 8.0 Hz, 2H), 2.37 (s, 3H), 0.99 (t, <i>J</i> = 8.0 Hz, 2H), 0.00 (s, 9H). MS (ESI) <i>m</i>/<i>z</i> 399 (M + H)<sup>+</sup>.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> <i>N</i>-(4-((4-Ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-4-methyl-3-((1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)oxy)benzamide (<b>30</b>)</h3><div class="NLM_p last">To a stirred solution of <b>28</b> (400 mg, 1 mmol) and aniline <b>29</b> (430 mg, 1.5 mmol) in 10 mL of dichloromethane were added HATU (570 mg, 1.5 mmol), DMAP (185 mg, 1.5 mmol), and DIEA (520 μL, 3 mmol). The reaction mixture was allowed to stand for 24 h at room temperature, then diluted with ethyl acetate and washed with water and brine. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, then concentrated and purified with column chromatography (dichloromethane/methanol = 20:1) to give the title compound as a colorless oil (600 mg, 90%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.21 (s, 1H), 8.12 (d, <i>J</i> = 5.6 Hz, 1H), 7.91 (d, <i>J</i> = 8.0 Hz, 1H), 7.74–7.68 (m, 2H), 7.69 (s, 1H), 7.41 (d, <i>J</i> = 8.0 Hz, 1H), 7.22 (d, <i>J</i> = 3.6, 1H), 6.37 (d, <i>J</i> = 3.6, 1H), 6.33 (d, <i>J</i> = 5.6, 1H), 5.64 (s, 2H), 3.61 (s, 2H), 3.55 (t, <i>J</i> = 8.0 Hz, 2H), 2.65–2.40 (m, 8H), 2.50 (q, <i>J</i> = 6.8 Hz, 2H), 2.28 (s, 3H), 1.24 (t, <i>J</i> = 6.8 Hz, 3H), 0.90 (t, <i>J</i> = 8.0 Hz, 2H), −0.08 (s, 9H). MS (ESI) <i>m</i>/<i>z</i> 668 (M + H)<sup>+</sup>.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> 3-((1<i>H</i>-Pyrrolo[2,3-<i>b</i>]pyridin-4-yl)oxy)-<i>N</i>-(4-((4-ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-4-methylbenzamide (<b>1</b>)</h3><div class="NLM_p last">To a stirred ice-cooled solution of <b>30</b> (330 mg, 0.5 mmol) in 5 mL of dichloromethane was added 1 mL of TFA. The reaction mixture was stirred for 30 min at 0 °C and then warmed to room temperature. After 5 h the reaction mixture was concentrated and dried under vacuum, then dissolved in 5 mL of THF, and 5 mL of 1 N NaOH water solution was added. The reaction mixture was stirred for 24 h and extracted with ethyl acetate. The combined organic phase was washed with brine and dried with Na<sub>2</sub>SO<sub>4</sub>, then filtered and concentrated and purified with column chromatography (dichloromethane/methanol = 10:1) to give the title compound as a white solid (188 mg, 70%). <sup>1</sup>H NMR (400 MHz, DMSO) δ 11.78 (bs, 1H), 10.44 (s, 1H), 8.16 (d, <i>J</i> = 2.4 Hz, 1H), 8.09 (d, <i>J</i> = 5.6 Hz, 1H), 8.02 (dd, <i>J</i> = 8.4, 1.6 Hz, 1H), 7.88 (dd, <i>J</i> = 8.0, 2.0 Hz, 1H), 7.78 (d, <i>J</i> = 2.0 Hz, 1H), 7.69 (d, <i>J</i> = 8.8 Hz, 1H), 7.58 (d, <i>J</i> = 8.0 Hz, 1H), 7.38 (dd, <i>J</i> = 3.2, 2.8, 1H), 6.32 (d, <i>J</i> = 5.6, 1H), 6.21 (dd, <i>J</i> = 3.2, 2.0 Hz, 1H), 3.56 (s, 2H), 2.52–2.30 (m, 8H), 2.50 (q, <i>J</i> = 7.2 Hz, 2H), 2.24 (s, 3H), 1.00 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (100 MHz, DMSO) δ 164.83, 157.26, 152.90, 151.59, 144.78, 138.50, 134.90, 134.11, 132.48, 132.21, 131.61, 125.31, 125.25, 124.04, 120.62, 117.80, 117.74, 110.13, 101.78, 97.24, 57.81, 52.97, 52.66, 51.94, 16.17, 12.18. MS (ESI) <i>m</i>/<i>z</i> 538 (M + H)<sup>+</sup>.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> <i>N</i>-(4-((4-Ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-3-iodo-4-methylbenzamide (<b>32</b>)</h3><div class="NLM_p last">To a stirred solution of 3-iodo-4-methylbenzoic acid <b>31</b> (262 mg, 1 mmol) and aniline <b>29</b> (430 mg, 1.5 mmol) in 10 mL of dichloromethane were added HATU (570 mg, 1.5 mmol), DMAP (185 mg, 1.5 mmol), and DIEA (520 μL, 3 mmol). The reaction mixture was allowed to stand for 24 h at room temperature, then diluted with ethyl acetate and washed with water and brine. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, then concentrated and purified with column chromatography (dichloromethane/methanol 20:1) to give the title compound as a yellow solid (480 mg, 90%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.35 (br, 1H), 8.33 (s, 1H), 7.91 (m, 2H), 7.80 (d, <i>J</i> = 8.4 Hz, 1H), 7.63 (d, <i>J</i> = 9.0, 1H), 7.32 (d, <i>J</i> = 8.4 Hz, 1H), 3.66 (s, 2H), 3.00–2.58 (m, 8H), 2.71 (m, 2H), 2.48 (s, 3H), 1.26 (t, <i>J</i> = 7.2 Hz, 3H). MS (ESI) <i>m</i>/<i>z</i> 532 (M + H)<sup>+</sup>.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> 4-Methoxy-1-((2-(trimethylsilyl)ethoxy)methyl)-5-vinyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>34</b>)</h3><div class="NLM_p last">To a stirred solution of <b>33</b> (400 mg, 1.20 mmol) in MeOH (4 mL) was added sodium methoxide (348 mg, 6.43 mmol). The mixture was stirred at 70 °C for 5 h before being cooled to room temperature and filtered through a Celite pad. The filtrate was concentrated under reduced pressure and partitioned between ethyl acetate and water. The aqueous layer was extracted with ethyl acetate three times. The combined organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo. The residue was used for the next step without purification. To a stirred solution of methyltriphenylphosphonium iodide (923 mg, 2.28 mmol) in THF (10 mL) was added <i>n</i>-butyllithium (2.5 M in hexane, 0.822 mL, 2.056 mmol) at −78 °C. After 30 min, the reaction mixture was slowly treated with the obtained residue in THF (5 mL) at −78 °C and stirred for 2 h at −78 °C before being quenched with saturated ammonium chloride solution. The reaction mixture was extracted with ethyl acetate three times, and the combined organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, then concentrated and purified with column chromatography (hexane/ethyl acetate = 3:1) to give title compound as a colorless oil (208 mg, 57% in two steps). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.38 (s, 1H), 7.22 (m, 1H), 6.97 (m, 1H), 6.74 (m, 1H), 5.77–5.50 (m, 1H), 5.25 (m, 1H), 4.33 (s, 3H), 3.55 (m, 2H), 0.90 (m, 2H), −0.06 (s, 9H). MS (ESI) <i>m</i>/<i>z</i> 305 (M + H)<sup>+</sup>.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> <i>tert</i>-Butyl 4-Methoxy-5-vinyl-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-1-carboxylate (<b>35</b>)</h3><div class="NLM_p last">To <b>34</b> (140 mg, 0.46 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) was added TFA (0.5 mL) at 0 °C. The reaction mixture was stirred for 30 min at 0 °C and then warmed to room temperature. After 5 h, the reaction mixture was concentrated in vacuo, then dissolved in 5 mL of THF and treated with 5 mL of 1 N NaOH. The reaction mixture was stirred for 24 h and extracted with ethyl acetate. The combined organic phase was washed with brine and dried with Na<sub>2</sub>SO<sub>4</sub>, then filtered and concentrated in vacuo. The residue was then dissolved in 5 mL of CH<sub>2</sub>Cl<sub>2</sub> and treated with Boc<sub>2</sub>O (200 mg, 0.92 mmol) and DIEA (240 μL, 1.38 mmol). The reaction mixture was stirred for 24 h and extracted with ethyl acetate, and the combined organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, then concentrated and purified with column chromatography (hexane/ethyl acetate = 2:1) to give the title compound as a white solid (100 mg, 80% in two steps). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.63 (s, 1H), 7.54 (m, 1H), 6.94 (m, 1H), 6.76 (m, 1H), 5.81 (m, 2H), 5.36 (m, 1H), 4.31 (s, 3H), 1.69 (s, 9H). MS (ESI) <i>m</i>/<i>z</i> 275 (M + H)<sup>+</sup>.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> (<i>E</i>)-<i>tert</i>-Butyl 5-(5-((4-((4-Ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)carbamoyl)-2-methylstyryl)-4-methoxy-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-1-carboxylate (<b>36</b>)</h3><div class="NLM_p last">To the mixture of <b>32</b> (58 mg, 0.110 mmol), <b>35</b> (32 mg, 0.116 mmol), DIEA (480 μL, 0.275 mmol), and tri-<i>tert</i>-butylphosphine (1.0 M in toluene, 11 μL, 0.022 mmol) was added Pd<sub>2</sub>(dba)<sub>3</sub> (10 mg, 0.011 mmol) at room temperature. The reaction mixture was degassed and stirred under Ar atmosphere at 80 °C for 15 h before being cooled to room temperature, then filtered and concentrated. The residue was purified with column chromatography (dichloromethane/methanol 20:1) to give the titled compound as a white solid (60 mg, 80%, <i>E</i>/<i>Z</i> > 20:1). <sup>1</sup>H NMR (600 MHz, DMSO) δ 8.50 (s, 1H), 8.49 (s, 1H), 8.13 (s, 1H), 7.97 (s, 1H), 7.90 (d, <i>J</i> = 8.4, 1H), 7.71 (d, <i>J</i> = 7.8, 1H), 7.64 (d, (d, <i>J</i> = 8.4, 1H), 7.50 (d, (d, <i>J</i> = 4.2, 1H), 7.30 (d, <i>J</i> = 16.8, 1H), 7.26 (d, <i>J</i> = 16.8, 1H), 7.20 (d, <i>J</i> = 7.8, 1H), 6.71 (d, <i>J</i> = 4.2, 1H), 4.24 (s, 3H), 3.58 (s, 2H), 2.55 (m, 4H), 2.49 (q, <i>J</i> = 7.2, 2H), 2.41 (s, 3H), 2.16 (m, 2H), 1.89 (m, 2H), 1.63 (s, 9H), 1.11 (t, <i>J</i> = 7.2, 3H). MS (ESI) <i>m</i>/<i>z</i> 678 (M + H)<sup>+</sup>.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> (<i>E</i>)-<i>N</i>-(4-((4-Ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-3-(2-(4-methoxy-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-5-yl)vinyl)-4-methylbenzamide (<b>2</b>)</h3><div class="NLM_p">To a solution of <b>36</b> (60 mg, 0.088 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) was added TFA (0.2 mL) at 0 °C. The reaction mixture was stirred at 0 °C for 2.5 h, then concentrated and purified with column chromatography (dichloromethane/methanol = 10:1) to give the title compound as a white solid (45 mg, 90%, <i>E</i>/<i>Z</i> > 20:1). <sup>1</sup>H NMR (600 MHz, DMSO) δ 11.73 (s, 1H), 10.52 (s, 1H), 8.50 (s, 1H), 8.23 (d, <i>J</i> = 14.4, 1H), 8.06 (d, <i>J</i> = 8.4, 1H), 7.78 (d, <i>J</i> = 8.4, 1H), 7.72 (d, <i>J</i> = 8.4, 1H), 7.44 (s, 1H), 7.43 (s, 1H), 7.37 (d, <i>J</i> = 13.8, 1H), 7.36 (d, <i>J</i> = 7.2, 1H), 6.82 (m, 1H), 4.35 (s, 3H), 3.56 (s, 2H), 2.60–2.20 (m, 10H), 2.48 (s, 3H), 0.99 (t, <i>J</i> = 7.2, 3H). <sup>13</sup>C NMR (100 MHz, DMSO) δ 166.14, 157.01, 151.66, 143.64, 139.80, 137.41, 132.78, 132.40, 131.64, 130.89, 127.65, 126.59, 125.35, 124.334, 124.22, 124.07, 117.73, 114.16, 108.40, 100.31, 59.52, 57.91, 53.21, 52.80, 52.01, 20.09, 12.38. MS (ESI) <i>m</i>/<i>z</i> 578 (M + H)<sup>+</sup>.</div><div class="NLM_p last">Compounds <b>3</b>–<b>26</b> were synthesized with same procedures as <b>1</b> and <b>2</b>. <b>37</b>–<b>39</b> were commercial from Selleckchem.com.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> TAK1–TAB1 Expression and Purification</h3><div class="NLM_p last">DNA encoding the TAK1–TAB1 fusion protein (kinase domain residues 31–303 and c-terminal domain residues 468–497) was obtained from GeneScript (GenScript USA Inc., 860 Centennial Avenue, Piscataway, NJ 08854, U.S.). This was cloned into the pFastBac His6 TEV LIC cloning vector (4B) (plasmid 30115). TAK1–TAB1 fusion protein was expressed in Hi5 insect cells and purified as described previously.<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27, 28)</a></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> TAK1–TAB1/1 Crystallization and Structure Determination</h3><div class="NLM_p last">TAK1–TAB1 was concentrated to 10 mg/mL and crystallized as reported previously<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> with minor modifications. Briefly, the crystals were obtained using the hanging-drop method at 20 °C in 4 μL drops by mixing protein with equal volumes of reservoir solution [0.65–0.75 M sodium citrate, 0.2 M NaCl, 0.1 M Tris, pH 7.0, and 5 mM adenosine]. The crystals were washed three times in reservoir solution without adenosine. A 10 mM solution of <b>1</b> was prepared, and crystals were back-soaked for ∼8–12 h. Crystals were frozen for data collection using 20% ethylene glycol as cryoprotectant. Diffraction data were collected at Argonne Advanced Photon Source (beamline 19-D) and processed with HKL3000.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The structure was solved by molecular replacement using Phaser,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> with inactive TAK1–TAB1 structures (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2YIY">2YIY</a>) as search model. Coot was used for model building,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> and refinement was carried out using both Phenix, version 1.8.4,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> and Refmac, version 5.8.0049.<a onclick="showRef(event, 'ref18 ref21'); return false;" href="javascript:void(0);" class="ref ref18 ref21">(18, 21)</a> Figures were generated by PyMol (The PyMOL Molecular Graphics System, version 1.6.0.0) and Meastro (version 1.5.014) from Schrödinger, LLC.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Ba/F3 Cell Proliferation Assay</h3><div class="NLM_p last">Compound efficacy against cell proliferation was conducted in 96-well plates. Compounds were added in serial dilutions to cell culture. After 48 h cocultured with compounds, cell viability was measured using CellTiter-Glo (Promega, Wisconsin), and IC<sub>50</sub> values were determined by XLfit4.0 (IDBS).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Cell Culture and Stimulations</h3><div class="NLM_p last">TAK1-deficient (TAK1–/−) and corresponding wild type (WT) mouse embryonic fibroblasts (MEFs) were a generous gift from S. Akira (Osaka University, Japan).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Human keratinocyte (HaCaT) cells and WT and TAK1–/– MEFs were cultured in 10 cm diameter dishes in Dulbecco’s modified Eagle medium supplemented with 10% fetal bovine serum, 1% penicillin/streptomycin mix, and 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine under a humidified atmosphere with 5% CO<sub>2</sub> at 37 °C. In order to knock down the indicated panels of human MAP4Ks, a pool of four siRNA duplexes designed against each target were purchased from Dharmacon (sold as SMARTpool siRNA) and transfected onto HaCaT cells as described previously.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Prior to stimulation with appropriate ligands, cells were cultured in DMEM containing 0.1% FBS for 16 h. Inhibitors were added 1 h prior to stimulation with TGFβ (50 pM, 45 min), human IL-1β (1 μg/mL, 10 min), or mouse IL-1α (5 ng/mL, 10 min). Cells were lysed in 0.5 mL of ice-cold complete lysis buffer (50 mM Tris-HCl, pH7.5, 1 mM EGTA, 1 mM EDTA, 1% Triton X-100, 1 mM sodium orthovanadate, 50 mM sodium flouride, 5 mM sodium pyrophosphate, 0.27 M sucrose, 5 mM β-glycerophosphate, 0.1% (v/v) 2-mercaptoethanol, 0.5 μM microcystin-LR, 1 tablet per 25 mL of complete protease inhibitor cocktail). The extracts were cleared by centrifuging at 16000<i>g</i> at 4 °C for 10 min and processed for Western blot analysis as described previously.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Western Blot</h3><div class="NLM_p last">Cells were harvested in lysis buffer consisting of 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, and 1% Triton X-100, 1 mM EDTA, 1 mM EGTA, and cocktails of protease and phosphatase inhibitors (Sigma-Aldrich, St. Louis, MO). Cell lysates were clarified by centrifugation for 5 min, and the protein concentration of the supernatants was determined using a modified Bradford assay (Bio-Rad, Hercules, CA). For immunoblotting, 20 μg of protein was loaded in each lane and was separated by SDS–PAGE on 4–12% gradient gels (Invitrogen, Carlsbad, CA), transferred to PVDF membranes and detected by immunoblotting with the following primary antibodies. Goat anti-mouse and anti-rabbit secondary antibodies (Santa Cruz Biotechnology, Santa Cruz, CA) conjugated to horseradish peroxidase were used at a 1:3000 dilution, and immunoreactive bands were detected by chemiluminescence (SuperSignal, Pierce, Rockford, IL) and film (Denville Scientific, South Plainfield, NJ).</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> In Vivo Pharmacokinetic Studies</h3><div class="NLM_p last">Male Swiss albino mice were dosed via tail vein (intravenous, solution in 20% w/v hydroxypropyl β-cyclodextrin in 25 mM sodium phosphate buffer, dose 1 mg/kg) or via oral gavage (suspensions in 0.5% w/v Na CMC with 0.1% v/v Tween-80 in water). Blood samples were collected at 0, 0.083 (for iv only), 0.25, 0.5, 1, 2, 4, 6 (for po only), 8, 12, and 24 h for the iv and po groups. The blood samples were collected from sets of three mice at each time point in labeled microcentrifuge tubes containing K<sub>2</sub>EDTA as an anticoagulant. Plasma samples were separated by centrifugation and stored below −70 °C until bioanalysis. All samples were processed for analysis by precipitation using acetonitrile and analyzed with a partially validated LC/MS/MS method (LLOQ, 1.138 ng/mL). Pharmacokinetic parameters were calculated using the noncompartmental analysis tool of WinNonlin Enterprise software (version 5.2).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27"><a href="/doi/suppl/10.1021/jm500480k">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37004" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37004" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Figures S1–S5; structures of <b>37</b>–<b>39</b> (Figure S6); Table S1–S4; structures and spectral data of <b>3</b>–<b>26</b>; Ambit profiling data of <b>1</b> and <b>2</b>; ActiveX profiling data of <b>1</b>, <b>2</b>, and <b>17</b>; KinomeScan profiling data and KiNativ assay data in xlsx format. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm500480k/suppl_file/jm500480k_si_001.pdf">jm500480k_si_001.pdf (894.78 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm500480k/suppl_file/jm500480k_si_002.xlsx">jm500480k_si_002.xlsx (25.8 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm500480k/suppl_file/jm500480k_si_003.xlsx">jm500480k_si_003.xlsx (46.76 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm500480k/suppl_file/jm500480k_si_004.xlsx">jm500480k_si_004.xlsx (190.22 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm500480k/suppl_file/jm500480k_si_005.xlsx">jm500480k_si_005.xlsx (19.87 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm500480k/suppl_file/jm500480k_si_006.xlsx">jm500480k_si_006.xlsx (20.2 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">X-ray coordinates and structure factors have been deposited in the Protein Data Bank, accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O91">4O91</a>.</p><div class="testing" data-doi="10.1021/jm500480k" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78147" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78147" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nathanael S. Gray</span> - <span class="hlFld-Affiliation affiliation">Dana Farber Cancer
Institute, Harvard Medical School, Boston, Massachusetts 02115, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#bcd2ddc8d4ddd2ddd9d0e3dbceddc5fcd8dadfd592d4ddcecaddced892d9d8c9"><span class="__cf_email__" data-cfemail="ddb3bca9b5bcb3bcb8b182baafbca49db9bbbeb4f3b5bcafabbcafb9f3b8b9a8">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Li Tan</span> - <span class="hlFld-Affiliation affiliation">Dana Farber Cancer
Institute, Harvard Medical School, Boston, Massachusetts 02115, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tyzoon Nomanbhoy</span> - <span class="hlFld-Affiliation affiliation">ActivX
Biosciences, La Jolla, California 92037, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Deepak Gurbani</span> - <span class="hlFld-Affiliation affiliation">Departments
of Biochemistry and Radiation Oncology, The University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew Patricelli</span> - <span class="hlFld-Affiliation affiliation">ActivX
Biosciences, La Jolla, California 92037, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Hunter</span> - <span class="hlFld-Affiliation affiliation">Departments
of Biochemistry and Radiation Oncology, The University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jiefei Geng</span> - <span class="hlFld-Affiliation affiliation">Department
of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lina Herhaus</span> - <span class="hlFld-Affiliation affiliation">MRC
Protein
Phosphorylation and Ubiquitylation Unit, College of Life Sciences, University of Dundee, Dow Street, Dundee DD1
5EH, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jianming Zhang</span> - <span class="hlFld-Affiliation affiliation">Dana Farber Cancer
Institute, Harvard Medical School, Boston, Massachusetts 02115, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eduardo Pauls</span> - <span class="hlFld-Affiliation affiliation">MRC
Protein
Phosphorylation and Ubiquitylation Unit, College of Life Sciences, University of Dundee, Dow Street, Dundee DD1
5EH, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Youngjin Ham</span> - <span class="hlFld-Affiliation affiliation">Dana Farber Cancer
Institute, Harvard Medical School, Boston, Massachusetts 02115, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hwan Geun Choi</span> - <span class="hlFld-Affiliation affiliation">Dana Farber Cancer
Institute, Harvard Medical School, Boston, Massachusetts 02115, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ting Xie</span> - <span class="hlFld-Affiliation affiliation">Dana Farber Cancer
Institute, Harvard Medical School, Boston, Massachusetts 02115, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xianming Deng</span> - <span class="hlFld-Affiliation affiliation">Dana Farber Cancer
Institute, Harvard Medical School, Boston, Massachusetts 02115, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sara J. Buhrlage</span> - <span class="hlFld-Affiliation affiliation">Dana Farber Cancer
Institute, Harvard Medical School, Boston, Massachusetts 02115, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Taebo Sim</span> - <span class="hlFld-Affiliation affiliation">Chemical
Kinomics Research Center, Korea Institute
of Science and Technology, 39-1, Hawolgok-dong, Seongbuk-gu, Seoul, 136-791, Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Philip Cohen</span> - <span class="hlFld-Affiliation affiliation">MRC
Protein
Phosphorylation and Ubiquitylation Unit, College of Life Sciences, University of Dundee, Dow Street, Dundee DD1
5EH, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gopal Sapkota</span> - <span class="hlFld-Affiliation affiliation">MRC
Protein
Phosphorylation and Ubiquitylation Unit, College of Life Sciences, University of Dundee, Dow Street, Dundee DD1
5EH, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kenneth D. Westover</span> - <span class="hlFld-Affiliation affiliation">Departments
of Biochemistry and Radiation Oncology, The University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d1910e3014-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85614" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85614" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This study was supported by research funding from NIH Grants CA130876-05 (N.S.G.), HG006097-03 (N.S.G), and CPRIT R1207 (K.D.W.). We thank Diana Tomchick, Zhe Chen, and the staff at the structural biology laboratory at UT Southwestern Medical Center and beamline 19ID for assistance with X-ray data collection and processing. Results shown in this report are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by UChicago Argonne, LLC, for the U.S. Department of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357. The Gen2.2 cells used in this study were generously provided by Dr. Joel Plumas and Dr. Laurence Chaperot. We thank Dr. Ying Li for her suggestions and help for this study.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i30" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i30"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i31" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i31"> Abbreviations Used</h2><tr><td class="NLM_term">TAK1</td><td class="NLM_def"><p class="first last">transforming growth factor β activated kinase 1</p></td></tr><tr><td class="NLM_term">MAP4K2</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase kinase kinase kinase 2</p></td></tr><tr><td class="NLM_term">GCK</td><td class="NLM_def"><p class="first last">germinal center kinase</p></td></tr><tr><td class="NLM_term">NF-κB</td><td class="NLM_def"><p class="first last">nuclear factor κ-light-chain-enhancer of activated B cells</p></td></tr><tr><td class="NLM_term">TGFβ</td><td class="NLM_def"><p class="first last">transforming growth factor β</p></td></tr><tr><td class="NLM_term">IKK</td><td class="NLM_def"><p class="first last">kinase of IκB</p></td></tr><tr><td class="NLM_term">IκB-α</td><td class="NLM_def"><p class="first last">nuclear factor of κ light polypeptide gene enhancer in B-cells inhibitor, α</p></td></tr><tr><td class="NLM_term">JNK</td><td class="NLM_def"><p class="first last">c-Jun N-terminal kinase</p></td></tr><tr><td class="NLM_term">ABL</td><td class="NLM_def"><p class="first last">Abelson murine leukemia viral oncogene homologue 1</p></td></tr><tr><td class="NLM_term">ARG</td><td class="NLM_def"><p class="first last">Abelson-related gene</p></td></tr><tr><td class="NLM_term">BCR</td><td class="NLM_def"><p class="first last">breakpoint cluster region protein</p></td></tr><tr><td class="NLM_term">EPHA2</td><td class="NLM_def"><p class="first last">ephrin type A receptor 2</p></td></tr><tr><td class="NLM_term">SRC</td><td class="NLM_def"><p class="first last">sarcoma</p></td></tr><tr><td class="NLM_term">CSK</td><td class="NLM_def"><p class="first last">C-SRC tyrosine kinase</p></td></tr><tr><td class="NLM_term">FES</td><td class="NLM_def"><p class="first last">feline sarcoma oncogene</p></td></tr><tr><td class="NLM_term">FER</td><td class="NLM_def"><p class="first last">feline sarcoma oncogen related tyrosine kinase</p></td></tr><tr><td class="NLM_term">LYN</td><td class="NLM_def"><p class="first last">tyrosine-protein kinase Lyn</p></td></tr><tr><td class="NLM_term">ZAK</td><td class="NLM_def"><p class="first last">sterile α motif and leucine zipper containing kinase AZK</p></td></tr><tr><td class="NLM_term">TNFα</td><td class="NLM_def"><p class="first last">tumor necrosis factors α</p></td></tr><tr><td class="NLM_term">IL-1α</td><td class="NLM_def"><p class="first last">interleukin 1α</p></td></tr><tr><td class="NLM_term">LPS</td><td class="NLM_def"><p class="first last">lipopolysaccharide</p></td></tr><tr><td class="NLM_term">TLR7</td><td class="NLM_def"><p class="first last">Toll-like receptor 7</p></td></tr><tr><td class="NLM_term">siRNA</td><td class="NLM_def"><p class="first last">small interfering RNA</p></td></tr><tr><td class="NLM_term">SMAD2</td><td class="NLM_def"><p class="first last">mothers against decapentaplegic homologue 2</p></td></tr><tr><td class="NLM_term">LIC</td><td class="NLM_def"><p class="first last">ligation independent cloning</p></td></tr><tr><td class="NLM_term"><i>T</i><sub>1/2</sub></td><td class="NLM_def"><p class="first last">half-life period</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under concentration–time curve</p></td></tr><tr><td class="NLM_term"><i>F</i></td><td class="NLM_def"><p class="first last">fraction of bioavailability</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin-layer chromatography</p></td></tr><tr><td class="NLM_term">rt</td><td class="NLM_def"><p class="first last">room temperature</p></td></tr><tr><td class="NLM_term">TMS</td><td class="NLM_def"><p class="first last">tetramethylsilane</p></td></tr><tr><td class="NLM_term">ppm</td><td class="NLM_def"><p class="first last">parts per million</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high performance liquid chromatography</p></td></tr><tr><td class="NLM_term">Boc</td><td class="NLM_def"><p class="first last"><i>N</i>-<i>tert</i>-butoxycarbonyl</p></td></tr><tr><td class="NLM_term">DIEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DMAP</td><td class="NLM_def"><p class="first last">4-(dimethylamino)pyridine</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last"><i>O</i>-(7-azabenzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyluronium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">Pd<sub>2</sub>(dba)<sub>3</sub></td><td class="NLM_def"><p class="first last">tris(dibenzylideneacetone)dipalladium(0)</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">2-(trimethylsilyl)ethoxymethyl</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i32">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41381" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41381" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 32 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">O’Hare, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shakespeare, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eide, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivera, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adrian, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalf, C. A.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyner, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loriaux, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbin, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wardwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ning, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keats, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundaramoorthi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snodgrass, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Commodore, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalgarno, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deininger, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Druker, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clackson, T.</span><span> </span><span class="NLM_article-title">AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">401</span><span class="NLM_x">–</span> <span class="NLM_lpage">412</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=401-412&author=T.+O%E2%80%99Hareauthor=W.+C.+Shakespeareauthor=X.+Zhuauthor=C.+A.+Eideauthor=V.+M.+Riveraauthor=F.+Wangauthor=L.+T.+Adrianauthor=T.+Zhouauthor=W.+S.+Huangauthor=Q.+Xuauthor=C.+A.+Metcalfauthor=J.+W.+Tynerauthor=M.+M.+Loriauxauthor=A.+S.+Corbinauthor=S.+Wardwellauthor=Y.+Ningauthor=J.+A.+Keatsauthor=Y.+Wangauthor=R.+Sundaramoorthiauthor=M.+Thomasauthor=D.+Zhouauthor=J.+Snodgrassauthor=L.+Commodoreauthor=T.+K.+Sawyerauthor=D.+C.+Dalgarnoauthor=M.+W.+Deiningerauthor=B.+J.+Drukerauthor=T.+Clackson&title=AP24534%2C+a+pan-BCR-ABL+inhibitor+for+chronic+myeloid+leukemia%2C+potently+inhibits+the+T315I+mutant+and+overcomes+mutation-based+resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Hare%26aufirst%3DT.%26aulast%3DShakespeare%26aufirst%3DW.%2BC.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DEide%26aufirst%3DC.%2BA.%26aulast%3DRivera%26aufirst%3DV.%2BM.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DAdrian%26aufirst%3DL.%2BT.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DW.%2BS.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DMetcalf%26aufirst%3DC.%2BA.%26aulast%3DTyner%26aufirst%3DJ.%2BW.%26aulast%3DLoriaux%26aufirst%3DM.%2BM.%26aulast%3DCorbin%26aufirst%3DA.%2BS.%26aulast%3DWardwell%26aufirst%3DS.%26aulast%3DNing%26aufirst%3DY.%26aulast%3DKeats%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DSundaramoorthi%26aufirst%3DR.%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DSnodgrass%26aufirst%3DJ.%26aulast%3DCommodore%26aufirst%3DL.%26aulast%3DSawyer%26aufirst%3DT.%2BK.%26aulast%3DDalgarno%26aufirst%3DD.%2BC.%26aulast%3DDeininger%26aufirst%3DM.%2BW.%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26aulast%3DClackson%26aufirst%3DT.%26atitle%3DAP24534%252C%2520a%2520pan-BCR-ABL%2520inhibitor%2520for%2520chronic%2520myeloid%2520leukemia%252C%2520potently%2520inhibits%2520the%2520T315I%2520mutant%2520and%2520overcomes%2520mutation-based%2520resistance%26jtitle%3DCancer%2520Cell%26date%3D2009%26volume%3D16%26spage%3D401%26epage%3D412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Gajiwala, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diehl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiNitto, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">English, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greig, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacques, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunney, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McTigue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molina, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quenzer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmett, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demetri, G. D.</span><span> </span><span class="NLM_article-title">KIT kinase mutants show unique mechanisms of drug resistance to imatinib and sunitinib in gastrointestinal stromal tumor patients</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">1542</span><span class="NLM_x">–</span> <span class="NLM_lpage">1547</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm500480k&amp;key=10.1073%2Fpnas.0812413106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm500480k&amp;key=19164557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm500480k&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvVOms78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=1542-1547&author=K.+S.+Gajiwalaauthor=J.+C.+Wuauthor=J.+Christensenauthor=G.+D.+Deshmukhauthor=W.+Diehlauthor=J.+P.+DiNittoauthor=J.+M.+Englishauthor=M.+J.+Greigauthor=Y.+A.+Heauthor=S.+L.+Jacquesauthor=E.+A.+Lunneyauthor=M.+McTigueauthor=D.+Molinaauthor=T.+Quenzerauthor=P.+A.+Wellsauthor=X.+Yuauthor=Y.+Zhangauthor=A.+Zouauthor=M.+R.+Emmettauthor=A.+G.+Marshallauthor=H.+M.+Zhangauthor=G.+D.+Demetri&title=KIT+kinase+mutants+show+unique+mechanisms+of+drug+resistance+to+imatinib+and+sunitinib+in+gastrointestinal+stromal+tumor+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">KIT kinase mutants show unique mechanisms of drug resistance to imatinib and sunitinib in gastrointestinal stromal tumor patients</span></div><div class="casAuthors">Gajiwala, Ketan S.; Wu, Joe C.; Christensen, James; Deshmukh, Gayatri D.; Diehl, Wade; DiNitto, Jonathan P.; English, Jessie M.; Greig, Michael J.; He, You-Ai; Jacques, Suzanne L.; Lunney, Elizabeth A.; McTigue, Michele; Molina, Dave; Quenzer, Terri; Wells, Peter A.; Yu, Xiu; Zhang, Yan; Zou, Aihua; Emmett, Mark R.; Marshall, Alan G.; Zhang, Hui-Min; Demetri, George D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1542-1547</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Most gastrointestinal stromal tumors (GISTs) exhibit aberrant activation of the receptor tyrosine kinase (RTK) KIT.  The efficacy of the inhibitors imatinib mesylate and sunitinib malate in GIST patients has been linked to their inhibition of these mutant KIT proteins.  However, patients on imatinib can acquire secondary KIT mutations that render the protein insensitive to the inhibitor.  Sunitinib has shown efficacy against certain imatinib-resistant mutants, although a subset that resides in the activation loop, including D816H/V, remains resistant.  Biochem. and structural studies were undertaken to det. the mol. basis of sunitinib resistance.  Our results show that sunitinib targets the autoinhibited conformation of WT KIT and that the D816H mutant undergoes a shift in conformational equil. toward the active state.  These findings provide a structural and enzymol. explanation for the resistance profile obsd. with the KIT inhibitors.  Prospectively, they have implications for understanding oncogenic kinase mutants and for circumventing drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkwFxa-p-iWbVg90H21EOLACvtfcHk0liN6zo4N79_Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvVOms78%253D&md5=dd226c914c6f9a258426c0f4984a5258</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0812413106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0812413106%26sid%3Dliteratum%253Aachs%26aulast%3DGajiwala%26aufirst%3DK.%2BS.%26aulast%3DWu%26aufirst%3DJ.%2BC.%26aulast%3DChristensen%26aufirst%3DJ.%26aulast%3DDeshmukh%26aufirst%3DG.%2BD.%26aulast%3DDiehl%26aufirst%3DW.%26aulast%3DDiNitto%26aufirst%3DJ.%2BP.%26aulast%3DEnglish%26aufirst%3DJ.%2BM.%26aulast%3DGreig%26aufirst%3DM.%2BJ.%26aulast%3DHe%26aufirst%3DY.%2BA.%26aulast%3DJacques%26aufirst%3DS.%2BL.%26aulast%3DLunney%26aufirst%3DE.%2BA.%26aulast%3DMcTigue%26aufirst%3DM.%26aulast%3DMolina%26aufirst%3DD.%26aulast%3DQuenzer%26aufirst%3DT.%26aulast%3DWells%26aufirst%3DP.%2BA.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZou%26aufirst%3DA.%26aulast%3DEmmett%26aufirst%3DM.%2BR.%26aulast%3DMarshall%26aufirst%3DA.%2BG.%26aulast%3DZhang%26aufirst%3DH.%2BM.%26aulast%3DDemetri%26aufirst%3DG.%2BD.%26atitle%3DKIT%2520kinase%2520mutants%2520show%2520unique%2520mechanisms%2520of%2520drug%2520resistance%2520to%2520imatinib%2520and%2520sunitinib%2520in%2520gastrointestinal%2520stromal%2520tumor%2520patients%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2009%26volume%3D106%26spage%3D1542%26epage%3D1547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Gould, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adhikari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aertgeerts, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Afroze, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackburn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderwood, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chau, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chouitar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duffey, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">England, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forsyth, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaulin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenspan, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iartchouk, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janowick, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langston, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizutani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paske, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renou, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rezaei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowland, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sintchak, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroud, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tregay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veiby, O. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vos, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyskocil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yano, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvin, K. M.</span><span> </span><span class="NLM_article-title">Design and optimization of potent and orally bioavailable tetrahydronaphthalene Raf inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1836</span><span class="NLM_x">–</span> <span class="NLM_lpage">1846</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101479y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm500480k&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisVWls7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1836-1846&author=A.+E.+Gouldauthor=R.+Adamsauthor=S.+Adhikariauthor=K.+Aertgeertsauthor=R.+Afrozeauthor=C.+Blackburnauthor=E.+F.+Calderwoodauthor=R.+Chauauthor=J.+Chouitarauthor=M.+O.+Duffeyauthor=D.+B.+Englandauthor=C.+Farrerauthor=N.+Forsythauthor=K.+Garciaauthor=J.+Gaulinauthor=P.+D.+Greenspanauthor=R.+Guoauthor=S.+J.+Harrisonauthor=S.+C.+Huangauthor=N.+Iartchoukauthor=D.+Janowickauthor=M.+S.+Kimauthor=B.+Kulkarniauthor=S.+P.+Langstonauthor=J.+X.+Liuauthor=L.+T.+Maauthor=S.+Menonauthor=H.+Mizutaniauthor=E.+Paskeauthor=C.+C.+Renouauthor=M.+Rezaeiauthor=R.+S.+Rowlandauthor=M.+D.+Sintchakauthor=M.+D.+Smithauthor=S.+G.+Stroudauthor=M.+Tregayauthor=Y.+Tianauthor=O.+P.+Veibyauthor=T.+J.+Vosauthor=S.+Vyskocilauthor=J.+Williamsauthor=T.+Xuauthor=J.+J.+Yangauthor=J.+Yanoauthor=H.+Zengauthor=D.+M.+Zhangauthor=Q.+Zhangauthor=K.+M.+Galvin&title=Design+and+optimization+of+potent+and+orally+bioavailable+tetrahydronaphthalene+Raf+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Optimization of Potent and Orally Bioavailable Tetrahydronaphthalene Raf Inhibitors</span></div><div class="casAuthors">Gould, Alexandra E.; Adams, Ruth; Adhikari, Sharmila; Aertgeerts, Kathleen; Afroze, Roushan; Blackburn, Christopher; Calderwood, Emily F.; Chau, Ryan; Chouitar, Jouhara; Duffey, Matthew O.; England, Dylan B.; Farrer, Cheryl; Forsyth, Nancy; Garcia, Khristofer; Gaulin, Jeffery; Greenspan, Paul D.; Guo, Ribo; Harrison, Sean J.; Huang, Shih-Chung; Iartchouk, Natalia; Janowick, Dave; Kim, Mi-Sook; Kulkarni, Bheemashankar; Langston, Steven P.; Liu, Jane X.; Ma, Li-Ting; Menon, Saurabh; Mizutani, Hirotake; Paske, Erin; Renou, Christelle C.; Rezaei, Mansoureh; Rowland, R. Scott; Sintchak, Michael D.; Smith, Michael D.; Stroud, Stephen G.; Tregay, Ming; Tian, Yuan; Veiby, Ole P.; Vos, Tricia J.; Vyskocil, Stepan; Williams, Juliet; Xu, Tianlin; Yang, Johnny J.; Yano, Jason; Zeng, Hongbo; Zhang, Dong Mei; Zhang, Qin; Galvin, Katherine M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1836-1846</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of mutant B-Raf signaling, through either direct inhibition of the enzyme or inhibition of MEK, the direct substrate of Raf, has been demonstrated preclinically to inhibit tumor growth.  Very recently, treatment of B-Raf mutant melanoma patients with a selective B-Raf inhibitor has resulted in promising preliminary evidence of antitumor activity.  This article describes the design and optimization of tetrahydronaphthalene-derived compds. as potent inhibitors of the Raf pathway in vitro and in vivo.  These compds. possess good pharmacokinetic properties in rodents and inhibit B-Raf mutant tumor growth in mouse xenograft models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNulHRlb4oULVg90H21EOLACvtfcHk0liUrZZqSs9PUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisVWls7g%253D&md5=568fb1b26a6685df082ac0337494a9c5</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Fjm101479y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101479y%26sid%3Dliteratum%253Aachs%26aulast%3DGould%26aufirst%3DA.%2BE.%26aulast%3DAdams%26aufirst%3DR.%26aulast%3DAdhikari%26aufirst%3DS.%26aulast%3DAertgeerts%26aufirst%3DK.%26aulast%3DAfroze%26aufirst%3DR.%26aulast%3DBlackburn%26aufirst%3DC.%26aulast%3DCalderwood%26aufirst%3DE.%2BF.%26aulast%3DChau%26aufirst%3DR.%26aulast%3DChouitar%26aufirst%3DJ.%26aulast%3DDuffey%26aufirst%3DM.%2BO.%26aulast%3DEngland%26aufirst%3DD.%2BB.%26aulast%3DFarrer%26aufirst%3DC.%26aulast%3DForsyth%26aufirst%3DN.%26aulast%3DGarcia%26aufirst%3DK.%26aulast%3DGaulin%26aufirst%3DJ.%26aulast%3DGreenspan%26aufirst%3DP.%2BD.%26aulast%3DGuo%26aufirst%3DR.%26aulast%3DHarrison%26aufirst%3DS.%2BJ.%26aulast%3DHuang%26aufirst%3DS.%2BC.%26aulast%3DIartchouk%26aufirst%3DN.%26aulast%3DJanowick%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DM.%2BS.%26aulast%3DKulkarni%26aufirst%3DB.%26aulast%3DLangston%26aufirst%3DS.%2BP.%26aulast%3DLiu%26aufirst%3DJ.%2BX.%26aulast%3DMa%26aufirst%3DL.%2BT.%26aulast%3DMenon%26aufirst%3DS.%26aulast%3DMizutani%26aufirst%3DH.%26aulast%3DPaske%26aufirst%3DE.%26aulast%3DRenou%26aufirst%3DC.%2BC.%26aulast%3DRezaei%26aufirst%3DM.%26aulast%3DRowland%26aufirst%3DR.%2BS.%26aulast%3DSintchak%26aufirst%3DM.%2BD.%26aulast%3DSmith%26aufirst%3DM.%2BD.%26aulast%3DStroud%26aufirst%3DS.%2BG.%26aulast%3DTregay%26aufirst%3DM.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DVeiby%26aufirst%3DO.%2BP.%26aulast%3DVos%26aufirst%3DT.%2BJ.%26aulast%3DVyskocil%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DJ.%2BJ.%26aulast%3DYano%26aufirst%3DJ.%26aulast%3DZeng%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DD.%2BM.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DGalvin%26aufirst%3DK.%2BM.%26atitle%3DDesign%2520and%2520optimization%2520of%2520potent%2520and%2520orally%2520bioavailable%2520tetrahydronaphthalene%2520Raf%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1836%26epage%3D1846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Simard, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Getlik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grutter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wulfert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabiller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauh, D.</span><span> </span><span class="NLM_article-title">Development of a fluorescent-tagged kinase assay system for the detection and characterization of allosteric kinase inhibitors</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">13286</span><span class="NLM_x">–</span> <span class="NLM_lpage">13296</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja902010p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm500480k&amp;key=1%3ACAS%3A528%3ADC%252BD1MXms1ensrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=13286-13296&author=J.+R.+Simardauthor=M.+Getlikauthor=C.+Grutterauthor=V.+Pawarauthor=S.+Wulfertauthor=M.+Rabillerauthor=D.+Rauh&title=Development+of+a+fluorescent-tagged+kinase+assay+system+for+the+detection+and+characterization+of+allosteric+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Fluorescent-Tagged Kinase Assay System for the Detection and Characterization of Allosteric Kinase Inhibitors</span></div><div class="casAuthors">Simard, Jeffrey R.; Getlik, Matthaus; Grutter, Christian; Pawar, Vijaykumar; Wulfert, Sabine; Rabiller, Matthias; Rauh, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">13286-13296</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Kinase disregulation disrupts the intricate network of intracellular signaling pathways and contributes to the onset of diseases such as cancer.  Although several kinase inhibitors are on the market, inhibitor selectivity and drug resistance mutations persist as fundamental challenges in the development of effective long-term treatments.  Chem. entities binding to less conserved allosteric sites would be expected to offer new opportunities for scaffold development.  Because no high-throughput method was previously available, a fluorescence-based kinase binding assay for identifying and characterizing ligands which stabilize the inactive kinase conformation was developed.  Here, a description of the development and validation of this assay using the serine/threonine kinase p38α is presented.  The covalent attachment of fluorophores to the activation loop of the kinase allowed to detect the conformational changes and measure the Kd, kon, and koff assocd. with the binding and dissocn. of ligands to the allosteric pocket.  The SAR of a synthesized focused library of pyrazolourea derivs., a scaffold known to bind with high affinity to the allosteric pocket of p38α, is also reported.  Addnl., the protein X-ray crystallog. was used together with this assay to examine the binding and dissocn. kinetics to characterize potent quinazoline- and quinoline-based type II inhibitors, which also utilize this binding pocket in p38α.  Last, the b-Raf inhibitor sorafenib was identified as a potent low nanomolar inhibitor of p38α and the protein X-ray crystallog. was used to confirm its unique binding mode to the inactive kinase conformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVNeYPzX2CHbVg90H21EOLACvtfcHk0liUrZZqSs9PUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXms1ensrk%253D&md5=f56e476572c7cdfb3411eb95b9759fca</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fja902010p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja902010p%26sid%3Dliteratum%253Aachs%26aulast%3DSimard%26aufirst%3DJ.%2BR.%26aulast%3DGetlik%26aufirst%3DM.%26aulast%3DGrutter%26aufirst%3DC.%26aulast%3DPawar%26aufirst%3DV.%26aulast%3DWulfert%26aufirst%3DS.%26aulast%3DRabiller%26aufirst%3DM.%26aulast%3DRauh%26aufirst%3DD.%26atitle%3DDevelopment%2520of%2520a%2520fluorescent-tagged%2520kinase%2520assay%2520system%2520for%2520the%2520detection%2520and%2520characterization%2520of%2520allosteric%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D13286%26epage%3D13296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Rational design of inhibitors that bind to inactive kinase conformations</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">358</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm500480k&amp;key=10.1038%2Fnchembio799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm500480k&amp;key=16783341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm500480k&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvFGjs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=358-364&author=Y.+Liuauthor=N.+S.+Gray&title=Rational+design+of+inhibitors+that+bind+to+inactive+kinase+conformations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Rational design of inhibitors that bind to inactive kinase conformations</span></div><div class="casAuthors">Liu, Yi; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">358-364</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The majority of kinase inhibitors, known as type I inhibitors that have been developed so far target the ATP binding site of the kinase in its active conformation, in which the activation loop is phosphorylated.  Recently, crystal structures of inhibitors such as imatinib, BIRB796, and sorafenib (BAY43-9006), known as type II inhibitors, have revealed a new binding mode that exploits an addnl. binding site immediately adjacent to the region occupied by ATP.  This pocket is made accessible by an activation-loop rearrangement that is characteristic of kinases in an inactive conformation.  The examn. of binding features of known type II inhibitors is discussed and a pharmacophore model currently used in the design of a new generation of structurally diverse type II inhibitors is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxahsMPlhgDbVg90H21EOLACvtfcHk0ljyg9_3dOT8tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvFGjs7g%253D&md5=4a9347a44a2cf4a412c9741fdcc5696b</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnchembio799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio799%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DRational%2520design%2520of%2520inhibitors%2520that%2520bind%2520to%2520inactive%2520kinase%2520conformations%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2006%26volume%3D2%26spage%3D358%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Miduturu, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwiatkowski, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brault, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwaller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">High-throughput kinase profiling: a more efficient approach toward the discovery of new kinase inhibitors</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">868</span><span class="NLM_x">–</span> <span class="NLM_lpage">879</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm500480k&amp;key=10.1016%2Fj.chembiol.2011.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm500480k&amp;key=21802008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm500480k&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpsFarurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=868-879&author=C.+V.+Miduturuauthor=X.+Dengauthor=N.+Kwiatkowskiauthor=W.+Yangauthor=L.+Braultauthor=P.+Filippakopoulosauthor=E.+Chungauthor=Q.+Yangauthor=J.+Schwallerauthor=S.+Knappauthor=R.+W.+Kingauthor=J.+D.+Leeauthor=S.+Herrgardauthor=P.+Zarrinkarauthor=N.+S.+Gray&title=High-throughput+kinase+profiling%3A+a+more+efficient+approach+toward+the+discovery+of+new+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">High-Throughput Kinase Profiling: A More Efficient Approach toward the Discovery of New Kinase Inhibitors</span></div><div class="casAuthors">Miduturu, Chandrasekhar V.; Deng, Xianming; Kwiatkowski, Nicholas; Yang, Wannian; Brault, Laurent; Filippakopoulos, Panagis; Chung, Eunah; Yang, Qingkai; Schwaller, Juerg; Knapp, Stefan; King, Randall W.; Lee, Jiing-Dwan; Herrgard, Sanna; Zarrinkar, Patrick; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">868-879</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Selective protein kinase inhibitors have only been developed against a small no. of kinase targets.  Here we demonstrate that "high-throughput kinase profiling" is an efficient method for the discovery of lead compds. for established as well as unexplored kinase targets.  We screened a library of 118 compds. constituting two distinct scaffolds (furan-thiazolidinediones and pyrimido-diazepines) against a panel of 353 kinases.  A distinct kinase selectivity profile was obsd. for each scaffold.  Selective inhibitors were identified with submicromolar cellular activity against PIM1, ERK5, ACK1, MPS1, PLK1-3, and Aurora A,B kinases.  In addn., we identified potent inhibitors for so far unexplored kinases such as DRAK1, HIPK2, and DCAMKL1 that await further evaluation.  This inhibitor-centric approach permits comprehensive assessment of a scaffold of interest and represents an efficient and general strategy for identifying new selective kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKLvN9eLNvybVg90H21EOLACvtfcHk0ljyg9_3dOT8tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpsFarurw%253D&md5=d62a4771b1215551f3913b93d6eca7ee</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2011.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2011.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DMiduturu%26aufirst%3DC.%2BV.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DKwiatkowski%26aufirst%3DN.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DBrault%26aufirst%3DL.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DChung%26aufirst%3DE.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DSchwaller%26aufirst%3DJ.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DKing%26aufirst%3DR.%2BW.%26aulast%3DLee%26aufirst%3DJ.%2BD.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DZarrinkar%26aufirst%3DP.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DHigh-throughput%2520kinase%2520profiling%253A%2520a%2520more%2520efficient%2520approach%2520toward%2520the%2520discovery%2520of%2520new%2520kinase%2520inhibitors%26jtitle%3DChem.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D868%26epage%3D879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Goldstein, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span> </span><span class="NLM_article-title">High-throughput kinase profiling as a platform for drug discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">391</span><span class="NLM_x">–</span> <span class="NLM_lpage">397</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm500480k&amp;key=10.1038%2Fnrd2541" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm500480k&amp;key=18404149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm500480k&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlt1agtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=391-397&author=D.+M.+Goldsteinauthor=N.+S.+Grayauthor=P.+P.+Zarrinkar&title=High-throughput+kinase+profiling+as+a+platform+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">High-throughput kinase profiling as a platform for drug discovery</span></div><div class="casAuthors">Goldstein, David M.; Gray, Nathanael S.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">391-397</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  High-throughput profiling of compd. libraries against large panels of kinases is becoming tech. feasible.  In contrast to the traditional linear, target-centric approach to discovery, this approach may provide a choice of targets to pursue that is guided by the quality of lead compds. available, rather than by target biol. alone, and could thereby significantly improve the productivity of kinase inhibitor discovery.  To fully exploit the potential of kinases as drug targets, novel strategies for the efficient discovery of inhibitors are required.  In contrast to the traditional, linear process of inhibitor discovery, high-throughput kinase profiling enables a parallel approach by interrogating compds. against hundreds of targets in a single screen.  Compd. potency and selectivity are detd. simultaneously, providing a choice of targets to pursue that is guided by the quality of lead compds. available, rather than by target biol. alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwnJ59cVxbJbVg90H21EOLACvtfcHk0ljyg9_3dOT8tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlt1agtbs%253D&md5=eaa61fd2958ff04fecf86a993f91833d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrd2541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2541%26sid%3Dliteratum%253Aachs%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DHigh-throughput%2520kinase%2520profiling%2520as%2520a%2520platform%2520for%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26spage%3D391%26epage%3D397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Pauls, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shpiro, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peggie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorcek, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">Essential role for IKKbeta in production of type 1 interferons by plasmacytoid dendritic cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">19216</span><span class="NLM_x">–</span> <span class="NLM_lpage">19228</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=19216-19228&author=E.+Paulsauthor=N.+Shpiroauthor=M.+Peggieauthor=E.+R.+Youngauthor=R.+J.+Sorcekauthor=L.+Tanauthor=H.+G.+Choiauthor=P.+Cohen&title=Essential+role+for+IKKbeta+in+production+of+type+1+interferons+by+plasmacytoid+dendritic+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPauls%26aufirst%3DE.%26aulast%3DShpiro%26aufirst%3DN.%26aulast%3DPeggie%26aufirst%3DM.%26aulast%3DYoung%26aufirst%3DE.%2BR.%26aulast%3DSorcek%26aufirst%3DR.%2BJ.%26aulast%3DTan%26aufirst%3DL.%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DEssential%2520role%2520for%2520IKKbeta%2520in%2520production%2520of%2520type%25201%2520interferons%2520by%2520plasmacytoid%2520dendritic%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D19216%26epage%3D19228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Dzamko, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inesta-Vaquera, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arthur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedrioli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span> </span><span class="NLM_article-title">The IkappaB kinase family phosphorylates the Parkinson’s disease kinase LRRK2 at Ser935 and Ser910 during Toll-like receptor signaling</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e39132</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e39132&author=N.+Dzamkoauthor=F.+Inesta-Vaqueraauthor=J.+Zhangauthor=C.+Xieauthor=H.+Caiauthor=S.+Arthurauthor=L.+Tanauthor=H.+Choiauthor=N.+Grayauthor=P.+Cohenauthor=P.+Pedrioliauthor=K.+Clarkauthor=D.+R.+Alessi&title=The+IkappaB+kinase+family+phosphorylates+the+Parkinson%E2%80%99s+disease+kinase+LRRK2+at+Ser935+and+Ser910+during+Toll-like+receptor+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDzamko%26aufirst%3DN.%26aulast%3DInesta-Vaquera%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DC.%26aulast%3DCai%26aufirst%3DH.%26aulast%3DArthur%26aufirst%3DS.%26aulast%3DTan%26aufirst%3DL.%26aulast%3DChoi%26aufirst%3DH.%26aulast%3DGray%26aufirst%3DN.%26aulast%3DCohen%26aufirst%3DP.%26aulast%3DPedrioli%26aufirst%3DP.%26aulast%3DClark%26aufirst%3DK.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26atitle%3DThe%2520IkappaB%2520kinase%2520family%2520phosphorylates%2520the%2520Parkinson%25E2%2580%2599s%2520disease%2520kinase%2520LRRK2%2520at%2520Ser935%2520and%2520Ser910%2520during%2520Toll-like%2520receptor%2520signaling%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De39132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Sakurai, H.</span><span> </span><span class="NLM_article-title">Targeting of TAK1 in inflammatory disorders and cancer</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">522</span><span class="NLM_x">–</span> <span class="NLM_lpage">530</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=522-530&author=H.+Sakurai&title=Targeting+of+TAK1+in+inflammatory+disorders+and+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSakurai%26aufirst%3DH.%26atitle%3DTargeting%2520of%2520TAK1%2520in%2520inflammatory%2520disorders%2520and%2520cancer%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2012%26volume%3D33%26spage%3D522%26epage%3D530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Dai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aye Thu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, P. C.</span><span> </span><span class="NLM_article-title">TAK1, more than just innate immunity</span> <span class="citation_source-journal">IUBMB Life</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">825</span><span class="NLM_x">–</span> <span class="NLM_lpage">834</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2012&pages=825-834&author=L.+Daiauthor=C.+Aye+Thuauthor=X.+Y.+Liuauthor=J.+Xiauthor=P.+C.+Cheung&title=TAK1%2C+more+than+just+innate+immunity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDai%26aufirst%3DL.%26aulast%3DAye%2BThu%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DX.%2BY.%26aulast%3DXi%26aufirst%3DJ.%26aulast%3DCheung%26aufirst%3DP.%2BC.%26atitle%3DTAK1%252C%2520more%2520than%2520just%2520innate%2520immunity%26jtitle%3DIUBMB%2520Life%26date%3D2012%26volume%3D64%26spage%3D825%26epage%3D834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Buglio, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palakurthi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byth, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toader, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saeh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neelapu, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Younes, A.</span><span> </span><span class="NLM_article-title">Essential role of TAK1 in regulating mantle cell lymphoma survival</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">355</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2012&pages=347-355&author=D.+Buglioauthor=S.+Palakurthiauthor=K.+Bythauthor=F.+Vegaauthor=D.+Toaderauthor=J.+Saehauthor=S.+S.+Neelapuauthor=A.+Younes&title=Essential+role+of+TAK1+in+regulating+mantle+cell+lymphoma+survival"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBuglio%26aufirst%3DD.%26aulast%3DPalakurthi%26aufirst%3DS.%26aulast%3DByth%26aufirst%3DK.%26aulast%3DVega%26aufirst%3DF.%26aulast%3DToader%26aufirst%3DD.%26aulast%3DSaeh%26aufirst%3DJ.%26aulast%3DNeelapu%26aufirst%3DS.%2BS.%26aulast%3DYounes%26aufirst%3DA.%26atitle%3DEssential%2520role%2520of%2520TAK1%2520in%2520regulating%2520mantle%2520cell%2520lymphoma%2520survival%26jtitle%3DBlood%26date%3D2012%26volume%3D120%26spage%3D347%26epage%3D355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Hornberger, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crew, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleinberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulvihill, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilde, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albertella, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadhim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maresca, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyn, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romashko, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokar, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turton, R.</span><span> </span><span class="NLM_article-title">Discovery of 7-aminofuro[2,3-<i>c</i>]pyridine inhibitors of TAK1: optimization of kinase selectivity and pharmacokinetics</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4511</span><span class="NLM_x">–</span> <span class="NLM_lpage">4516</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4511-4516&author=K.+R.+Hornbergerauthor=X.+Chenauthor=A.+P.+Crewauthor=A.+Kleinbergauthor=L.+Maauthor=M.+J.+Mulvihillauthor=J.+Wangauthor=V.+L.+Wildeauthor=M.+Albertellaauthor=M.+Bittnerauthor=A.+Cookeauthor=S.+Kadhimauthor=J.+Kahlerauthor=P.+Marescaauthor=E.+Mayauthor=P.+Meynauthor=D.+Romashkoauthor=B.+Tokarauthor=R.+Turton&title=Discovery+of+7-aminofuro%5B2%2C3-c%5Dpyridine+inhibitors+of+TAK1%3A+optimization+of+kinase+selectivity+and+pharmacokinetics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHornberger%26aufirst%3DK.%2BR.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCrew%26aufirst%3DA.%2BP.%26aulast%3DKleinberg%26aufirst%3DA.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DMulvihill%26aufirst%3DM.%2BJ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWilde%26aufirst%3DV.%2BL.%26aulast%3DAlbertella%26aufirst%3DM.%26aulast%3DBittner%26aufirst%3DM.%26aulast%3DCooke%26aufirst%3DA.%26aulast%3DKadhim%26aufirst%3DS.%26aulast%3DKahler%26aufirst%3DJ.%26aulast%3DMaresca%26aufirst%3DP.%26aulast%3DMay%26aufirst%3DE.%26aulast%3DMeyn%26aufirst%3DP.%26aulast%3DRomashko%26aufirst%3DD.%26aulast%3DTokar%26aufirst%3DB.%26aulast%3DTurton%26aufirst%3DR.%26atitle%3DDiscovery%2520of%25207-aminofuro%255B2%252C3-c%255Dpyridine%2520inhibitors%2520of%2520TAK1%253A%2520optimization%2520of%2520kinase%2520selectivity%2520and%2520pharmacokinetics%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4511%26epage%3D4516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Hornberger, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crew, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleinberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medeiros, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulvihill, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarrant, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weng, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilde, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albertella, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maresca, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyn, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peick, W.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romashko, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanowitz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokar, B.</span><span> </span><span class="NLM_article-title">Discovery and optimization of 7-aminofuro[2,3-<i>c</i>]pyridine inhibitors of TAK1</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4517</span><span class="NLM_x">–</span> <span class="NLM_lpage">4522</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4517-4522&author=K.+R.+Hornbergerauthor=D.+M.+Bergerauthor=A.+P.+Crewauthor=H.+Dongauthor=A.+Kleinbergauthor=A.+H.+Liauthor=M.+R.+Medeirosauthor=M.+J.+Mulvihillauthor=K.+Siuauthor=J.+Tarrantauthor=J.+Wangauthor=F.+Wengauthor=V.+L.+Wildeauthor=M.+Albertellaauthor=M.+Bittnerauthor=A.+Cookeauthor=M.+J.+Grayauthor=P.+Marescaauthor=E.+Mayauthor=P.+Meynauthor=W.+Peickauthor=D.+Romashkoauthor=M.+Tanowitzauthor=B.+Tokar&title=Discovery+and+optimization+of+7-aminofuro%5B2%2C3-c%5Dpyridine+inhibitors+of+TAK1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHornberger%26aufirst%3DK.%2BR.%26aulast%3DBerger%26aufirst%3DD.%2BM.%26aulast%3DCrew%26aufirst%3DA.%2BP.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DKleinberg%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DA.%2BH.%26aulast%3DMedeiros%26aufirst%3DM.%2BR.%26aulast%3DMulvihill%26aufirst%3DM.%2BJ.%26aulast%3DSiu%26aufirst%3DK.%26aulast%3DTarrant%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWeng%26aufirst%3DF.%26aulast%3DWilde%26aufirst%3DV.%2BL.%26aulast%3DAlbertella%26aufirst%3DM.%26aulast%3DBittner%26aufirst%3DM.%26aulast%3DCooke%26aufirst%3DA.%26aulast%3DGray%26aufirst%3DM.%2BJ.%26aulast%3DMaresca%26aufirst%3DP.%26aulast%3DMay%26aufirst%3DE.%26aulast%3DMeyn%26aufirst%3DP.%26aulast%3DPeick%26aufirst%3DW.%26aulast%3DRomashko%26aufirst%3DD.%26aulast%3DTanowitz%26aufirst%3DM.%26aulast%3DTokar%26aufirst%3DB.%26atitle%3DDiscovery%2520and%2520optimization%2520of%25207-aminofuro%255B2%252C3-c%255Dpyridine%2520inhibitors%2520of%2520TAK1%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4517%26epage%3D4522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Kilty, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryckmans, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Hoorn, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, L. H.</span><span> </span><span class="NLM_article-title">TAK 1 Inhibition in the DFG-out conformation</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">500</span><span class="NLM_x">–</span> <span class="NLM_lpage">505</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm500480k&amp;key=10.1111%2Fcbdd.12169" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm500480k&amp;key=23745990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm500480k&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1ahtLbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2013&pages=500-505&author=I.+Kiltyauthor=M.+P.+Greenauthor=A.+S.+Bellauthor=D.+G.+Brownauthor=P.+G.+Doddauthor=C.+Hewsonauthor=S.+J.+Hughesauthor=C.+Phillipsauthor=T.+Ryckmansauthor=R.+T.+Smithauthor=W.+P.+van+Hoornauthor=P.+Cohenauthor=L.+H.+Jones&title=TAK+1+Inhibition+in+the+DFG-out+conformation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">TAK1 Inhibition in the DFG-Out Conformation</span></div><div class="casAuthors">Kilty, Iain; Green, Martin P.; Bell, Andrew S.; Brown, David G.; Dodd, Peter G.; Hewson, Christopher; Hughes, Samantha J.; Phillips, Christopher; Ryckmans, Thomas; Smith, Robert T.; van Hoorn, Willem P.; Cohen, Philip; Jones, Lyn H.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">500-505</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The first example of an inhibitor of the kinase TAK1 that binds in the DFG-out conformation is disclosed.  These preliminary studies used kinase-targeted screening and structure-based drug design to create a mol. with dual pharmacol. inhibition of p38 and TAK1 that demonstrated significant activity in a cell-based, anti-inflammatory assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr09m3E0JuQAbVg90H21EOLACvtfcHk0lj3M9WUQ5B7KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1ahtLbO&md5=685f1ceb03231ae1b421301be95a2885</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.12169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.12169%26sid%3Dliteratum%253Aachs%26aulast%3DKilty%26aufirst%3DI.%26aulast%3DGreen%26aufirst%3DM.%2BP.%26aulast%3DBell%26aufirst%3DA.%2BS.%26aulast%3DBrown%26aufirst%3DD.%2BG.%26aulast%3DDodd%26aufirst%3DP.%2BG.%26aulast%3DHewson%26aufirst%3DC.%26aulast%3DHughes%26aufirst%3DS.%2BJ.%26aulast%3DPhillips%26aufirst%3DC.%26aulast%3DRyckmans%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DR.%2BT.%26aulast%3Dvan%2BHoorn%26aufirst%3DW.%2BP.%26aulast%3DCohen%26aufirst%3DP.%26aulast%3DJones%26aufirst%3DL.%2BH.%26atitle%3DTAK%25201%2520Inhibition%2520in%2520the%2520DFG-out%2520conformation%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2013%26volume%3D82%26spage%3D500%26epage%3D505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Ivanov, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kehrl, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronai, Z.</span><span> </span><span class="NLM_article-title">Role of TRAF2/GCK in melanoma sensitivity to UV-induced apoptosis</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">933</span><span class="NLM_x">–</span> <span class="NLM_lpage">942</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2000&pages=933-942&author=V.+N.+Ivanovauthor=J.+H.+Kehrlauthor=Z.+Ronai&title=Role+of+TRAF2%2FGCK+in+melanoma+sensitivity+to+UV-induced+apoptosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIvanov%26aufirst%3DV.%2BN.%26aulast%3DKehrl%26aufirst%3DJ.%2BH.%26aulast%3DRonai%26aufirst%3DZ.%26atitle%3DRole%2520of%2520TRAF2%252FGCK%2520in%2520melanoma%2520sensitivity%2520to%2520UV-induced%2520apoptosis%26jtitle%3DOncogene%26date%3D2000%26volume%3D19%26spage%3D933%26epage%3D942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Zhang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inesta-Vaquera, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niepel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ficarro, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machleidt, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marto, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sim, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laughlin, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LoGrasso, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patricelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomanbhoy, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorger, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Discovery of potent and selective covalent inhibitors of JNK</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">154</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm500480k&amp;key=10.1016%2Fj.chembiol.2011.11.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm500480k&amp;key=22284361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm500480k&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Ghurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=140-154&author=T.+Zhangauthor=F.+Inesta-Vaqueraauthor=M.+Niepelauthor=J.+Zhangauthor=S.+B.+Ficarroauthor=T.+Machleidtauthor=T.+Xieauthor=J.+A.+Martoauthor=N.+Kimauthor=T.+Simauthor=J.+D.+Laughlinauthor=H.+Parkauthor=P.+V.+LoGrassoauthor=M.+Patricelliauthor=T.+K.+Nomanbhoyauthor=P.+K.+Sorgerauthor=D.+R.+Alessiauthor=N.+S.+Gray&title=Discovery+of+potent+and+selective+covalent+inhibitors+of+JNK"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Selective Covalent Inhibitors of JNK</span></div><div class="casAuthors">Zhang, Tinghu; Inesta-Vaquera, Francisco; Niepel, Mario; Zhang, Jianming; Ficarro, Scott B.; Machleidt, Thomas; Xie, Ting; Marto, Jarrod A.; Kim, Nam Doo; Sim, Taebo; Laughlin, John D.; Park, Hajeung; LoGrasso, Philip V.; Patricelli, Matt; Nomanbhoy, Tyzoon K.; Sorger, Peter K.; Alessi, Dario R.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">140-154</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The mitogen-activated kinases JNK1/2/3 are key enzymes in signaling modules that transduce and integrate extracellular stimuli into coordinated cellular response.  Here, we report the discovery of irreversible inhibitors of JNK1/2/3.  We describe two JNK3 cocrystal structures at 2.60 and 2.97 Å resoln. that show the compds. form covalent bonds with a conserved cysteine residue.  JNK-IN-8 is a selective JNK inhibitor that inhibits phosphorylation of c-Jun, a direct substrate of JNK, in cells exposed to submicromolar drug in a manner that depends on covalent modification of the conserved cysteine residue.  Extensive biochem., cellular, and pathway-based profiling establish the selectivity of JNK-IN-8 for JNK and suggests that the compd. will be broadly useful as a pharmacol. probe of JNK-dependent signal transduction.  Potential lead compds. have also been identified for kinases, including IRAK1, PIK3C3, PIP4K2C, and PIP5K3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXs0FY7FSmt7Vg90H21EOLACvtfcHk0lgi-vMMqmWQ8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Ghurw%253D&md5=f7d9647fb2be162c637b1d31a778ceb4</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2011.11.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2011.11.010%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DInesta-Vaquera%26aufirst%3DF.%26aulast%3DNiepel%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DFicarro%26aufirst%3DS.%2BB.%26aulast%3DMachleidt%26aufirst%3DT.%26aulast%3DXie%26aufirst%3DT.%26aulast%3DMarto%26aufirst%3DJ.%2BA.%26aulast%3DKim%26aufirst%3DN.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DLaughlin%26aufirst%3DJ.%2BD.%26aulast%3DPark%26aufirst%3DH.%26aulast%3DLoGrasso%26aufirst%3DP.%2BV.%26aulast%3DPatricelli%26aufirst%3DM.%26aulast%3DNomanbhoy%26aufirst%3DT.%2BK.%26aulast%3DSorger%26aufirst%3DP.%2BK.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520covalent%2520inhibitors%2520of%2520JNK%26jtitle%3DChem.%2520Biol.%26date%3D2012%26volume%3D19%26spage%3D140%26epage%3D154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Sapkota, G. P.</span><span> </span><span class="NLM_article-title">The TGFbeta-induced phosphorylation and activation of p38 mitogen-activated protein kinase is mediated by MAP3K4 and MAP3K10 but not TAK1</span> <span class="citation_source-journal">Open Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">130067</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm500480k&amp;key=10.1098%2Frsob.130067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm500480k&amp;key=23760366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm500480k&amp;key=1%3ACAS%3A280%3ADC%252BC3sjhsFSgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=130067&author=G.+P.+Sapkota&title=The+TGFbeta-induced+phosphorylation+and+activation+of+p38+mitogen-activated+protein+kinase+is+mediated+by+MAP3K4+and+MAP3K10+but+not+TAK1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The TGFβ-induced phosphorylation and activation of p38 mitogen-activated protein kinase is mediated by MAP3K4 and MAP3K10 but not TAK1</span></div><div class="casAuthors">Sapkota Gopal P</div><div class="citationInfo"><span class="NLM_cas:title">Open biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">130067</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The signalling pathways downstream of the transforming growth factor beta (TGFβ) family of cytokines play critical roles in all aspects of cellular homeostasis.  The phosphorylation and activation of p38 mitogen-activated protein kinase (MAPK) has been implicated in TGFβ-induced epithelial-to-mesenchymal transition and apoptosis.  The precise molecular mechanisms by which TGFβ cytokines induce the phosphorylation and activation of p38 MAPK are unclear.  In this study, I demonstrate that TGFβ-activated kinase 1 (TAK1/MAP3K7) does not play a role in the TGFβ-induced phosphorylation and activation of p38 MAPK in MEFs and HaCaT keratinocytes.  Instead, RNAi-mediated depletion of MAP3K4 and MAP3K10 results in the inhibition of the TGFβ-induced p38 MAPK phosphorylation.  Furthermore, the depletion of MAP3K10 from cells homozygously knocked-in with a catalytically inactive mutant of MAP3K4 completely abolishes the TGFβ-induced phosphorylation of p38 MAPK, implying that among MAP3Ks, MAP3K4 and MAP3K10 are sufficient for mediating the TGFβ-induced activation of p38 MAPK.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTjQjrjW36P2lf1XRtfYM0dfW6udTcc2eZF8DQcQvrbvbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sjhsFSgtw%253D%253D&md5=dd33d804cedf752115dd6a3aab906dc2</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1098%2Frsob.130067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1098%252Frsob.130067%26sid%3Dliteratum%253Aachs%26aulast%3DSapkota%26aufirst%3DG.%2BP.%26atitle%3DThe%2520TGFbeta-induced%2520phosphorylation%2520and%2520activation%2520of%2520p38%2520mitogen-activated%2520protein%2520kinase%2520is%2520mediated%2520by%2520MAP3K4%2520and%2520MAP3K10%2520but%2520not%2520TAK1%26jtitle%3DOpen%2520Biol.%26date%3D2013%26volume%3D3%26spage%3D130067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Patricelli, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szardenings, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liyanage, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomanbhoy, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissig, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aban, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozarich, J. W.</span><span> </span><span class="NLM_article-title">Functional interrogation of the kinome using nucleotide acyl phosphates</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">350</span><span class="NLM_x">–</span> <span class="NLM_lpage">358</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi062142x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm500480k&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhtlaru7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=350-358&author=M.+P.+Patricelliauthor=A.+K.+Szardeningsauthor=M.+Liyanageauthor=T.+K.+Nomanbhoyauthor=M.+Wuauthor=H.+Weissigauthor=A.+Abanauthor=D.+Chunauthor=S.+Tannerauthor=J.+W.+Kozarich&title=Functional+interrogation+of+the+kinome+using+nucleotide+acyl+phosphates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Functional Interrogation of the Kinome Using Nucleotide Acyl Phosphates</span></div><div class="casAuthors">Patricelli, Matthew P.; Szardenings, A. Katrin; Liyanage, Marek; Nomanbhoy, Tyzoon K.; Wu, Min; Weissig, Helge; Aban, Arwin; Chun, Doris; Tanner, Stephen; Kozarich, John W.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">350-358</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The central role of protein kinases in signal transduction pathways has generated intense interest in targeting these enzymes for a wide range of therapeutic indications.  Here we report a method for identifying and quantifying protein kinases in any biol. sample or tissue from any species.  The procedure relies on acyl phosphate-contg. nucleotides, prepd. from a biotin deriv. and ATP or ADP.  The acyl phosphate probes react selectively and covalently at the ATP binding sites of at least 75% of the known human protein kinases.  Biotinylated peptide fragments from labeled proteomes are captured and then sequenced and identified using a mass spectrometry-based anal. platform to det. the kinases present and their relative levels.  Further, direct competition between the probes and inhibitors can be assessed to det. inhibitor potency and selectivity against native protein kinases, as well as hundreds of other ATPases.  The ability to broadly profile kinase activities in native proteomes offers an exciting prospect for both target discovery and inhibitor selectivity profiling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiUQQGW0LLn7Vg90H21EOLACvtfcHk0licVCoda3DhyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhtlaru7rO&md5=a912b834ff5456f09f1c45ddceb15dca</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fbi062142x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi062142x%26sid%3Dliteratum%253Aachs%26aulast%3DPatricelli%26aufirst%3DM.%2BP.%26aulast%3DSzardenings%26aufirst%3DA.%2BK.%26aulast%3DLiyanage%26aufirst%3DM.%26aulast%3DNomanbhoy%26aufirst%3DT.%2BK.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DWeissig%26aufirst%3DH.%26aulast%3DAban%26aufirst%3DA.%26aulast%3DChun%26aufirst%3DD.%26aulast%3DTanner%26aufirst%3DS.%26aulast%3DKozarich%26aufirst%3DJ.%2BW.%26atitle%3DFunctional%2520interrogation%2520of%2520the%2520kinome%2520using%2520nucleotide%2520acyl%2520phosphates%26jtitle%3DBiochemistry%26date%3D2007%26volume%3D46%26spage%3D350%26epage%3D358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Patricelli, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomanbhoy, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagannathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aban, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okerberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herring, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissig, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozarich, J. W.</span><span> </span><span class="NLM_article-title">In situ kinase profiling reveals functionally relevant properties of native kinases</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">699</span><span class="NLM_x">–</span> <span class="NLM_lpage">710</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm500480k&amp;key=10.1016%2Fj.chembiol.2011.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm500480k&amp;key=21700206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm500480k&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotVejtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=699-710&author=M.+P.+Patricelliauthor=T.+K.+Nomanbhoyauthor=J.+Wuauthor=H.+Brownauthor=D.+Zhouauthor=J.+Zhangauthor=S.+Jagannathanauthor=A.+Abanauthor=E.+Okerbergauthor=C.+Herringauthor=B.+Nordinauthor=H.+Weissigauthor=Q.+Yangauthor=J.+D.+Leeauthor=N.+S.+Grayauthor=J.+W.+Kozarich&title=In+situ+kinase+profiling+reveals+functionally+relevant+properties+of+native+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">In Situ Kinase Profiling Reveals Functionally Relevant Properties of Native Kinases</span></div><div class="casAuthors">Patricelli, Matthew P.; Nomanbhoy, Tyzoon K.; Wu, Jiangyue; Brown, Heidi; Zhou, David; Zhang, Jianming; Jagannathan, Subadhra; Aban, Arwin; Okerberg, Eric; Herring, Chris; Nordin, Brian; Weissig, Helge; Yang, Qingkai; Lee, Jiing-Dwan; Gray, Nathanael S.; Kozarich, John W.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">699-710</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Protein kinases are intensely studied mediators of cellular signaling, yet important questions remain regarding their regulation and in vivo properties.  Here, we use a probe-based chemoprotemics platform to profile several well studied kinase inhibitors against >200 kinases in native cell proteomes and reveal biol. targets for some of these inhibitors.  Several striking differences were identified between native and recombinant kinase inhibitory profiles, in particular, for the Raf kinases.  The native kinase binding profiles presented here closely mirror the cellular activity of these inhibitors, even when the inhibition profiles differ dramatically from recombinant assay results.  Addnl., Raf activation events could be detected on live cell treatment with inhibitors.  These studies highlight the complexities of protein kinase behavior in the cellular context and demonstrate that profiling with only recombinant/purified enzymes can be misleading.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopb21npuaC_rVg90H21EOLACvtfcHk0licVCoda3DhyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotVejtbo%253D&md5=dda091b895850c95131f80c3aba9e8c7</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2011.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2011.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DPatricelli%26aufirst%3DM.%2BP.%26aulast%3DNomanbhoy%26aufirst%3DT.%2BK.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DJagannathan%26aufirst%3DS.%26aulast%3DAban%26aufirst%3DA.%26aulast%3DOkerberg%26aufirst%3DE.%26aulast%3DHerring%26aufirst%3DC.%26aulast%3DNordin%26aufirst%3DB.%26aulast%3DWeissig%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DLee%26aufirst%3DJ.%2BD.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DKozarich%26aufirst%3DJ.%2BW.%26atitle%3DIn%2520situ%2520kinase%2520profiling%2520reveals%2520functionally%2520relevant%2520properties%2520of%2520native%2520kinases%26jtitle%3DChem.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D699%26epage%3D710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Lebakken, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddle, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frazee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eliason, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichling, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogel, K. W.</span><span> </span><span class="NLM_article-title">Development and applications of a broad-coverage, TR-FRET-based kinase binding assay platform</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">924</span><span class="NLM_x">–</span> <span class="NLM_lpage">935</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm500480k&amp;key=10.1177%2F1087057109339207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm500480k&amp;key=19564447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm500480k&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlSjtLnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=924-935&author=C.+S.+Lebakkenauthor=S.+M.+Riddleauthor=U.+Singhauthor=W.+J.+Frazeeauthor=H.+C.+Eliasonauthor=Y.+Gaoauthor=L.+J.+Reichlingauthor=B.+D.+Marksauthor=K.+W.+Vogel&title=Development+and+applications+of+a+broad-coverage%2C+TR-FRET-based+kinase+binding+assay+platform"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Development and applications of a broad-coverage, TR-FRET-based kinase binding assay platform</span></div><div class="casAuthors">Lebakken, Connie S.; Riddle, Steven M.; Singh, Upinder; Frazee, W. Jack; Eliason, Hildegard C.; Gao, Yi; Reichling, Laurie J.; Marks, Bryan D.; Vogel, Kurt W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">924-935</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">The expansion of kinase assay technologies over the past decade has mirrored the growing interest in kinases as drug targets.  As a result, there is no shortage of convenient, fluorescence-based methods available to assay targets that span the kinome.  The authors recently reported on the development of a non-activity-based assay to characterize kinase inhibitors that depended on displacement of an Alexa Fluor 647 conjugate of staurosporine (a "tracer") from a particular kinase.  Kinase inhibitors were characterized by a change in fluorescence lifetime of the tracer when it was bound to a kinase relative to when it was displaced by an inhibitor.  Here, the authors report on improvements to this strategy by reconfiguring the assay in a time-resolved fluorescence resonance energy transfer (TR-FRET) format that simplifies instrumentation requirements and allows for the use of a substantially lower concn. of kinase than was required in the fluorescence-lifetime-based format.  The authors use this new assay to demonstrate several aspects of the binding assay format that are advantageous relative to traditional activity-based assays.  The TR-FRET binding format facilitates the assay of compds. against low-activity kinases, allows for the characterization of type II kinase inhibitors either using nonactivated kinases or by monitoring compd. potency over time, and ensures that the signal being detected is specific to the kinase of interest and not a contaminating kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqPbcMF0-PD7Vg90H21EOLACvtfcHk0licVCoda3DhyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlSjtLnM&md5=f8df51adf90d821e480cf706213cc096</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1177%2F1087057109339207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057109339207%26sid%3Dliteratum%253Aachs%26aulast%3DLebakken%26aufirst%3DC.%2BS.%26aulast%3DRiddle%26aufirst%3DS.%2BM.%26aulast%3DSingh%26aufirst%3DU.%26aulast%3DFrazee%26aufirst%3DW.%2BJ.%26aulast%3DEliason%26aufirst%3DH.%2BC.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DReichling%26aufirst%3DL.%2BJ.%26aulast%3DMarks%26aufirst%3DB.%2BD.%26aulast%3DVogel%26aufirst%3DK.%2BW.%26atitle%3DDevelopment%2520and%2520applications%2520of%2520a%2520broad-coverage%252C%2520TR-FRET-based%2520kinase%2520binding%2520assay%2520platform%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2009%26volume%3D14%26spage%3D924%26epage%3D935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Ninomiya-Tsuji, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kajino, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohtomo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mihara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuchiya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, K.</span><span> </span><span class="NLM_article-title">A resorcylic acid lactone, 5<i>Z</i>-7-oxozeaenol, prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">18485</span><span class="NLM_x">–</span> <span class="NLM_lpage">18490</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=18485-18490&author=J.+Ninomiya-Tsujiauthor=T.+Kajinoauthor=K.+Onoauthor=T.+Ohtomoauthor=M.+Matsumotoauthor=M.+Shiinaauthor=M.+Miharaauthor=M.+Tsuchiyaauthor=K.+Matsumoto&title=A+resorcylic+acid+lactone%2C+5Z-7-oxozeaenol%2C+prevents+inflammation+by+inhibiting+the+catalytic+activity+of+TAK1+MAPK+kinase+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNinomiya-Tsuji%26aufirst%3DJ.%26aulast%3DKajino%26aufirst%3DT.%26aulast%3DOno%26aufirst%3DK.%26aulast%3DOhtomo%26aufirst%3DT.%26aulast%3DMatsumoto%26aufirst%3DM.%26aulast%3DShiina%26aufirst%3DM.%26aulast%3DMihara%26aufirst%3DM.%26aulast%3DTsuchiya%26aufirst%3DM.%26aulast%3DMatsumoto%26aufirst%3DK.%26atitle%3DA%2520resorcylic%2520acid%2520lactone%252C%25205Z-7-oxozeaenol%252C%2520prevents%2520inflammation%2520by%2520inhibiting%2520the%2520catalytic%2520activity%2520of%2520TAK1%2520MAPK%2520kinase%2520kinase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D18485%26epage%3D18490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Arana-Argaez, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delgado-Rizo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pizano-Martinez, O. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez-Garcia, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin-Marquez, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz-Gomez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petri, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armendariz-Borunda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espinosa-Ramirez, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuniga-Tamayo, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrera-Esparza, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vazquez-Del Mercado, M.</span><span> </span><span class="NLM_article-title">Inhibitors of MAPK pathway ERK1/2 or p38 prevent the IL-1{beta}-induced up-regulation of SRP72 autoantigen in Jurkat cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">32824</span><span class="NLM_x">–</span> <span class="NLM_lpage">32833</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=32824-32833&author=V.+E.+Arana-Argaezauthor=V.+Delgado-Rizoauthor=O.+E.+Pizano-Martinezauthor=E.+A.+Martinez-Garciaauthor=B.+T.+Martin-Marquezauthor=A.+Munoz-Gomezauthor=M.+H.+Petriauthor=J.+Armendariz-Borundaauthor=G.+Espinosa-Ramirezauthor=D.+A.+Zuniga-Tamayoauthor=R.+Herrera-Esparzaauthor=M.+Vazquez-Del+Mercado&title=Inhibitors+of+MAPK+pathway+ERK1%2F2+or+p38+prevent+the+IL-1%7Bbeta%7D-induced+up-regulation+of+SRP72+autoantigen+in+Jurkat+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArana-Argaez%26aufirst%3DV.%2BE.%26aulast%3DDelgado-Rizo%26aufirst%3DV.%26aulast%3DPizano-Martinez%26aufirst%3DO.%2BE.%26aulast%3DMartinez-Garcia%26aufirst%3DE.%2BA.%26aulast%3DMartin-Marquez%26aufirst%3DB.%2BT.%26aulast%3DMunoz-Gomez%26aufirst%3DA.%26aulast%3DPetri%26aufirst%3DM.%2BH.%26aulast%3DArmendariz-Borunda%26aufirst%3DJ.%26aulast%3DEspinosa-Ramirez%26aufirst%3DG.%26aulast%3DZuniga-Tamayo%26aufirst%3DD.%2BA.%26aulast%3DHerrera-Esparza%26aufirst%3DR.%26aulast%3DVazquez-Del%2BMercado%26aufirst%3DM.%26atitle%3DInhibitors%2520of%2520MAPK%2520pathway%2520ERK1%252F2%2520or%2520p38%2520prevent%2520the%2520IL-1%257Bbeta%257D-induced%2520up-regulation%2520of%2520SRP72%2520autoantigen%2520in%2520Jurkat%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D32824%26epage%3D32833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Pereira, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igea, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canovas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolado, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nebreda, A. R.</span><span> </span><span class="NLM_article-title">Inhibition of p38 MAPK sensitizes tumour cells to cisplatin-induced apoptosis mediated by reactive oxygen species and JNK</span> <span class="citation_source-journal">EMBO Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1759</span><span class="NLM_x">–</span> <span class="NLM_lpage">1774</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm500480k&amp;key=10.1002%2Femmm.201302732" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm500480k&amp;key=24115572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm500480k&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWms73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=1759-1774&author=L.+Pereiraauthor=A.+Igeaauthor=B.+Canovasauthor=I.+Doladoauthor=A.+R.+Nebreda&title=Inhibition+of+p38+MAPK+sensitizes+tumour+cells+to+cisplatin-induced+apoptosis+mediated+by+reactive+oxygen+species+and+JNK"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of p38 MAPK sensitizes tumour cells to cisplatin-induced apoptosis mediated by reactive oxygen species and JNK</span></div><div class="casAuthors">Pereira, Lorena; Igea, Ana; Canovas, Begona; Dolado, Ignacio; Nebreda, Angel R.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1759-1774</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The p38 MAPK pathway is an important regulator of many cellular responses.  It is well established that p38 MAPK signalling neg. regulates epithelial cell transformation, but enhanced p38 MAPK activity has been also correlated with bad clin. prognosis in some tumor types.  Here, we provide genetic and pharmacol. evidence showing that p38 MAPK inhibition cooperates with the chemotherapeutic agent cisplatin to kill tumor cells.  We show that p38 MAPK inhibition results in ROS upregulation, which in turn activates the JNK pathway via inactivation of phosphatases, sensitizing human tumor cells to cisplatin-induced apoptosis.  Using a mouse model for breast cancer, we confirm that inhibition of p38 MAPK cooperates with cisplatin treatment to reduce tumor size and malignancy in vivo.  Taken together, our results illustrate a new function of p38 MAPK that helps tumor cells to survive chemotherapeutic drug treatments, and reveal that the combination of p38 MAPK inhibitors with cisplatin can be potentially exploited for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7MKSX0-D5tbVg90H21EOLACvtfcHk0lh9yWesqd7bPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWms73K&md5=9a4a89c0c5aae156fa159d37833cbb41</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Femmm.201302732&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Femmm.201302732%26sid%3Dliteratum%253Aachs%26aulast%3DPereira%26aufirst%3DL.%26aulast%3DIgea%26aufirst%3DA.%26aulast%3DCanovas%26aufirst%3DB.%26aulast%3DDolado%26aufirst%3DI.%26aulast%3DNebreda%26aufirst%3DA.%2BR.%26atitle%3DInhibition%2520of%2520p38%2520MAPK%2520sensitizes%2520tumour%2520cells%2520to%2520cisplatin-induced%2520apoptosis%2520mediated%2520by%2520reactive%2520oxygen%2520species%2520and%2520JNK%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2013%26volume%3D5%26spage%3D1759%26epage%3D1774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Sato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanjo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ninomiya-Tsuji, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akira, S.</span><span> </span><span class="NLM_article-title">Essential function for the kinase TAK1 in innate and adaptive immune responses</span> <span class="citation_source-journal">Nat. Immunol</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1087</span><span class="NLM_x">–</span> <span class="NLM_lpage">1095</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm500480k&amp;key=10.1038%2Fni1255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm500480k&amp;key=16186825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm500480k&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFamsb7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=1087-1095&author=S.+Satoauthor=H.+Sanjoauthor=K.+Takedaauthor=J.+Ninomiya-Tsujiauthor=M.+Yamamotoauthor=T.+Kawaiauthor=K.+Matsumotoauthor=O.+Takeuchiauthor=S.+Akira&title=Essential+function+for+the+kinase+TAK1+in+innate+and+adaptive+immune+responses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Essential function for the kinase TAK1 in innate and adaptive immune responses</span></div><div class="casAuthors">Sato, Shintaro; Sanjo, Hideki; Takeda, Kiyoshi; Ninomiya-Tsuji, Jun; Yamamoto, Masahiro; Kawai, Taro; Matsumoto, Kunihiro; Takeuchi, Osamu; Akira, Shizuo</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1087-1095</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Transforming growth factor-β-activated kinase 1 (TAK1) has been linked to interleukin 1 receptor and tumor necrosis factor receptor signaling.  Here the authors generated mouse strains with conditional expression of a Map3k7 allele encoding part of TAK1.  TAK1-deficient embryonic fibroblasts demonstrated loss of responses to interleukin 1β and tumor necrosis factor.  Studies of mice with B cell-specific TAK1 deficiency showed that TAK1 was indispensable for cellular responses to Toll-like receptor ligands, CD40 and B cell receptor crosslinking.  In addn., antigen-induced immune responses were considerably impaired in mice with B cell-specific TAK1 deficiency.  TAK1-deficient cells failed to activate transcription factor NF-κB and mitogen-activated protein kinases in response to interleukin 1β, tumor necrosis factor and Toll-like receptor ligands.  However, TAK1-deficient B cells were able to activate NF-κB but not the kinase Jnk in response to B cell receptor stimulation.  These results collectively indicate that TAK1 is key in the cellular response to a variety of stimuli.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrq9Ks8rBWwNbVg90H21EOLACvtfcHk0lh9yWesqd7bPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFamsb7K&md5=7d9a7b4799b65cc1c53f4c2ec57c8943</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fni1255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni1255%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DS.%26aulast%3DSanjo%26aufirst%3DH.%26aulast%3DTakeda%26aufirst%3DK.%26aulast%3DNinomiya-Tsuji%26aufirst%3DJ.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DKawai%26aufirst%3DT.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DTakeuchi%26aufirst%3DO.%26aulast%3DAkira%26aufirst%3DS.%26atitle%3DEssential%2520function%2520for%2520the%2520kinase%2520TAK1%2520in%2520innate%2520and%2520adaptive%2520immune%2520responses%26jtitle%3DNat.%2520Immunol%26date%3D2005%26volume%3D6%26spage%3D1087%26epage%3D1095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Schirmer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santi, D. V.</span><span> </span><span class="NLM_article-title">Targeted covalent inactivation of protein kinases by resorcylic acid lactone polyketides</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">4234</span><span class="NLM_x">–</span> <span class="NLM_lpage">4239</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm500480k&amp;key=10.1073%2Fpnas.0600445103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm500480k&amp;key=16537514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm500480k&amp;key=1%3ACAS%3A528%3ADC%252BD28XivFWhsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=4234-4239&author=A.+Schirmerauthor=J.+Kennedyauthor=S.+Murliauthor=R.+Reidauthor=D.+V.+Santi&title=Targeted+covalent+inactivation+of+protein+kinases+by+resorcylic+acid+lactone+polyketides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted covalent inactivation of protein kinases by resorcylic acid lactone polyketides</span></div><div class="casAuthors">Schirmer, Andreas; Kennedy, Jonathan; Murli, Sumati; Reid, Ralph; Santi, Daniel V.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4234-4239</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Resorcylic acid lactones contg. a cis-enone are susceptible to Michael addn. reactions and are potent inhibitors of several protein kinases.  A structural-bioinformatics anal. identified a conserved Cys residue in the ATP-binding site of the kinases reported to be inhibited by cis-enone resorcylic acid lactones but absent in those that are not.  Mining of the kinome database revealed that a subset of some 46 kinases contained this Cys residue.  Screening a panel of 124 kinases with the resorcylic acid lactone hypothemycin showed that 18 of 19 targets contg. the conserved Cys were inhibited.  Kinetic analyses showed time-dependent inhibition, a hallmark of covalent inactivation, and biochem. studies of the interaction of extracellular signal-regulated kinase (ERK)2 with hypothemycin confirmed covalent adduct formation.  Resorcylic acid lactones are unique among kinase inhibitors in that they target mitogen-activated protein (MAP) kinase pathways at four levels: mitogen receptors, MAP kinase kinase (MEK)1/2 and ERK1/2, and certain downstream ERK substrates.  Cell lines dependent on the activation of Tyr kinase mitogen receptor targets of the resorcylic acid lactones were unusually sensitive toward hypothemycin and showed the expected inhibition of kinase phosphorylation due to inhibition of the mitogen receptors and/or MEK1/2 and ERK1/2.  Among cells without mitogen receptor targets, those harboring an ERK pathway-activating B-RAF V600E mutation were selectively and potently inhibited by hypothemycin.  Hypothemycin also prevented stimulated activation of the p38 cascade through inhibition of the Cys-contg. targets MEK3/6 and TGF-β-activated kinase 1 and of the JNK/SAPK (c-Jun N-terminal kinase/stress-activated protein kinase) cascade through inhibition of MEK4/7.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraww22qbwEYLVg90H21EOLACvtfcHk0lh9yWesqd7bPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XivFWhsr0%253D&md5=6a4be819f2c2a5a601e5c9cb75faf433</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0600445103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0600445103%26sid%3Dliteratum%253Aachs%26aulast%3DSchirmer%26aufirst%3DA.%26aulast%3DKennedy%26aufirst%3DJ.%26aulast%3DMurli%26aufirst%3DS.%26aulast%3DReid%26aufirst%3DR.%26aulast%3DSanti%26aufirst%3DD.%2BV.%26atitle%3DTargeted%2520covalent%2520inactivation%2520of%2520protein%2520kinases%2520by%2520resorcylic%2520acid%2520lactone%2520polyketides%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D4234%26epage%3D4239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Brown, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vial, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dedi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunster, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheetham, G. M.</span><span> </span><span class="NLM_article-title">Structural basis for the interaction of TAK1 kinase with its activating protein TAB1</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">354</span><span class="NLM_x">, </span> <span class="NLM_fpage">1013</span><span class="NLM_x">–</span> <span class="NLM_lpage">1020</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=354&publication_year=2005&pages=1013-1020&author=K.+Brownauthor=S.+C.+Vialauthor=N.+Dediauthor=J.+M.+Longauthor=N.+J.+Dunsterauthor=G.+M.+Cheetham&title=Structural+basis+for+the+interaction+of+TAK1+kinase+with+its+activating+protein+TAB1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DK.%26aulast%3DVial%26aufirst%3DS.%2BC.%26aulast%3DDedi%26aufirst%3DN.%26aulast%3DLong%26aufirst%3DJ.%2BM.%26aulast%3DDunster%26aufirst%3DN.%2BJ.%26aulast%3DCheetham%26aufirst%3DG.%2BM.%26atitle%3DStructural%2520basis%2520for%2520the%2520interaction%2520of%2520TAK1%2520kinase%2520with%2520its%2520activating%2520protein%2520TAB1%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2005%26volume%3D354%26spage%3D1013%26epage%3D1020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsen, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byth, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toader, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saeh, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span> </span><span class="NLM_article-title">Mechanism and in vitro pharmacology of TAK1 inhibition by (5<i>Z</i>)-7-Oxozeaenol</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">643</span><span class="NLM_x">–</span> <span class="NLM_lpage">650</span></span><div class="citationLinks">[<a href="/doi/10.1021/cb3005897" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=643-650&author=J.+Wuauthor=F.+Powellauthor=N.+A.+Larsenauthor=Z.+Laiauthor=K.+F.+Bythauthor=J.+Readauthor=R.+F.+Guauthor=M.+Rothauthor=D.+Toaderauthor=J.+C.+Saehauthor=H.+Chen&title=Mechanism+and+in+vitro+pharmacology+of+TAK1+inhibition+by+%285Z%29-7-Oxozeaenol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fcb3005897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb3005897%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DPowell%26aufirst%3DF.%26aulast%3DLarsen%26aufirst%3DN.%2BA.%26aulast%3DLai%26aufirst%3DZ.%26aulast%3DByth%26aufirst%3DK.%2BF.%26aulast%3DRead%26aufirst%3DJ.%26aulast%3DGu%26aufirst%3DR.%2BF.%26aulast%3DRoth%26aufirst%3DM.%26aulast%3DToader%26aufirst%3DD.%26aulast%3DSaeh%26aufirst%3DJ.%2BC.%26aulast%3DChen%26aufirst%3DH.%26atitle%3DMechanism%2520and%2520in%2520vitro%2520pharmacology%2520of%2520TAK1%2520inhibition%2520by%2520%25285Z%2529-7-Oxozeaenol%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D643%26epage%3D650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Minor, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cymborowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otwinowski, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chruszcz, M.</span><span> </span><span class="NLM_article-title">HKL-3000: the integration of data reduction and structure solution—from diffraction images to an initial model in minutes</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">859</span><span class="NLM_x">–</span> <span class="NLM_lpage">866</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=859-866&author=W.+Minorauthor=M.+Cymborowskiauthor=Z.+Otwinowskiauthor=M.+Chruszcz&title=HKL-3000%3A+the+integration+of+data+reduction+and+structure+solution%E2%80%94from+diffraction+images+to+an+initial+model+in+minutes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMinor%26aufirst%3DW.%26aulast%3DCymborowski%26aufirst%3DM.%26aulast%3DOtwinowski%26aufirst%3DZ.%26aulast%3DChruszcz%26aufirst%3DM.%26atitle%3DHKL-3000%253A%2520the%2520integration%2520of%2520data%2520reduction%2520and%2520structure%2520solution%25E2%2580%2594from%2520diffraction%2520images%2520to%2520an%2520initial%2520model%2520in%2520minutes%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2006%26volume%3D62%26spage%3D859%26epage%3D866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Collaborative Computational Project, Number 4.</span><span> </span><span class="NLM_article-title">The CCP4 suite: programs for protein crystallography</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">760</span><span class="NLM_x">–</span> <span class="NLM_lpage">763</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm500480k&amp;key=10.1107%2FS0907444994003112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm500480k&amp;key=15299374" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1994&pages=760-763&author=Collaborative+Computational+Project%2C+Number+4.&title=The+CCP4+suite%3A+programs+for+protein+crystallography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1107%2FS0907444994003112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444994003112%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DThe%2520CCP4%2520suite%253A%2520programs%2520for%2520protein%2520crystallography%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1994%26volume%3D50%26spage%3D760%26epage%3D763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Coot: model-building tools for molecular graphics</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2126</span><span class="NLM_x">–</span> <span class="NLM_lpage">2132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm500480k&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm500480k&amp;key=15572765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm500480k&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+model-building+tools+for+molecular+graphics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0ljhwu6epXN8fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2126%26epage%3D2132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Afonine, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunkoczi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Echols, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Headd, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapral, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriarty, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oeffner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terwilliger, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwart, P. H.</span><span> </span><span class="NLM_article-title">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">221</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm500480k&amp;key=10.1107%2FS0907444909052925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm500480k&amp;key=20124702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm500480k&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=213-221&author=P.+D.+Adamsauthor=P.+V.+Afonineauthor=G.+Bunkocziauthor=V.+B.+Chenauthor=I.+W.+Davisauthor=N.+Echolsauthor=J.+J.+Headdauthor=L.+W.+Hungauthor=G.+J.+Kapralauthor=R.+W.+Grosse-Kunstleveauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+Oeffnerauthor=R.+J.+Readauthor=D.+C.+Richardsonauthor=J.+S.+Richardsonauthor=T.+C.+Terwilligerauthor=P.+H.+Zwart&title=PHENIX%3A+a+comprehensive+Python-based+system+for+macromolecular+structure+solution"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span></div><div class="casAuthors">Adams, Paul D.; Afonine, Pavel V.; Bunkoczi, Gabor; Chen, Vincent B.; Davis, Ian W.; Echols, Nathaniel; Headd, Jeffrey J.; Hung, Li Wei; Kapral, Gary J.; Grosse-Kunstleve, Ralf W.; McCoy, Airlie J.; Moriarty, Nigel W.; Oeffner, Robert; Read, Randy J.; Richardson, David C.; Richardson, Jane S.; Terwilliger, Thomas C.; Zwart, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-221</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  Macromol. X-ray crystallog. is routinely applied to understand biol. processes at a mol. level.  However, significant time and effort are still required to solve and complete many of these structures because of the need for manual interpretation of complex numerical data using many software packages and the repeated use of interactive three-dimensional graphics.  PHENIX has been developed to provide a comprehensive system for macromol. crystallog. structure soln. with an emphasis on the automation of all procedures.  This has relied on the development of algorithms that minimize or eliminate subjective input, the development of algorithms that automate procedures that are traditionally performed by hand and, finally, the development of a framework that allows a tight integration between the algorithms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm_HgKRpa-ObVg90H21EOLACvtfcHk0lgmD8UjtfHBhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D&md5=67b439ff4bd61c659cae37ca4209b7bc</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1107%2FS0907444909052925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909052925%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DBunkoczi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DHung%26aufirst%3DL.%2BW.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DOeffner%26aufirst%3DR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26atitle%3DPHENIX%253A%2520a%2520comprehensive%2520Python-based%2520system%2520for%2520macromolecular%2520structure%2520solution%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D213%26epage%3D221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 45 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Johan J. N. Veerman, Yorik B. Bruseker, Eddy Damen, Erik H. Heijne, Wendy van Bruggen, Koen F. W. Hekking, Rob Winkel, Christopher D. Hupp, Anthony D. Keefe, Julie Liu, Heather A. Thomson, Ying Zhang, John W. Cuozzo, Andrew J. McRiner, Mark J. Mulvihill, Peter van Rijnsbergen, Birgit Zech, Louis M. Renzetti, Lee Babiss, <span class="NLM_string-name hlFld-ContribAuthor">Gerhard Müller</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 2,4-1H-Imidazole Carboxamides as Potent and Selective TAK1 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>12 </em>
                                    (4)
                                     , 555-562. <a href="https://doi.org/10.1021/acsmedchemlett.0c00547" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00547</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00547%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B2%25252C4-1H-Imidazole%252BCarboxamides%252Bas%252BPotent%252Band%252BSelective%252BTAK1%252BInhibitors%26aulast%3DVeerman%26aufirst%3DJohan%2BJ.%2BN.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D12102020%26date%3D24022021%26date%3D03032021%26volume%3D12%26issue%3D4%26spage%3D555%26epage%3D562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ryan H. B. Smith, Zaigham M. Khan, Peter Man-Un Ung, Alex P. Scopton, Lisa Silber, Seshat M. Mack, Alexander M. Real, Avner Schlessinger, <span class="NLM_string-name hlFld-ContribAuthor">Arvin C. Dar</span>. </span><span class="cited-content_cbyCitation_article-title">Type II Binders Targeting the “GLR-Out” Conformation of the Pseudokinase STRADα. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2021,</strong> <em>60 </em>
                                    (4)
                                     , 289-302. <a href="https://doi.org/10.1021/acs.biochem.0c00714" title="DOI URL">https://doi.org/10.1021/acs.biochem.0c00714</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.biochem.0c00714&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.biochem.0c00714%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%26atitle%3DType%252BII%252BBinders%252BTargeting%252Bthe%252B%2525E2%252580%25259CGLR-Out%2525E2%252580%25259D%252BConformation%252Bof%252Bthe%252BPseudokinase%252BSTRAD%2525CE%2525B1%26aulast%3DSmith%26aufirst%3DRyan%2BH.%2BB.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D16092020%26date%3D14122020%26date%3D13012021%26volume%3D60%26issue%3D4%26spage%3D289%26epage%3D302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Rizwana Afroz, Ying Zhou, Peter J. Little, Suowen Xu, Raafat Mohamed, Jennifer Stow, <span class="NLM_string-name hlFld-ContribAuthor">Danielle Kamato</span>. </span><span class="cited-content_cbyCitation_article-title">Toll-like Receptor 4 Stimulates Gene Expression via Smad2 Linker Region Phosphorylation in Vascular Smooth Muscle Cells. </span><span class="cited-content_cbyCitation_journal-name">ACS Pharmacology & Translational Science</span><span> <strong>2020,</strong> <em>3 </em>
                                    (3)
                                     , 524-534. <a href="https://doi.org/10.1021/acsptsci.9b00113" title="DOI URL">https://doi.org/10.1021/acsptsci.9b00113</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsptsci.9b00113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsptsci.9b00113%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Pharmacology%2520%2526%2520Translational%2520Science%26atitle%3DToll-like%252BReceptor%252B4%252BStimulates%252BGene%252BExpression%252Bvia%252BSmad2%252BLinker%252BRegion%252BPhosphorylation%252Bin%252BVascular%252BSmooth%252BMuscle%252BCells%26aulast%3DAfroz%26aufirst%3DRizwana%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D12122019%26date%3D19032020%26date%3D11032020%26volume%3D3%26issue%3D3%26spage%3D524%26epage%3D534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hanna Cho, Injae Shin, Eunhye Ju, Seunghye Choi, Wooyoung Hur, Haelee Kim, Eunmi Hong, Nam Doo Kim, Hwan Geun Choi, Nathanael S. Gray, <span class="NLM_string-name hlFld-ContribAuthor">Taebo Sim</span>. </span><span class="cited-content_cbyCitation_article-title">First SAR Study for Overriding NRAS Mutant Driven Acute Myeloid Leukemia. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (18)
                                     , 8353-8373. <a href="https://doi.org/10.1021/acs.jmedchem.8b00882" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00882</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00882&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00882%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFirst%252BSAR%252BStudy%252Bfor%252BOverriding%252BNRAS%252BMutant%252BDriven%252BAcute%252BMyeloid%252BLeukemia%26aulast%3DCho%26aufirst%3DHanna%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D04062018%26date%3D11092018%26date%3D28082018%26volume%3D61%26issue%3D18%26spage%3D8353%26epage%3D8373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chun-Hui  Zhang</span>, <span class="hlFld-ContribAuthor ">Kai  Chen</span>, <span class="hlFld-ContribAuthor ">Yan  Jiao</span>, <span class="hlFld-ContribAuthor ">Lin-Li  Li</span>, <span class="hlFld-ContribAuthor ">Ya-Ping  Li</span>, <span class="hlFld-ContribAuthor ">Rong-Jie  Zhang</span>, <span class="hlFld-ContribAuthor ">Ming-Wu  Zheng</span>, <span class="hlFld-ContribAuthor ">Lei  Zhong</span>, <span class="hlFld-ContribAuthor ">Shen-Zhen  Huang</span>, <span class="hlFld-ContribAuthor ">Chun-Li  Song</span>, <span class="hlFld-ContribAuthor ">Wan-Ting  Lin</span>, <span class="hlFld-ContribAuthor ">Jiao  Yang</span>, <span class="hlFld-ContribAuthor ">Rong  Xiang</span>, <span class="hlFld-ContribAuthor ">Bing  Peng</span>, <span class="hlFld-ContribAuthor ">Jun-Hong  Han</span>, <span class="hlFld-ContribAuthor ">Guang-Wen  Lu</span>, <span class="hlFld-ContribAuthor ">Yu-Quan  Wei</span>, and <span class="hlFld-ContribAuthor ">Sheng-Yong  Yang</span>  . </span><span class="cited-content_cbyCitation_article-title">From Lead to Drug Candidate: Optimization of 3-(Phenylethynyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine Derivatives as Agents for the Treatment of Triple Negative Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (21)
                                     , 9788-9805. <a href="https://doi.org/10.1021/acs.jmedchem.6b00943" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00943</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00943&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00943%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFrom%252BLead%252Bto%252BDrug%252BCandidate%25253A%252BOptimization%252Bof%252B3-%252528Phenylethynyl%252529-1H-pyrazolo%25255B3%25252C4-d%25255Dpyrimidin-4-amine%252BDerivatives%252Bas%252BAgents%252Bfor%252Bthe%252BTreatment%252Bof%252BTriple%252BNegative%252BBreast%252BCancer%26aulast%3DZhang%26aufirst%3DChun-Hui%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D26062016%26date%3D26102016%26date%3D10112016%26date%3D14102016%26volume%3D59%26issue%3D21%26spage%3D9788%26epage%3D9805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Linxin  Zhu</span>, <span class="hlFld-ContribAuthor ">Suraj  Lama</span>, <span class="hlFld-ContribAuthor ">Leilei  Tu</span>, <span class="hlFld-ContribAuthor ">Gregory J.  Dusting</span>, <span class="hlFld-ContribAuthor ">Jiang-Hui  Wang</span>, <span class="hlFld-ContribAuthor ">Guei-Sheung  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">TAK1 signaling is a potential therapeutic target for pathological angiogenesis. </span><span class="cited-content_cbyCitation_journal-name">Angiogenesis</span><span> <strong>2021,</strong> <em>24 </em>
                                    (3)
                                     , 453-470. <a href="https://doi.org/10.1007/s10456-021-09787-5" title="DOI URL">https://doi.org/10.1007/s10456-021-09787-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10456-021-09787-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10456-021-09787-5%26sid%3Dliteratum%253Aachs%26jtitle%3DAngiogenesis%26atitle%3DTAK1%252Bsignaling%252Bis%252Ba%252Bpotential%252Btherapeutic%252Btarget%252Bfor%252Bpathological%252Bangiogenesis%26aulast%3DZhu%26aufirst%3DLinxin%26date%3D2021%26date%3D2021%26volume%3D24%26issue%3D3%26spage%3D453%26epage%3D470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shirong  Li</span>, <span class="hlFld-ContribAuthor ">Jing  Fu</span>, <span class="hlFld-ContribAuthor ">Jun  Yang</span>, <span class="hlFld-ContribAuthor ">Huihui  Ma</span>, <span class="hlFld-ContribAuthor ">Divaya  Bhutani</span>, <span class="hlFld-ContribAuthor ">Markus Y.  Mapara</span>, <span class="hlFld-ContribAuthor ">Christophe  Marcireau</span>, <span class="hlFld-ContribAuthor ">Suzanne  Lentzsch</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the GCK pathway: a novel and selective therapeutic strategy against RAS-mutated multiple myeloma. </span><span class="cited-content_cbyCitation_journal-name">Blood</span><span> <strong>2021,</strong> <em>137 </em>
                                    (13)
                                     , 1754-1764. <a href="https://doi.org/10.1182/blood.2020006334" title="DOI URL">https://doi.org/10.1182/blood.2020006334</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1182/blood.2020006334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1182%2Fblood.2020006334%26sid%3Dliteratum%253Aachs%26jtitle%3DBlood%26atitle%3DTargeting%252Bthe%252BGCK%252Bpathway%25253A%252Ba%252Bnovel%252Band%252Bselective%252Btherapeutic%252Bstrategy%252Bagainst%252BRAS-mutated%252Bmultiple%252Bmyeloma%26aulast%3DLi%26aufirst%3DShirong%26date%3D2021%26volume%3D137%26issue%3D13%26spage%3D1754%26epage%3D1764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dengqiu  Xu</span>, <span class="hlFld-ContribAuthor ">Sijia  Li</span>, <span class="hlFld-ContribAuthor ">Lu  Wang</span>, <span class="hlFld-ContribAuthor ">Jingwei  Jiang</span>, <span class="hlFld-ContribAuthor ">Lei  Zhao</span>, <span class="hlFld-ContribAuthor ">Xiaofei  Huang</span>, <span class="hlFld-ContribAuthor ">Zeren  Sun</span>, <span class="hlFld-ContribAuthor ">Chunjie  Li</span>, <span class="hlFld-ContribAuthor ">Lixin  Sun</span>, <span class="hlFld-ContribAuthor ">Xihua  Li</span>, <span class="hlFld-ContribAuthor ">Zhenzhou  Jiang</span>, <span class="hlFld-ContribAuthor ">Luyong  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">TAK1 inhibition improves myoblast differentiation and alleviates fibrosis in a mouse model of Duchenne muscular dystrophy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cachexia, Sarcopenia and Muscle</span><span> <strong>2021,</strong> <em>12 </em>
                                    (1)
                                     , 192-208. <a href="https://doi.org/10.1002/jcsm.12650" title="DOI URL">https://doi.org/10.1002/jcsm.12650</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jcsm.12650&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjcsm.12650%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cachexia%252C%2520Sarcopenia%2520and%2520Muscle%26atitle%3DTAK1%252Binhibition%252Bimproves%252Bmyoblast%252Bdifferentiation%252Band%252Balleviates%252Bfibrosis%252Bin%252Ba%252Bmouse%252Bmodel%252Bof%252BDuchenne%252Bmuscular%252Bdystrophy%26aulast%3DXu%26aufirst%3DDengqiu%26date%3D2021%26date%3D2020%26volume%3D12%26issue%3D1%26spage%3D192%26epage%3D208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuxuan  Chen</span>, <span class="hlFld-ContribAuthor ">Han  Han</span>, <span class="hlFld-ContribAuthor ">Gayoung  Seo</span>, <span class="hlFld-ContribAuthor ">Rebecca Elizabeth  Vargas</span>, <span class="hlFld-ContribAuthor ">Bing  Yang</span>, <span class="hlFld-ContribAuthor ">Kimberly  Chuc</span>, <span class="hlFld-ContribAuthor ">Huabin  Zhao</span>, <span class="hlFld-ContribAuthor ">Wenqi  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Systematic analysis of the Hippo pathway organization and oncogenic alteration in evolution. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-020-60120-4" title="DOI URL">https://doi.org/10.1038/s41598-020-60120-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-020-60120-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-020-60120-4%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DSystematic%252Banalysis%252Bof%252Bthe%252BHippo%252Bpathway%252Borganization%252Band%252Boncogenic%252Balteration%252Bin%252Bevolution%26aulast%3DChen%26aufirst%3DYuxuan%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin  Schröder</span>, <span class="hlFld-ContribAuthor ">Li  Tan</span>, <span class="hlFld-ContribAuthor ">Jinhua  Wang</span>, <span class="hlFld-ContribAuthor ">Yanke  Liang</span>, <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>, <span class="hlFld-ContribAuthor ">Stefan  Knapp</span>, <span class="hlFld-ContribAuthor ">Apirat  Chaikuad</span>. </span><span class="cited-content_cbyCitation_article-title">Catalytic Domain Plasticity of MKK7 Reveals Structural Mechanisms of Allosteric Activation and Diverse Targeting Opportunities. </span><span class="cited-content_cbyCitation_journal-name">Cell Chemical Biology</span><span> <strong>2020,</strong> <em>27 </em>
                                    (10)
                                     , 1285-1295.e4. <a href="https://doi.org/10.1016/j.chembiol.2020.07.014" title="DOI URL">https://doi.org/10.1016/j.chembiol.2020.07.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2020.07.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2020.07.014%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Chemical%2520Biology%26atitle%3DCatalytic%252BDomain%252BPlasticity%252Bof%252BMKK7%252BReveals%252BStructural%252BMechanisms%252Bof%252BAllosteric%252BActivation%252Band%252BDiverse%252BTargeting%252BOpportunities%26aulast%3DSchr%25C3%25B6der%26aufirst%3DMartin%26date%3D2020%26volume%3D27%26issue%3D10%26spage%3D1285%26epage%3D1295.e4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amy L.  Strong</span>, <span class="hlFld-ContribAuthor ">Philip J.  Spreadborough</span>, <span class="hlFld-ContribAuthor ">Chase A.  Pagani</span>, <span class="hlFld-ContribAuthor ">Ryan M.  Haskins</span>, <span class="hlFld-ContribAuthor ">Devaveena  Dey</span>, <span class="hlFld-ContribAuthor ">Patrick D.  Grimm</span>, <span class="hlFld-ContribAuthor ">Keiko  Kaneko</span>, <span class="hlFld-ContribAuthor ">Simone  Marini</span>, <span class="hlFld-ContribAuthor ">Amanda K.  Huber</span>, <span class="hlFld-ContribAuthor ">Charles  Hwang</span>, <span class="hlFld-ContribAuthor ">Kenneth  Westover</span>, <span class="hlFld-ContribAuthor ">Yuji  Mishina</span>, <span class="hlFld-ContribAuthor ">Matthew J.  Bradley</span>, <span class="hlFld-ContribAuthor ">Benjamin  Levi</span>, <span class="hlFld-ContribAuthor ">Thomas A.  Davis</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecule inhibition of non-canonical (TAK1-mediated) BMP signaling results in reduced chondrogenic ossification and heterotopic ossification in a rat model of blast-associated combat-related lower limb trauma. </span><span class="cited-content_cbyCitation_journal-name">Bone</span><span> <strong>2020,</strong> <em>139 </em>, 115517. <a href="https://doi.org/10.1016/j.bone.2020.115517" title="DOI URL">https://doi.org/10.1016/j.bone.2020.115517</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bone.2020.115517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bone.2020.115517%26sid%3Dliteratum%253Aachs%26jtitle%3DBone%26atitle%3DSmall%252Bmolecule%252Binhibition%252Bof%252Bnon-canonical%252B%252528TAK1-mediated%252529%252BBMP%252Bsignaling%252Bresults%252Bin%252Breduced%252Bchondrogenic%252Bossification%252Band%252Bheterotopic%252Bossification%252Bin%252Ba%252Brat%252Bmodel%252Bof%252Bblast-associated%252Bcombat-related%252Blower%252Blimb%252Btrauma%26aulast%3DStrong%26aufirst%3DAmy%2BL.%26date%3D2020%26volume%3D139%26spage%3D115517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Juliane  Totzke</span>, <span class="hlFld-ContribAuthor ">Scott A.  Scarneo</span>, <span class="hlFld-ContribAuthor ">Kelly W.  Yang</span>, <span class="hlFld-ContribAuthor ">Timothy A. J.  Haystead</span>. </span><span class="cited-content_cbyCitation_article-title">TAK1: a potent tumour necrosis factor inhibitor for the treatment of inflammatory diseases. </span><span class="cited-content_cbyCitation_journal-name">Open Biology</span><span> <strong>2020,</strong> <em>10 </em>
                                    (9)
                                     , 200099. <a href="https://doi.org/10.1098/rsob.200099" title="DOI URL">https://doi.org/10.1098/rsob.200099</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1098/rsob.200099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1098%2Frsob.200099%26sid%3Dliteratum%253Aachs%26jtitle%3DOpen%2520Biology%26atitle%3DTAK1%25253A%252Ba%252Bpotent%252Btumour%252Bnecrosis%252Bfactor%252Binhibitor%252Bfor%252Bthe%252Btreatment%252Bof%252Binflammatory%252Bdiseases%26aulast%3DTotzke%26aufirst%3DJuliane%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D9%26spage%3D200099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nina  Friese</span>, <span class="hlFld-ContribAuthor ">Mattis Benno  Gierschner</span>, <span class="hlFld-ContribAuthor ">Patrik  Schadzek</span>, <span class="hlFld-ContribAuthor ">Yvonne  Roger</span>, <span class="hlFld-ContribAuthor ">Andrea  Hoffmann</span>. </span><span class="cited-content_cbyCitation_article-title">Regeneration of Damaged Tendon-Bone Junctions (Entheses)—TAK1 as a Potential Node Factor. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (15)
                                     , 5177. <a href="https://doi.org/10.3390/ijms21155177" title="DOI URL">https://doi.org/10.3390/ijms21155177</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21155177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21155177%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DRegeneration%252Bof%252BDamaged%252BTendon-Bone%252BJunctions%252B%252528Entheses%252529%2525E2%252580%252594TAK1%252Bas%252Ba%252BPotential%252BNode%252BFactor%26aulast%3DFriese%26aufirst%3DNina%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D15%26spage%3D5177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel  P O’Malley</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in inhibitors of C-terminal SRC kinase. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2020,</strong> <em>12 </em>
                                    (16)
                                     , 1447-1449. <a href="https://doi.org/10.4155/fmc-2020-0125" title="DOI URL">https://doi.org/10.4155/fmc-2020-0125</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2020-0125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2020-0125%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvances%252Bin%252Binhibitors%252Bof%252BC-terminal%252BSRC%252Bkinase%26aulast%3DP%25C2%25A0O%25E2%2580%2599Malley%26aufirst%3DDaniel%26date%3D2020%26volume%3D12%26issue%3D16%26spage%3D1447%26epage%3D1449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dejuan  Sun</span>, <span class="hlFld-ContribAuthor ">Yuqian  Zhao</span>, <span class="hlFld-ContribAuthor ">Shouyue  Zhang</span>, <span class="hlFld-ContribAuthor ">Lan  Zhang</span>, <span class="hlFld-ContribAuthor ">Bo  Liu</span>, <span class="hlFld-ContribAuthor ">Liang  Ouyang</span>. </span><span class="cited-content_cbyCitation_article-title">Dual-target kinase drug design: Current strategies and future directions in cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>188 </em>, 112025. <a href="https://doi.org/10.1016/j.ejmech.2019.112025" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.112025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.112025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.112025%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDual-target%252Bkinase%252Bdrug%252Bdesign%25253A%252BCurrent%252Bstrategies%252Band%252Bfuture%252Bdirections%252Bin%252Bcancer%252Btherapy%26aulast%3DSun%26aufirst%3DDejuan%26date%3D2020%26volume%3D188%26spage%3D112025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Scott A.  Scarneo</span>, <span class="hlFld-ContribAuthor ">Philip F.  Hughes</span>, <span class="hlFld-ContribAuthor ">Kelly W.  Yang</span>, <span class="hlFld-ContribAuthor ">David A.  Carlson</span>, <span class="hlFld-ContribAuthor ">Deepak  Gurbani</span>, <span class="hlFld-ContribAuthor ">Kenneth D.  Westover</span>, <span class="hlFld-ContribAuthor ">Timothy A.J.  Haystead</span>. </span><span class="cited-content_cbyCitation_article-title">A highly selective inhibitor of interleukin-1 receptor–associated kinases 1/4 (IRAK-1/4) delineates the distinct signaling roles of IRAK-1/4 and the TAK1 kinase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2020,</strong> <em>295 </em>
                                    (6)
                                     , 1565-1574. <a href="https://doi.org/10.1074/jbc.RA119.011857" title="DOI URL">https://doi.org/10.1074/jbc.RA119.011857</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.RA119.011857&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.RA119.011857%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DA%252Bhighly%252Bselective%252Binhibitor%252Bof%252Binterleukin-1%252Breceptor%2525E2%252580%252593associated%252Bkinases%252B1%25252F4%252B%252528IRAK-1%25252F4%252529%252Bdelineates%252Bthe%252Bdistinct%252Bsignaling%252Broles%252Bof%252BIRAK-1%25252F4%252Band%252Bthe%252BTAK1%252Bkinase%26aulast%3DScarneo%26aufirst%3DScott%2BA.%26date%3D2020%26volume%3D295%26issue%3D6%26spage%3D1565%26epage%3D1574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Seok Jong  Kang</span>, <span class="hlFld-ContribAuthor ">Jung Wuk  Lee</span>, <span class="hlFld-ContribAuthor ">Jiho  Song</span>, <span class="hlFld-ContribAuthor ">Jiwon  Park</span>, <span class="hlFld-ContribAuthor ">Jaeyul  Choi</span>, <span class="hlFld-ContribAuthor ">Kwee Hyun  Suh</span>, <span class="hlFld-ContribAuthor ">Kyung Hoon  Min</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological activity of 2-cyanoacrylamide derivatives tethered to imidazopyridine as TAK1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2020,</strong> <em>35 </em>
                                    (1)
                                     , 1928-1936. <a href="https://doi.org/10.1080/14756366.2020.1833876" title="DOI URL">https://doi.org/10.1080/14756366.2020.1833876</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2020.1833876&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2020.1833876%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bactivity%252Bof%252B2-cyanoacrylamide%252Bderivatives%252Btethered%252Bto%252Bimidazopyridine%252Bas%252BTAK1%252Binhibitors%26aulast%3DKang%26aufirst%3DSeok%2BJong%26date%3D2020%26date%3D2020%26volume%3D35%26issue%3D1%26spage%3D1928%26epage%3D1936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adolfo  Cuesta</span>, <span class="hlFld-ContribAuthor ">Jack  Taunton</span>. </span><span class="cited-content_cbyCitation_article-title">Lysine-Targeted Inhibitors and Chemoproteomic Probes. </span><span class="cited-content_cbyCitation_journal-name">Annual Review of Biochemistry</span><span> <strong>2019,</strong> <em>88 </em>
                                    (1)
                                     , 365-381. <a href="https://doi.org/10.1146/annurev-biochem-061516-044805" title="DOI URL">https://doi.org/10.1146/annurev-biochem-061516-044805</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1146/annurev-biochem-061516-044805&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1146%2Fannurev-biochem-061516-044805%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnual%2520Review%2520of%2520Biochemistry%26atitle%3DLysine-Targeted%252BInhibitors%252Band%252BChemoproteomic%252BProbes%26aulast%3DCuesta%26aufirst%3DAdolfo%26date%3D2019%26volume%3D88%26issue%3D1%26spage%3D365%26epage%3D381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanfa  He</span>, <span class="hlFld-ContribAuthor ">Jianzhen  Liu</span>, <span class="hlFld-ContribAuthor ">Yongjun  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaoli  Zhu</span>, <span class="hlFld-ContribAuthor ">Zhengchao  Fan</span>, <span class="hlFld-ContribAuthor ">Chongbin  Li</span>, <span class="hlFld-ContribAuthor ">Hang  Yin</span>, <span class="hlFld-ContribAuthor ">Ying  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Role of miR‐486‐5p in regulating renal cell carcinoma cell proliferation and apoptosis via TGF‐β–activated kinase 1. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cellular Biochemistry</span><span> <strong>2019,</strong> <em>120 </em>
                                    (3)
                                     , 2954-2963. <a href="https://doi.org/10.1002/jcb.26900" title="DOI URL">https://doi.org/10.1002/jcb.26900</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jcb.26900&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjcb.26900%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cellular%2520Biochemistry%26atitle%3DRole%252Bof%252BmiR%2525E2%252580%252590486%2525E2%252580%2525905p%252Bin%252Bregulating%252Brenal%252Bcell%252Bcarcinoma%252Bcell%252Bproliferation%252Band%252Bapoptosis%252Bvia%252BTGF%2525E2%252580%252590%2525CE%2525B2%2525E2%252580%252593activated%252Bkinase%252B1%26aulast%3DHe%26aufirst%3DYanfa%26date%3D2019%26date%3D2018%26volume%3D120%26issue%3D3%26spage%3D2954%26epage%3D2963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qizhao  Ma</span>, <span class="hlFld-ContribAuthor ">Ling  Gu</span>, <span class="hlFld-ContribAuthor ">Shiping  Liao</span>, <span class="hlFld-ContribAuthor ">Yanjiang  Zheng</span>, <span class="hlFld-ContribAuthor ">Shu  Zhang</span>, <span class="hlFld-ContribAuthor ">Yueyan  Cao</span>, <span class="hlFld-ContribAuthor ">Ji  Zhang</span>, <span class="hlFld-ContribAuthor ">Yufang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">NG25, a novel inhibitor of TAK1, suppresses KRAS-mutant colorectal cancer growth in vitro and in vivo. </span><span class="cited-content_cbyCitation_journal-name">Apoptosis</span><span> <strong>2019,</strong> <em>24 </em>
                                    (1-2)
                                     , 83-94. <a href="https://doi.org/10.1007/s10495-018-1498-z" title="DOI URL">https://doi.org/10.1007/s10495-018-1498-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10495-018-1498-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10495-018-1498-z%26sid%3Dliteratum%253Aachs%26jtitle%3DApoptosis%26atitle%3DNG25%25252C%252Ba%252Bnovel%252Binhibitor%252Bof%252BTAK1%25252C%252Bsuppresses%252BKRAS-mutant%252Bcolorectal%252Bcancer%252Bgrowth%252Bin%252Bvitro%252Band%252Bin%252Bvivo%26aulast%3DMa%26aufirst%3DQizhao%26date%3D2019%26date%3D2018%26volume%3D24%26issue%3D1-2%26spage%3D83%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Seok Jong  Kang</span>, <span class="hlFld-ContribAuthor ">Jung Wuk  Lee</span>, <span class="hlFld-ContribAuthor ">Shin Hyuck  Chung</span>, <span class="hlFld-ContribAuthor ">Sun Young  Jang</span>, <span class="hlFld-ContribAuthor ">Jaeyul  Choi</span>, <span class="hlFld-ContribAuthor ">Kwee Hyun  Suh</span>, <span class="hlFld-ContribAuthor ">Young Hoon  Kim</span>, <span class="hlFld-ContribAuthor ">Young Jin  Ham</span>, <span class="hlFld-ContribAuthor ">Kyung Hoon  Min</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and anti-tumor activity of imidazopyrazines as TAK1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>163 </em>, 660-670. <a href="https://doi.org/10.1016/j.ejmech.2018.12.025" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.12.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.12.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.12.025%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Banti-tumor%252Bactivity%252Bof%252Bimidazopyrazines%252Bas%252BTAK1%252Binhibitors%26aulast%3DKang%26aufirst%3DSeok%2BJong%26date%3D2019%26volume%3D163%26spage%3D660%26epage%3D670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lili  Du</span>, <span class="hlFld-ContribAuthor ">Jesse D.  Roberts</span>. </span><span class="cited-content_cbyCitation_article-title">Transforming growth factor-β downregulates sGC subunit expression in pulmonary artery smooth muscle cells via MEK and ERK signaling. </span><span class="cited-content_cbyCitation_journal-name">American Journal of Physiology-Lung Cellular and Molecular Physiology</span><span> <strong>2019,</strong> <em>316 </em>
                                    (1)
                                     , L20-L34. <a href="https://doi.org/10.1152/ajplung.00319.2018" title="DOI URL">https://doi.org/10.1152/ajplung.00319.2018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1152/ajplung.00319.2018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1152%2Fajplung.00319.2018%26sid%3Dliteratum%253Aachs%26jtitle%3DAmerican%2520Journal%2520of%2520Physiology-Lung%2520Cellular%2520and%2520Molecular%2520Physiology%26atitle%3DTransforming%252Bgrowth%252Bfactor-%2525CE%2525B2%252Bdownregulates%252BsGC%252Bsubunit%252Bexpression%252Bin%252Bpulmonary%252Bartery%252Bsmooth%252Bmuscle%252Bcells%252Bvia%252BMEK%252Band%252BERK%252Bsignaling%26aulast%3DDu%26aufirst%3DLili%26date%3D2019%26volume%3D316%26issue%3D1%26spage%3DL20%26epage%3DL34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bin  Li</span>, <span class="hlFld-ContribAuthor ">Panpan  Xi</span>, <span class="hlFld-ContribAuthor ">Zhenglei  Wang</span>, <span class="hlFld-ContribAuthor ">Xiangan  Han</span>, <span class="hlFld-ContribAuthor ">Yuanyuan  Xu</span>, <span class="hlFld-ContribAuthor ">Yuanshu  Zhang</span>, <span class="hlFld-ContribAuthor ">Jinfeng  Miao</span>. </span><span class="cited-content_cbyCitation_article-title">PI3K/Akt/mTOR signaling pathway participates in Streptococcus uberis-induced inflammation in mammary epithelial cells in concert with the classical TLRs/NF-ĸB pathway. </span><span class="cited-content_cbyCitation_journal-name">Veterinary Microbiology</span><span> <strong>2018,</strong> <em>227 </em>, 103-111. <a href="https://doi.org/10.1016/j.vetmic.2018.10.031" title="DOI URL">https://doi.org/10.1016/j.vetmic.2018.10.031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.vetmic.2018.10.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.vetmic.2018.10.031%26sid%3Dliteratum%253Aachs%26jtitle%3DVeterinary%2520Microbiology%26atitle%3DPI3K%25252FAkt%25252FmTOR%252Bsignaling%252Bpathway%252Bparticipates%252Bin%252BStreptococcus%252Buberis-induced%252Binflammation%252Bin%252Bmammary%252Bepithelial%252Bcells%252Bin%252Bconcert%252Bwith%252Bthe%252Bclassical%252BTLRs%25252FNF-%2525C4%2525B8B%252Bpathway%26aulast%3DLi%26aufirst%3DBin%26date%3D2018%26volume%3D227%26spage%3D103%26epage%3D111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yiyan  Zheng</span>, <span class="hlFld-ContribAuthor ">Ritika  Sethi</span>, <span class="hlFld-ContribAuthor ">Lingegowda S.  Mangala</span>, <span class="hlFld-ContribAuthor ">Charlotte  Taylor</span>, <span class="hlFld-ContribAuthor ">Juliet  Goldsmith</span>, <span class="hlFld-ContribAuthor ">Ming  Wang</span>, <span class="hlFld-ContribAuthor ">Kenta  Masuda</span>, <span class="hlFld-ContribAuthor ">Mohammad  Karaminejadranjbar</span>, <span class="hlFld-ContribAuthor ">David  Mannion</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Miranda</span>, <span class="hlFld-ContribAuthor ">Sandra  Herrero-Gonzalez</span>, <span class="hlFld-ContribAuthor ">Karin  Hellner</span>, <span class="hlFld-ContribAuthor ">Fiona  Chen</span>, <span class="hlFld-ContribAuthor ">Abdulkhaliq  Alsaadi</span>, <span class="hlFld-ContribAuthor ">Ashwag  Albukhari</span>, <span class="hlFld-ContribAuthor ">Donatien Chedom  Fotso</span>, <span class="hlFld-ContribAuthor ">Christopher  Yau</span>, <span class="hlFld-ContribAuthor ">Dahai  Jiang</span>, <span class="hlFld-ContribAuthor ">Sunila  Pradeep</span>, <span class="hlFld-ContribAuthor ">Cristian  Rodriguez-Aguayo</span>, <span class="hlFld-ContribAuthor ">Gabriel  Lopez-Berestein</span>, <span class="hlFld-ContribAuthor ">Stefan  Knapp</span>, <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>, <span class="hlFld-ContribAuthor ">Leticia  Campo</span>, <span class="hlFld-ContribAuthor ">Kevin A.  Myers</span>, <span class="hlFld-ContribAuthor ">Sunanda  Dhar</span>, <span class="hlFld-ContribAuthor ">David  Ferguson</span>, <span class="hlFld-ContribAuthor ">Robert C.  Bast</span>, <span class="hlFld-ContribAuthor ">Anil K.  Sood</span>, <span class="hlFld-ContribAuthor ">Frank  von Delft</span>, <span class="hlFld-ContribAuthor ">Ahmed Ashour  Ahmed</span>. </span><span class="cited-content_cbyCitation_article-title">Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylation. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2018,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-017-02811-7" title="DOI URL">https://doi.org/10.1038/s41467-017-02811-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-017-02811-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-017-02811-7%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DTuning%252Bmicrotubule%252Bdynamics%252Bto%252Benhance%252Bcancer%252Btherapy%252Bby%252Bmodulating%252BFER-mediated%252BCRMP2%252Bphosphorylation%26aulast%3DZheng%26aufirst%3DYiyan%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ricardo J.  Antonia</span>, <span class="hlFld-ContribAuthor ">Albert S.  Baldwin</span>. </span><span class="cited-content_cbyCitation_article-title">IKK promotes cytokine-induced and cancer-associated AMPK activity and attenuates phenformin-induced cell death in LKB1-deficient cells. </span><span class="cited-content_cbyCitation_journal-name">Science Signaling</span><span> <strong>2018,</strong> <em>11 </em>
                                    (538)
                                     , eaan5850. <a href="https://doi.org/10.1126/scisignal.aan5850" title="DOI URL">https://doi.org/10.1126/scisignal.aan5850</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1126/scisignal.aan5850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1126%2Fscisignal.aan5850%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%2520Signaling%26atitle%3DIKK%252Bpromotes%252Bcytokine-induced%252Band%252Bcancer-associated%252BAMPK%252Bactivity%252Band%252Battenuates%252Bphenformin-induced%252Bcell%252Bdeath%252Bin%252BLKB1-deficient%252Bcells%26aulast%3DAntonia%26aufirst%3DRicardo%2BJ.%26date%3D2018%26date%3D2018%26volume%3D11%26issue%3D538%26spage%3Deaan5850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nulgumnalli Manjunathaiah  Raghavendra</span>, <span class="hlFld-ContribAuthor ">Divya  Pingili</span>, <span class="hlFld-ContribAuthor ">Sundeep  Kadasi</span>, <span class="hlFld-ContribAuthor ">Akhila  Mettu</span>, <span class="hlFld-ContribAuthor ">S.V.U.M.  Prasad</span>. </span><span class="cited-content_cbyCitation_article-title">Dual or multi-targeting inhibitors: The next generation anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>143 </em>, 1277-1300. <a href="https://doi.org/10.1016/j.ejmech.2017.10.021" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.10.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.10.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.10.021%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDual%252Bor%252Bmulti-targeting%252Binhibitors%25253A%252BThe%252Bnext%252Bgeneration%252Banticancer%252Bagents%26aulast%3DRaghavendra%26aufirst%3DNulgumnalli%2BManjunathaiah%26date%3D2018%26volume%3D143%26spage%3D1277%26epage%3D1300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takayuki  Irie</span>, <span class="hlFld-ContribAuthor ">Masaaki  Sawa</span>. </span><span class="cited-content_cbyCitation_article-title">7-Azaindole: A Versatile Scaffold for Developing Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">CHEMICAL & PHARMACEUTICAL BULLETIN</span><span> <strong>2018,</strong> <em>66 </em>
                                    (1)
                                     , 29-36. <a href="https://doi.org/10.1248/cpb.c17-00380" title="DOI URL">https://doi.org/10.1248/cpb.c17-00380</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1248/cpb.c17-00380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1248%2Fcpb.c17-00380%26sid%3Dliteratum%253Aachs%26jtitle%3DCHEMICAL%2520%2526%2520PHARMACEUTICAL%2520BULLETIN%26atitle%3D7-Azaindole%25253A%252BA%252BVersatile%252BScaffold%252Bfor%252BDeveloping%252BKinase%252BInhibitors%26aulast%3DIrie%26aufirst%3DTakayuki%26date%3D2018%26volume%3D66%26issue%3D1%26spage%3D29%26epage%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Norbert  Handler</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacophore Generation for Multiple Ligands. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 275-312. <a href="https://doi.org/10.1002/9783527674381.ch10" title="DOI URL">https://doi.org/10.1002/9783527674381.ch10</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527674381.ch10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527674381.ch10%26sid%3Dliteratum%253Aachs%26atitle%3DPharmacophore%252BGeneration%252Bfor%252BMultiple%252BLigands%26aulast%3DHandler%26aufirst%3DNorbert%26date%3D2017%26date%3D2017%26spage%3D275%26epage%3D312%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DDrug%252BSelectivity%26aulast%3DHandler%26aufirst%3DNorbert%26date%3D2017%26volume%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hua  Wang</span>, <span class="hlFld-ContribAuthor ">Zhong  Chen</span>, <span class="hlFld-ContribAuthor ">Yu  Li</span>, <span class="hlFld-ContribAuthor ">Qiaoyun  Ji</span>. </span><span class="cited-content_cbyCitation_article-title">NG25, an inhibitor of transforming growth factor‑β‑activated kinase 1, ameliorates neuronal apoptosis in neonatal hypoxic‑ischemic rats. </span><span class="cited-content_cbyCitation_journal-name">Molecular Medicine Reports</span><span> <strong>2017,</strong> <em> </em><a href="https://doi.org/10.3892/mmr.2017.8024" title="DOI URL">https://doi.org/10.3892/mmr.2017.8024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3892/mmr.2017.8024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3892%2Fmmr.2017.8024%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Medicine%2520Reports%26atitle%3DNG25%25252C%252Ban%252Binhibitor%252Bof%252Btransforming%252Bgrowth%252Bfactor%2525E2%252580%252591%2525CE%2525B2%2525E2%252580%252591activated%252Bkinase%252B1%25252C%252Bameliorates%252Bneuronal%252Bapoptosis%252Bin%252Bneonatal%252Bhypoxic%2525E2%252580%252591ischemic%252Brats%26aulast%3DWang%26aufirst%3DHua%26date%3D2017%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raffaela  Santoro</span>, <span class="hlFld-ContribAuthor ">Carmine  Carbone</span>, <span class="hlFld-ContribAuthor ">Geny  Piro</span>, <span class="hlFld-ContribAuthor ">Paul J.  Chiao</span>, <span class="hlFld-ContribAuthor ">Davide  Melisi</span>. </span><span class="cited-content_cbyCitation_article-title">TAK -ing aim at chemoresistance: The emerging role of MAP3K7 as a target for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Drug Resistance Updates</span><span> <strong>2017,</strong> <em>33-35 </em>, 36-42. <a href="https://doi.org/10.1016/j.drup.2017.10.004" title="DOI URL">https://doi.org/10.1016/j.drup.2017.10.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drup.2017.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drup.2017.10.004%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Resistance%2520Updates%26atitle%3DTAK%252B-ing%252Baim%252Bat%252Bchemoresistance%25253A%252BThe%252Bemerging%252Brole%252Bof%252BMAP3K7%252Bas%252Ba%252Btarget%252Bfor%252Bcancer%252Btherapy%26aulast%3DSantoro%26aufirst%3DRaffaela%26date%3D2017%26volume%3D33-35%26spage%3D36%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manoj B.  Menon</span>, <span class="hlFld-ContribAuthor ">Julia  Gropengießer</span>, <span class="hlFld-ContribAuthor ">Jessica  Fischer</span>, <span class="hlFld-ContribAuthor ">Lena  Novikova</span>, <span class="hlFld-ContribAuthor ">Anne  Deuretzbacher</span>, <span class="hlFld-ContribAuthor ">Juri  Lafera</span>, <span class="hlFld-ContribAuthor ">Hanna  Schimmeck</span>, <span class="hlFld-ContribAuthor ">Nicole  Czymmeck</span>, <span class="hlFld-ContribAuthor ">Natalia  Ronkina</span>, <span class="hlFld-ContribAuthor ">Alexey  Kotlyarov</span>, <span class="hlFld-ContribAuthor ">Martin  Aepfelbacher</span>, <span class="hlFld-ContribAuthor ">Matthias  Gaestel</span>, <span class="hlFld-ContribAuthor ">Klaus  Ruckdeschel</span>. </span><span class="cited-content_cbyCitation_article-title">p38MAPK/MK2-dependent phosphorylation controls cytotoxic RIPK1 signalling in inflammation and infection. </span><span class="cited-content_cbyCitation_journal-name">Nature Cell Biology</span><span> <strong>2017,</strong> <em>19 </em>
                                    (10)
                                     , 1248-1259. <a href="https://doi.org/10.1038/ncb3614" title="DOI URL">https://doi.org/10.1038/ncb3614</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/ncb3614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fncb3614%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Cell%2520Biology%26atitle%3Dp38MAPK%25252FMK2-dependent%252Bphosphorylation%252Bcontrols%252Bcytotoxic%252BRIPK1%252Bsignalling%252Bin%252Binflammation%252Band%2525C2%2525A0infection%26aulast%3DMenon%26aufirst%3DManoj%2BB.%26date%3D2017%26date%3D2017%26volume%3D19%26issue%3D10%26spage%3D1248%26epage%3D1259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Juliane  Totzke</span>, <span class="hlFld-ContribAuthor ">Deepak  Gurbani</span>, <span class="hlFld-ContribAuthor ">Rene  Raphemot</span>, <span class="hlFld-ContribAuthor ">Philip F.  Hughes</span>, <span class="hlFld-ContribAuthor ">Khaldon  Bodoor</span>, <span class="hlFld-ContribAuthor ">David A.  Carlson</span>, <span class="hlFld-ContribAuthor ">David R.  Loiselle</span>, <span class="hlFld-ContribAuthor ">Asim K.  Bera</span>, <span class="hlFld-ContribAuthor ">Liesl S.  Eibschutz</span>, <span class="hlFld-ContribAuthor ">Marisha M.  Perkins</span>, <span class="hlFld-ContribAuthor ">Amber L.  Eubanks</span>, <span class="hlFld-ContribAuthor ">Phillip L.  Campbell</span>, <span class="hlFld-ContribAuthor ">David A.  Fox</span>, <span class="hlFld-ContribAuthor ">Kenneth D.  Westover</span>, <span class="hlFld-ContribAuthor ">Timothy A.J.  Haystead</span>, <span class="hlFld-ContribAuthor ">Emily R.  Derbyshire</span>. </span><span class="cited-content_cbyCitation_article-title">Takinib, a Selective TAK1 Inhibitor, Broadens the Therapeutic Efficacy of TNF-α Inhibition for Cancer and Autoimmune Disease. </span><span class="cited-content_cbyCitation_journal-name">Cell Chemical Biology</span><span> <strong>2017,</strong> <em>24 </em>
                                    (8)
                                     , 1029-1039.e7. <a href="https://doi.org/10.1016/j.chembiol.2017.07.011" title="DOI URL">https://doi.org/10.1016/j.chembiol.2017.07.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2017.07.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2017.07.011%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Chemical%2520Biology%26atitle%3DTakinib%25252C%252Ba%252BSelective%252BTAK1%252BInhibitor%25252C%252BBroadens%252Bthe%252BTherapeutic%252BEfficacy%252Bof%252BTNF-%2525CE%2525B1%252BInhibition%252Bfor%252BCancer%252Band%252BAutoimmune%252BDisease%26aulast%3DTotzke%26aufirst%3DJuliane%26date%3D2017%26volume%3D24%26issue%3D8%26spage%3D1029%26epage%3D1039.e7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gholamreza  Haqshenas</span>, <span class="hlFld-ContribAuthor ">Jianmin  Wu</span>, <span class="hlFld-ContribAuthor ">Kaylene J.  Simpson</span>, <span class="hlFld-ContribAuthor ">Roger J.  Daly</span>, <span class="hlFld-ContribAuthor ">Hans J.  Netter</span>, <span class="hlFld-ContribAuthor ">Thomas F.  Baumert</span>, <span class="hlFld-ContribAuthor ">Christian  Doerig</span>. </span><span class="cited-content_cbyCitation_article-title">Signalome-wide assessment of host cell response to hepatitis C virus. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2017,</strong> <em>8 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/ncomms15158" title="DOI URL">https://doi.org/10.1038/ncomms15158</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/ncomms15158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fncomms15158%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DSignalome-wide%252Bassessment%252Bof%252Bhost%252Bcell%252Bresponse%252Bto%252Bhepatitis%252BC%252Bvirus%26aulast%3DHaqshenas%26aufirst%3DGholamreza%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li  Tan</span>, <span class="hlFld-ContribAuthor ">Deepak  Gurbani</span>, <span class="hlFld-ContribAuthor ">Ellen L.  Weisberg</span>, <span class="hlFld-ContribAuthor ">Douglas S.  Jones</span>, <span class="hlFld-ContribAuthor ">Suman  Rao</span>, <span class="hlFld-ContribAuthor ">William D.  Singer</span>, <span class="hlFld-ContribAuthor ">Faviola M.  Bernard</span>, <span class="hlFld-ContribAuthor ">Samar  Mowafy</span>, <span class="hlFld-ContribAuthor ">Annie  Jenney</span>, <span class="hlFld-ContribAuthor ">Guangyan  Du</span>, <span class="hlFld-ContribAuthor ">Atsushi  Nonami</span>, <span class="hlFld-ContribAuthor ">James D.  Griffin</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Lauffenburger</span>, <span class="hlFld-ContribAuthor ">Kenneth D.  Westover</span>, <span class="hlFld-ContribAuthor ">Peter K.  Sorger</span>, <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>. </span><span class="cited-content_cbyCitation_article-title">Studies of TAK1-centered polypharmacology with novel covalent TAK1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (4)
                                     , 1320-1328. <a href="https://doi.org/10.1016/j.bmc.2016.11.034" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.11.034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.11.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.11.034%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DStudies%252Bof%252BTAK1-centered%252Bpolypharmacology%252Bwith%252Bnovel%252Bcovalent%252BTAK1%252Binhibitors%26aulast%3DTan%26aufirst%3DLi%26date%3D2017%26volume%3D25%26issue%3D4%26spage%3D1320%26epage%3D1328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takaaki  Miura</span>, <span class="hlFld-ContribAuthor ">Atsushi  Matsuo</span>, <span class="hlFld-ContribAuthor ">Terushige  Muraoka</span>, <span class="hlFld-ContribAuthor ">Mitsuaki  Ide</span>, <span class="hlFld-ContribAuthor ">Kenji  Morikami</span>, <span class="hlFld-ContribAuthor ">Takayuki  Kamikawa</span>, <span class="hlFld-ContribAuthor ">Masamichi  Nishihara</span>, <span class="hlFld-ContribAuthor ">Hirotaka  Kashiwagi</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of a selective inhibitor of transforming growth factor β-activated kinase 1 by biosensor-based screening of focused libraries. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (4)
                                     , 1031-1036. <a href="https://doi.org/10.1016/j.bmcl.2016.12.064" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.12.064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.12.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.12.064%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252Ba%252Bselective%252Binhibitor%252Bof%252Btransforming%252Bgrowth%252Bfactor%252B%2525CE%2525B2-activated%252Bkinase%252B1%252Bby%252Bbiosensor-based%252Bscreening%252Bof%252Bfocused%252Blibraries%26aulast%3DMiura%26aufirst%3DTakaaki%26date%3D2017%26volume%3D27%26issue%3D4%26spage%3D1031%26epage%3D1036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li  Tan</span>, <span class="hlFld-ContribAuthor ">Deepak  Gurbani</span>, <span class="hlFld-ContribAuthor ">Ellen L.  Weisberg</span>, <span class="hlFld-ContribAuthor ">John C.  Hunter</span>, <span class="hlFld-ContribAuthor ">Lianbo  Li</span>, <span class="hlFld-ContribAuthor ">Douglas S.  Jones</span>, <span class="hlFld-ContribAuthor ">Scott B.  Ficarro</span>, <span class="hlFld-ContribAuthor ">Samar  Mowafy</span>, <span class="hlFld-ContribAuthor ">Chun-Pong  Tam</span>, <span class="hlFld-ContribAuthor ">Suman  Rao</span>, <span class="hlFld-ContribAuthor ">Guangyan  Du</span>, <span class="hlFld-ContribAuthor ">James D.  Griffin</span>, <span class="hlFld-ContribAuthor ">Peter K.  Sorger</span>, <span class="hlFld-ContribAuthor ">Jarrod A.  Marto</span>, <span class="hlFld-ContribAuthor ">Kenneth D.  Westover</span>, <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-guided development of covalent TAK1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (3)
                                     , 838-846. <a href="https://doi.org/10.1016/j.bmc.2016.11.035" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.11.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.11.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.11.035%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DStructure-guided%252Bdevelopment%252Bof%252Bcovalent%252BTAK1%252Binhibitors%26aulast%3DTan%26aufirst%3DLi%26date%3D2017%26volume%3D25%26issue%3D3%26spage%3D838%26epage%3D846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Douglas S  Jones</span>, <span class="hlFld-ContribAuthor ">Anne P  Jenney</span>, <span class="hlFld-ContribAuthor ">Jennifer L  Swantek</span>, <span class="hlFld-ContribAuthor ">John M  Burke</span>, <span class="hlFld-ContribAuthor ">Douglas A  Lauffenburger</span>, <span class="hlFld-ContribAuthor ">Peter K  Sorger</span>. </span><span class="cited-content_cbyCitation_article-title">Profiling drugs for rheumatoid arthritis that inhibit synovial fibroblast activation. </span><span class="cited-content_cbyCitation_journal-name">Nature Chemical Biology</span><span> <strong>2017,</strong> <em>13 </em>
                                    (1)
                                     , 38-45. <a href="https://doi.org/10.1038/nchembio.2211" title="DOI URL">https://doi.org/10.1038/nchembio.2211</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nchembio.2211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnchembio.2211%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Chemical%2520Biology%26atitle%3DProfiling%252Bdrugs%252Bfor%252Brheumatoid%252Barthritis%252Bthat%252Binhibit%252Bsynovial%252Bfibroblast%252Bactivation%26aulast%3DJones%26aufirst%3DDouglas%2BS%26date%3D2017%26date%3D2016%26volume%3D13%26issue%3D1%26spage%3D38%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhenyu  Wang</span>, <span class="hlFld-ContribAuthor ">Huiyuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Minghao  Shi</span>, <span class="hlFld-ContribAuthor ">Yang  Yu</span>, <span class="hlFld-ContribAuthor ">Hao  Wang</span>, <span class="hlFld-ContribAuthor ">Wen-Ming  Cao</span>, <span class="hlFld-ContribAuthor ">Yanling  Zhao</span>, <span class="hlFld-ContribAuthor ">Hong  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">TAK1 inhibitor NG25 enhances doxorubicin-mediated apoptosis in breast cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2016,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep32737" title="DOI URL">https://doi.org/10.1038/srep32737</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep32737&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep32737%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DTAK1%252Binhibitor%252BNG25%252Benhances%252Bdoxorubicin-mediated%252Bapoptosis%252Bin%252Bbreast%252Bcancer%252Bcells%26aulast%3DWang%26aufirst%3DZhenyu%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sabrina  Fechtner</span>, <span class="hlFld-ContribAuthor ">David A.  Fox</span>, <span class="hlFld-ContribAuthor ">Salahuddin  Ahmed</span>. </span><span class="cited-content_cbyCitation_article-title">Transforming growth factor β activated kinase 1: a potential therapeutic target for rheumatic diseases. </span><span class="cited-content_cbyCitation_journal-name">Rheumatology</span><span> <strong>2016,</strong> <em>19 </em>, kew301. <a href="https://doi.org/10.1093/rheumatology/kew301" title="DOI URL">https://doi.org/10.1093/rheumatology/kew301</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/rheumatology/kew301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Frheumatology%2Fkew301%26sid%3Dliteratum%253Aachs%26jtitle%3DRheumatology%26atitle%3DTransforming%252Bgrowth%252Bfactor%252B%2525CE%2525B2%252Bactivated%252Bkinase%252B1%25253A%252Ba%252Bpotential%252Btherapeutic%252Btarget%252Bfor%252Brheumatic%252Bdiseases%26aulast%3DFechtner%26aufirst%3DSabrina%26date%3D2016%26date%3D2016%26volume%3D19%26spage%3Dkew301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ashraf Kareem  El-Damasy</span>, <span class="hlFld-ContribAuthor ">Nam-Chul  Cho</span>, <span class="hlFld-ContribAuthor ">Ghilsoo  Nam</span>, <span class="hlFld-ContribAuthor ">Ae Nim  Pae</span>, <span class="hlFld-ContribAuthor ">Gyochang  Keum</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Nanomolar Multikinase Inhibitor (KST016366): A New Benzothiazole Derivative with Remarkable Broad-Spectrum Antiproliferative Activity. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2016,</strong> <em>11 </em>
                                    (15)
                                     , 1587-1595. <a href="https://doi.org/10.1002/cmdc.201600224" title="DOI URL">https://doi.org/10.1002/cmdc.201600224</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201600224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201600224%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DDiscovery%252Bof%252Ba%252BNanomolar%252BMultikinase%252BInhibitor%252B%252528KST016366%252529%25253A%252BA%252BNew%252BBenzothiazole%252BDerivative%252Bwith%252BRemarkable%252BBroad-Spectrum%252BAntiproliferative%252BActivity%26aulast%3DEl-Damasy%26aufirst%3DAshraf%2BKareem%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D15%26spage%3D1587%26epage%3D1595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julie Marie  Matthews</span>, <span class="hlFld-ContribAuthor ">Shruti  Bhatt</span>, <span class="hlFld-ContribAuthor ">Matthew P.  Patricelli</span>, <span class="hlFld-ContribAuthor ">Tyzoon K.  Nomanbhoy</span>, <span class="hlFld-ContribAuthor ">Xiaoyu  Jiang</span>, <span class="hlFld-ContribAuthor ">Yasodha  Natkunam</span>, <span class="hlFld-ContribAuthor ">Andrew J.  Gentles</span>, <span class="hlFld-ContribAuthor ">Ezequiel  Martinez</span>, <span class="hlFld-ContribAuthor ">Daxing  Zhu</span>, <span class="hlFld-ContribAuthor ">Jennifer Rose  Chapman</span>, <span class="hlFld-ContribAuthor ">Elena  Cortizas</span>, <span class="hlFld-ContribAuthor ">Ragini  Shyam</span>, <span class="hlFld-ContribAuthor ">Shideh  Chinichian</span>, <span class="hlFld-ContribAuthor ">Ranjana  Advani</span>, <span class="hlFld-ContribAuthor ">Li  Tan</span>, <span class="hlFld-ContribAuthor ">Jianming  Zhang</span>, <span class="hlFld-ContribAuthor ">Hwan Geun  Choi</span>, <span class="hlFld-ContribAuthor ">Robert  Tibshirani</span>, <span class="hlFld-ContribAuthor ">Sara J.  Buhrlage</span>, <span class="hlFld-ContribAuthor ">Dita  Gratzinger</span>, <span class="hlFld-ContribAuthor ">Ramiro  Verdun</span>, <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>, <span class="hlFld-ContribAuthor ">Izidore S.  Lossos</span>. </span><span class="cited-content_cbyCitation_article-title">Pathophysiological significance and therapeutic targeting of germinal center kinase in diffuse large B-cell lymphoma. </span><span class="cited-content_cbyCitation_journal-name">Blood</span><span> <strong>2016,</strong> <em>128 </em>
                                    (2)
                                     , 239-248. <a href="https://doi.org/10.1182/blood-2016-02-696856" title="DOI URL">https://doi.org/10.1182/blood-2016-02-696856</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1182/blood-2016-02-696856&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1182%2Fblood-2016-02-696856%26sid%3Dliteratum%253Aachs%26jtitle%3DBlood%26atitle%3DPathophysiological%252Bsignificance%252Band%252Btherapeutic%252Btargeting%252Bof%252Bgerminal%252Bcenter%252Bkinase%252Bin%252Bdiffuse%252Blarge%252BB-cell%252Blymphoma%26aulast%3DMatthews%26aufirst%3DJulie%2BMarie%26date%3D2016%26volume%3D128%26issue%3D2%26spage%3D239%26epage%3D248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Catherine M. K.  Ho</span>, <span class="hlFld-ContribAuthor ">I’ah Z.  Donovan-Banfield</span>, <span class="hlFld-ContribAuthor ">Li  Tan</span>, <span class="hlFld-ContribAuthor ">Tinghu  Zhang</span>, <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>, <span class="hlFld-ContribAuthor ">Blair L.  Strang</span>, . </span><span class="cited-content_cbyCitation_article-title">Inhibition of IKKα by BAY61-3606 Reveals IKKα-Dependent Histone H3 Phosphorylation in Human Cytomegalovirus Infected Cells. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2016,</strong> <em>11 </em>
                                    (3)
                                     , e0150339. <a href="https://doi.org/10.1371/journal.pone.0150339" title="DOI URL">https://doi.org/10.1371/journal.pone.0150339</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0150339&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0150339%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DInhibition%252Bof%252BIKK%2525CE%2525B1%252Bby%252BBAY61-3606%252BReveals%252BIKK%2525CE%2525B1-Dependent%252BHistone%252BH3%252BPhosphorylation%252Bin%252BHuman%252BCytomegalovirus%252BInfected%252BCells%26aulast%3DHo%26aufirst%3DCatherine%2BM.%2BK.%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D3%26spage%3De0150339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthieu Cornelis Johannes  Bosman</span>, <span class="hlFld-ContribAuthor ">Jan Jacob  Schuringa</span>, <span class="hlFld-ContribAuthor ">Edo  Vellenga</span>. </span><span class="cited-content_cbyCitation_article-title">Constitutive NF-κB activation in AML: Causes and treatment strategies. </span><span class="cited-content_cbyCitation_journal-name">Critical Reviews in Oncology/Hematology</span><span> <strong>2016,</strong> <em>98 </em>, 35-44. <a href="https://doi.org/10.1016/j.critrevonc.2015.10.001" title="DOI URL">https://doi.org/10.1016/j.critrevonc.2015.10.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.critrevonc.2015.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.critrevonc.2015.10.001%26sid%3Dliteratum%253Aachs%26jtitle%3DCritical%2520Reviews%2520in%2520Oncology%252FHematology%26atitle%3DConstitutive%252BNF-%2525CE%2525BAB%252Bactivation%252Bin%252BAML%25253A%252BCauses%252Band%252Btreatment%252Bstrategies%26aulast%3DBosman%26aufirst%3DMatthieu%2BCornelis%2BJohannes%26date%3D2016%26volume%3D98%26spage%3D35%26epage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Terushige  Muraoka</span>, <span class="hlFld-ContribAuthor ">Mitsuaki  Ide</span>, <span class="hlFld-ContribAuthor ">Machiko  Irie</span>, <span class="hlFld-ContribAuthor ">Kenji  Morikami</span>, <span class="hlFld-ContribAuthor ">Takaaki  Miura</span>, <span class="hlFld-ContribAuthor ">Masamichi  Nishihara</span>, <span class="hlFld-ContribAuthor ">Hirotaka  Kashiwagi</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a Method for Converting a TAK1 Type I Inhibitor into a Type II or c-Helix-Out Inhibitor by Structure-Based Drug Design (SBDD). </span><span class="cited-content_cbyCitation_journal-name">CHEMICAL & PHARMACEUTICAL BULLETIN</span><span> <strong>2016,</strong> <em>64 </em>
                                    (11)
                                     , 1622-1629. <a href="https://doi.org/10.1248/cpb.c16-00606" title="DOI URL">https://doi.org/10.1248/cpb.c16-00606</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1248/cpb.c16-00606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1248%2Fcpb.c16-00606%26sid%3Dliteratum%253Aachs%26jtitle%3DCHEMICAL%2520%2526%2520PHARMACEUTICAL%2520BULLETIN%26atitle%3DDevelopment%252Bof%252Ba%252BMethod%252Bfor%252BConverting%252Ba%252BTAK1%252BType%252BI%252BInhibitor%252Binto%252Ba%252BType%252BII%252Bor%252Bc-Helix-Out%252BInhibitor%252Bby%252BStructure-Based%252BDrug%252BDesign%252B%252528SBDD%252529%26aulast%3DMuraoka%26aufirst%3DTerushige%26date%3D2016%26volume%3D64%26issue%3D11%26spage%3D1622%26epage%3D1629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marta  Lopez-Pelaez</span>, <span class="hlFld-ContribAuthor ">Douglas J.  Lamont</span>, <span class="hlFld-ContribAuthor ">Mark  Peggie</span>, <span class="hlFld-ContribAuthor ">Natalia  Shpiro</span>, <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>, <span class="hlFld-ContribAuthor ">Philip  Cohen</span>. </span><span class="cited-content_cbyCitation_article-title">Protein kinase IKKβ-catalyzed phosphorylation of IRF5 at Ser462 induces its dimerization and nuclear translocation in myeloid cells. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2014,</strong> <em>111 </em>
                                    (49)
                                     , 17432-17437. <a href="https://doi.org/10.1073/pnas.1418399111" title="DOI URL">https://doi.org/10.1073/pnas.1418399111</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1418399111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1418399111%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DProtein%252Bkinase%252BIKK%2525CE%2525B2-catalyzed%252Bphosphorylation%252Bof%252BIRF5%252Bat%252BSer462%252Binduces%252Bits%252Bdimerization%252Band%252Bnuclear%252Btranslocation%252Bin%252Bmyeloid%252Bcells%26aulast%3DLopez-Pelaez%26aufirst%3DMarta%26date%3D2014%26date%3D2014%26volume%3D111%26issue%3D49%26spage%3D17432%26epage%3D17437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/medium/jm-2014-00480k_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/large/jm-2014-00480k_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500480k&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/medium/jm-2014-00480k_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/large/jm-2014-00480k_0013.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. General pharmacophore model for the rational design of type II inhibitors. (a) Examples of known type II inhibitors, which can be divided into a “type I” head (black) attached to a “type II” tail (blue). (b) Schematic representation of the rational design of new type II kinase inhibitors: A, hydrogen bond acceptor; D, hydrogen bond donor; HRB, hinge-region binding; HM, hydrophobic motif.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/large/jm-2014-00480k_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500480k&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/medium/jm-2014-00480k_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/large/jm-2014-00480k_0014.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Chemical structures of “lead” compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/large/jm-2014-00480k_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500480k&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/medium/jm-2014-00480k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/large/jm-2014-00480k_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 3-((1<i>H</i>-Pyrrolo[2,3-<i>b</i>]pyridin-4-yl)oxy)-<i>N</i>-(4-((4-ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-4-methylbenzamide <b>1</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/large/jm-2014-00480k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500480k&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 3-hydroxy-4-methylbenzoic acid, K<sub>2</sub>CO<sub>3</sub>, DMSO, 100 °C; (b) Pd/C, MeOH; (c) <b>29</b>, HATU, DMAP, DIEA, CH<sub>2</sub>Cl<sub>2</sub>; (d) (i) TFA, CH<sub>2</sub>Cl<sub>2</sub>, (ii) LiOH, H<sub>2</sub>O/THF.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/medium/jm-2014-00480k_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/large/jm-2014-00480k_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of (<i>E</i>)-<i>N</i>-(4-((4-Ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-3-(2-(4-methoxy-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-5-yl)vinyl)-4-methylbenzamide <b>2</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/large/jm-2014-00480k_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500480k&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>29</b>, HATU, DMAP, DIEA, CH<sub>2</sub>Cl<sub>2;</sub> (b) NaOMe, MeOH, 60 °C; (c) MePPh<sub>3</sub>I, <i>n</i>-BuLi, THF, −78 °C to rt; (d) (i) TFA, DCM, (ii) LiOH, H<sub>2</sub>O/THF; (e) Boc<sub>2</sub>O, DMAP, CH<sub>2</sub>Cl<sub>2</sub>; (f) <b>32</b>, Pd<sub>2</sub>(dba)<sub>3</sub>, P(<i>t</i>-Bu)<sub>3</sub>, DIEA, 80 °C; (g) TFA/CH<sub>2</sub>Cl<sub>2</sub>, 0 °C.</p></p></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/medium/jm-2014-00480k_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/large/jm-2014-00480k_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Compound <b>1</b> is a type II inhibitor. (a) Binding of <b>1</b> to the active site of TAK1–TAB1 results in the DFG-out conformation characterized by type II inhibitors. (b) The structure of adenosine bound to the active site of TAK1–TAB1 (PDBID 2EVA) is provided for comparison and shows the DFG-in conformation. The DFG motif is highlighted in red. (c) Key interactions of <b>1</b> with TAK1. (d) Molecular model of the binding mode of MAP4K2 with <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/large/jm-2014-00480k_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500480k&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/medium/jm-2014-00480k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/large/jm-2014-00480k_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Evaluation of the ability of compounds to block TNFα-induced phosphorylation of IKKα/β and stabilize IκB-α in L929 cells. L929 cells were pretreated with indicated (a) TAK1/MAP4K2 inhibitors (<b>1</b>, <b>2</b>, <b>3</b>, <b>4</b>, <b>5</b>, <b>7</b>, <b>10</b>) and covalent TAK1 inhibitor (<b>37</b>), (b) more selective MAP4K2 inhibitors (<b>12</b>, <b>16</b>, <b>17</b>, <b>11</b>) and p38 inhibitor (<b>38</b>) at a concentration of 100 nM for 30 min, and then TNFα was added and incubated for 5 min. Samples were collected and subjected to Western blot. Tubulin was used as a loading control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/large/jm-2014-00480k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500480k&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/medium/jm-2014-00480k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/large/jm-2014-00480k_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Evaluation of the ability of compounds to inhibit IL-1α, LPS, or CL097-induced phosphorylation of p105, p38, and JNK in several cell types. (a–c) 293 IL-1R, MEFs, and RAW cells were pretreated with <b>1</b> at different concentrations for 1 h and then stimulated with IL-1α or LPS for 30 min. Samples were collected and subjected to Western blot for phosphorylation of p105, p38, JNK1/2, and total p38. (d) Gen2.2 cells were pretreated with <b>1</b>, <b>S1</b>, and <b>16</b> at 1 μM for 1 h and then stimulated with CL097 for 30 min. Samples were collected and subjected to Western blot.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/large/jm-2014-00480k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500480k&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/medium/jm-2014-00480k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/large/jm-2014-00480k_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Evaluation of signaling following depletion of MAP4Ks by siRNA and evaluation of the ability of selective MAP4K2 inhibitors <b>16</b> and <b>17</b> to inhibit signaling in wild-type and TAK1-null MEF cells. (a) HaCaT cells were transfected with pools of four different siRNAs targeted against the indicated MAP4Ks. At 48 h after transfection cells were left untreated or treated with TGFβ or IL-1β prior to lysis and Western blot. (b) Wild type and TAK1-null MEFs cells were pretreated with selective MAP4K2 inhibitor compounds <b>16</b> and <b>17</b> for 1 h, followed by stimulation with TGFβ or IL-1α. Samples were collected and subjected to Western blot.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-1/jm500480k/20150717/images/large/jm-2014-00480k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500480k&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i32">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65200" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65200" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 32 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">O’Hare, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shakespeare, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eide, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivera, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adrian, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalf, C. A.,  3rd</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyner, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loriaux, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corbin, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wardwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ning, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keats, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundaramoorthi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snodgrass, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Commodore, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalgarno, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deininger, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Druker, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clackson, T.</span><span> </span><span class="NLM_article-title">AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">401</span><span class="NLM_x">–</span> <span class="NLM_lpage">412</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2009&pages=401-412&author=T.+O%E2%80%99Hareauthor=W.+C.+Shakespeareauthor=X.+Zhuauthor=C.+A.+Eideauthor=V.+M.+Riveraauthor=F.+Wangauthor=L.+T.+Adrianauthor=T.+Zhouauthor=W.+S.+Huangauthor=Q.+Xuauthor=C.+A.+Metcalfauthor=J.+W.+Tynerauthor=M.+M.+Loriauxauthor=A.+S.+Corbinauthor=S.+Wardwellauthor=Y.+Ningauthor=J.+A.+Keatsauthor=Y.+Wangauthor=R.+Sundaramoorthiauthor=M.+Thomasauthor=D.+Zhouauthor=J.+Snodgrassauthor=L.+Commodoreauthor=T.+K.+Sawyerauthor=D.+C.+Dalgarnoauthor=M.+W.+Deiningerauthor=B.+J.+Drukerauthor=T.+Clackson&title=AP24534%2C+a+pan-BCR-ABL+inhibitor+for+chronic+myeloid+leukemia%2C+potently+inhibits+the+T315I+mutant+and+overcomes+mutation-based+resistance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Hare%26aufirst%3DT.%26aulast%3DShakespeare%26aufirst%3DW.%2BC.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DEide%26aufirst%3DC.%2BA.%26aulast%3DRivera%26aufirst%3DV.%2BM.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DAdrian%26aufirst%3DL.%2BT.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DW.%2BS.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DMetcalf%26aufirst%3DC.%2BA.%26aulast%3DTyner%26aufirst%3DJ.%2BW.%26aulast%3DLoriaux%26aufirst%3DM.%2BM.%26aulast%3DCorbin%26aufirst%3DA.%2BS.%26aulast%3DWardwell%26aufirst%3DS.%26aulast%3DNing%26aufirst%3DY.%26aulast%3DKeats%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DSundaramoorthi%26aufirst%3DR.%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DSnodgrass%26aufirst%3DJ.%26aulast%3DCommodore%26aufirst%3DL.%26aulast%3DSawyer%26aufirst%3DT.%2BK.%26aulast%3DDalgarno%26aufirst%3DD.%2BC.%26aulast%3DDeininger%26aufirst%3DM.%2BW.%26aulast%3DDruker%26aufirst%3DB.%2BJ.%26aulast%3DClackson%26aufirst%3DT.%26atitle%3DAP24534%252C%2520a%2520pan-BCR-ABL%2520inhibitor%2520for%2520chronic%2520myeloid%2520leukemia%252C%2520potently%2520inhibits%2520the%2520T315I%2520mutant%2520and%2520overcomes%2520mutation-based%2520resistance%26jtitle%3DCancer%2520Cell%26date%3D2009%26volume%3D16%26spage%3D401%26epage%3D412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Gajiwala, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diehl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiNitto, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">English, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greig, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacques, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lunney, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McTigue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molina, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quenzer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmett, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demetri, G. D.</span><span> </span><span class="NLM_article-title">KIT kinase mutants show unique mechanisms of drug resistance to imatinib and sunitinib in gastrointestinal stromal tumor patients</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">1542</span><span class="NLM_x">–</span> <span class="NLM_lpage">1547</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm500480k&amp;key=10.1073%2Fpnas.0812413106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm500480k&amp;key=19164557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm500480k&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhvVOms78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=1542-1547&author=K.+S.+Gajiwalaauthor=J.+C.+Wuauthor=J.+Christensenauthor=G.+D.+Deshmukhauthor=W.+Diehlauthor=J.+P.+DiNittoauthor=J.+M.+Englishauthor=M.+J.+Greigauthor=Y.+A.+Heauthor=S.+L.+Jacquesauthor=E.+A.+Lunneyauthor=M.+McTigueauthor=D.+Molinaauthor=T.+Quenzerauthor=P.+A.+Wellsauthor=X.+Yuauthor=Y.+Zhangauthor=A.+Zouauthor=M.+R.+Emmettauthor=A.+G.+Marshallauthor=H.+M.+Zhangauthor=G.+D.+Demetri&title=KIT+kinase+mutants+show+unique+mechanisms+of+drug+resistance+to+imatinib+and+sunitinib+in+gastrointestinal+stromal+tumor+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">KIT kinase mutants show unique mechanisms of drug resistance to imatinib and sunitinib in gastrointestinal stromal tumor patients</span></div><div class="casAuthors">Gajiwala, Ketan S.; Wu, Joe C.; Christensen, James; Deshmukh, Gayatri D.; Diehl, Wade; DiNitto, Jonathan P.; English, Jessie M.; Greig, Michael J.; He, You-Ai; Jacques, Suzanne L.; Lunney, Elizabeth A.; McTigue, Michele; Molina, Dave; Quenzer, Terri; Wells, Peter A.; Yu, Xiu; Zhang, Yan; Zou, Aihua; Emmett, Mark R.; Marshall, Alan G.; Zhang, Hui-Min; Demetri, George D.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1542-1547</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Most gastrointestinal stromal tumors (GISTs) exhibit aberrant activation of the receptor tyrosine kinase (RTK) KIT.  The efficacy of the inhibitors imatinib mesylate and sunitinib malate in GIST patients has been linked to their inhibition of these mutant KIT proteins.  However, patients on imatinib can acquire secondary KIT mutations that render the protein insensitive to the inhibitor.  Sunitinib has shown efficacy against certain imatinib-resistant mutants, although a subset that resides in the activation loop, including D816H/V, remains resistant.  Biochem. and structural studies were undertaken to det. the mol. basis of sunitinib resistance.  Our results show that sunitinib targets the autoinhibited conformation of WT KIT and that the D816H mutant undergoes a shift in conformational equil. toward the active state.  These findings provide a structural and enzymol. explanation for the resistance profile obsd. with the KIT inhibitors.  Prospectively, they have implications for understanding oncogenic kinase mutants and for circumventing drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkwFxa-p-iWbVg90H21EOLACvtfcHk0ljyo5ekT2GSpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhvVOms78%253D&md5=dd226c914c6f9a258426c0f4984a5258</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0812413106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0812413106%26sid%3Dliteratum%253Aachs%26aulast%3DGajiwala%26aufirst%3DK.%2BS.%26aulast%3DWu%26aufirst%3DJ.%2BC.%26aulast%3DChristensen%26aufirst%3DJ.%26aulast%3DDeshmukh%26aufirst%3DG.%2BD.%26aulast%3DDiehl%26aufirst%3DW.%26aulast%3DDiNitto%26aufirst%3DJ.%2BP.%26aulast%3DEnglish%26aufirst%3DJ.%2BM.%26aulast%3DGreig%26aufirst%3DM.%2BJ.%26aulast%3DHe%26aufirst%3DY.%2BA.%26aulast%3DJacques%26aufirst%3DS.%2BL.%26aulast%3DLunney%26aufirst%3DE.%2BA.%26aulast%3DMcTigue%26aufirst%3DM.%26aulast%3DMolina%26aufirst%3DD.%26aulast%3DQuenzer%26aufirst%3DT.%26aulast%3DWells%26aufirst%3DP.%2BA.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZou%26aufirst%3DA.%26aulast%3DEmmett%26aufirst%3DM.%2BR.%26aulast%3DMarshall%26aufirst%3DA.%2BG.%26aulast%3DZhang%26aufirst%3DH.%2BM.%26aulast%3DDemetri%26aufirst%3DG.%2BD.%26atitle%3DKIT%2520kinase%2520mutants%2520show%2520unique%2520mechanisms%2520of%2520drug%2520resistance%2520to%2520imatinib%2520and%2520sunitinib%2520in%2520gastrointestinal%2520stromal%2520tumor%2520patients%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2009%26volume%3D106%26spage%3D1542%26epage%3D1547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Gould, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adhikari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aertgeerts, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Afroze, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackburn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderwood, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chau, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chouitar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duffey, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">England, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forsyth, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaulin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenspan, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iartchouk, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janowick, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulkarni, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langston, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizutani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paske, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renou, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rezaei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowland, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sintchak, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroud, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tregay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veiby, O. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vos, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vyskocil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yano, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvin, K. M.</span><span> </span><span class="NLM_article-title">Design and optimization of potent and orally bioavailable tetrahydronaphthalene Raf inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1836</span><span class="NLM_x">–</span> <span class="NLM_lpage">1846</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101479y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm500480k&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisVWls7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1836-1846&author=A.+E.+Gouldauthor=R.+Adamsauthor=S.+Adhikariauthor=K.+Aertgeertsauthor=R.+Afrozeauthor=C.+Blackburnauthor=E.+F.+Calderwoodauthor=R.+Chauauthor=J.+Chouitarauthor=M.+O.+Duffeyauthor=D.+B.+Englandauthor=C.+Farrerauthor=N.+Forsythauthor=K.+Garciaauthor=J.+Gaulinauthor=P.+D.+Greenspanauthor=R.+Guoauthor=S.+J.+Harrisonauthor=S.+C.+Huangauthor=N.+Iartchoukauthor=D.+Janowickauthor=M.+S.+Kimauthor=B.+Kulkarniauthor=S.+P.+Langstonauthor=J.+X.+Liuauthor=L.+T.+Maauthor=S.+Menonauthor=H.+Mizutaniauthor=E.+Paskeauthor=C.+C.+Renouauthor=M.+Rezaeiauthor=R.+S.+Rowlandauthor=M.+D.+Sintchakauthor=M.+D.+Smithauthor=S.+G.+Stroudauthor=M.+Tregayauthor=Y.+Tianauthor=O.+P.+Veibyauthor=T.+J.+Vosauthor=S.+Vyskocilauthor=J.+Williamsauthor=T.+Xuauthor=J.+J.+Yangauthor=J.+Yanoauthor=H.+Zengauthor=D.+M.+Zhangauthor=Q.+Zhangauthor=K.+M.+Galvin&title=Design+and+optimization+of+potent+and+orally+bioavailable+tetrahydronaphthalene+Raf+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Optimization of Potent and Orally Bioavailable Tetrahydronaphthalene Raf Inhibitors</span></div><div class="casAuthors">Gould, Alexandra E.; Adams, Ruth; Adhikari, Sharmila; Aertgeerts, Kathleen; Afroze, Roushan; Blackburn, Christopher; Calderwood, Emily F.; Chau, Ryan; Chouitar, Jouhara; Duffey, Matthew O.; England, Dylan B.; Farrer, Cheryl; Forsyth, Nancy; Garcia, Khristofer; Gaulin, Jeffery; Greenspan, Paul D.; Guo, Ribo; Harrison, Sean J.; Huang, Shih-Chung; Iartchouk, Natalia; Janowick, Dave; Kim, Mi-Sook; Kulkarni, Bheemashankar; Langston, Steven P.; Liu, Jane X.; Ma, Li-Ting; Menon, Saurabh; Mizutani, Hirotake; Paske, Erin; Renou, Christelle C.; Rezaei, Mansoureh; Rowland, R. Scott; Sintchak, Michael D.; Smith, Michael D.; Stroud, Stephen G.; Tregay, Ming; Tian, Yuan; Veiby, Ole P.; Vos, Tricia J.; Vyskocil, Stepan; Williams, Juliet; Xu, Tianlin; Yang, Johnny J.; Yano, Jason; Zeng, Hongbo; Zhang, Dong Mei; Zhang, Qin; Galvin, Katherine M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1836-1846</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of mutant B-Raf signaling, through either direct inhibition of the enzyme or inhibition of MEK, the direct substrate of Raf, has been demonstrated preclinically to inhibit tumor growth.  Very recently, treatment of B-Raf mutant melanoma patients with a selective B-Raf inhibitor has resulted in promising preliminary evidence of antitumor activity.  This article describes the design and optimization of tetrahydronaphthalene-derived compds. as potent inhibitors of the Raf pathway in vitro and in vivo.  These compds. possess good pharmacokinetic properties in rodents and inhibit B-Raf mutant tumor growth in mouse xenograft models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNulHRlb4oULVg90H21EOLACvtfcHk0lj-HblyhQ5XjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisVWls7g%253D&md5=568fb1b26a6685df082ac0337494a9c5</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Fjm101479y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101479y%26sid%3Dliteratum%253Aachs%26aulast%3DGould%26aufirst%3DA.%2BE.%26aulast%3DAdams%26aufirst%3DR.%26aulast%3DAdhikari%26aufirst%3DS.%26aulast%3DAertgeerts%26aufirst%3DK.%26aulast%3DAfroze%26aufirst%3DR.%26aulast%3DBlackburn%26aufirst%3DC.%26aulast%3DCalderwood%26aufirst%3DE.%2BF.%26aulast%3DChau%26aufirst%3DR.%26aulast%3DChouitar%26aufirst%3DJ.%26aulast%3DDuffey%26aufirst%3DM.%2BO.%26aulast%3DEngland%26aufirst%3DD.%2BB.%26aulast%3DFarrer%26aufirst%3DC.%26aulast%3DForsyth%26aufirst%3DN.%26aulast%3DGarcia%26aufirst%3DK.%26aulast%3DGaulin%26aufirst%3DJ.%26aulast%3DGreenspan%26aufirst%3DP.%2BD.%26aulast%3DGuo%26aufirst%3DR.%26aulast%3DHarrison%26aufirst%3DS.%2BJ.%26aulast%3DHuang%26aufirst%3DS.%2BC.%26aulast%3DIartchouk%26aufirst%3DN.%26aulast%3DJanowick%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DM.%2BS.%26aulast%3DKulkarni%26aufirst%3DB.%26aulast%3DLangston%26aufirst%3DS.%2BP.%26aulast%3DLiu%26aufirst%3DJ.%2BX.%26aulast%3DMa%26aufirst%3DL.%2BT.%26aulast%3DMenon%26aufirst%3DS.%26aulast%3DMizutani%26aufirst%3DH.%26aulast%3DPaske%26aufirst%3DE.%26aulast%3DRenou%26aufirst%3DC.%2BC.%26aulast%3DRezaei%26aufirst%3DM.%26aulast%3DRowland%26aufirst%3DR.%2BS.%26aulast%3DSintchak%26aufirst%3DM.%2BD.%26aulast%3DSmith%26aufirst%3DM.%2BD.%26aulast%3DStroud%26aufirst%3DS.%2BG.%26aulast%3DTregay%26aufirst%3DM.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DVeiby%26aufirst%3DO.%2BP.%26aulast%3DVos%26aufirst%3DT.%2BJ.%26aulast%3DVyskocil%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DJ.%2BJ.%26aulast%3DYano%26aufirst%3DJ.%26aulast%3DZeng%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DD.%2BM.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DGalvin%26aufirst%3DK.%2BM.%26atitle%3DDesign%2520and%2520optimization%2520of%2520potent%2520and%2520orally%2520bioavailable%2520tetrahydronaphthalene%2520Raf%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1836%26epage%3D1846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Simard, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Getlik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grutter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wulfert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabiller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauh, D.</span><span> </span><span class="NLM_article-title">Development of a fluorescent-tagged kinase assay system for the detection and characterization of allosteric kinase inhibitors</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">13286</span><span class="NLM_x">–</span> <span class="NLM_lpage">13296</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja902010p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm500480k&amp;key=1%3ACAS%3A528%3ADC%252BD1MXms1ensrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=13286-13296&author=J.+R.+Simardauthor=M.+Getlikauthor=C.+Grutterauthor=V.+Pawarauthor=S.+Wulfertauthor=M.+Rabillerauthor=D.+Rauh&title=Development+of+a+fluorescent-tagged+kinase+assay+system+for+the+detection+and+characterization+of+allosteric+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Fluorescent-Tagged Kinase Assay System for the Detection and Characterization of Allosteric Kinase Inhibitors</span></div><div class="casAuthors">Simard, Jeffrey R.; Getlik, Matthaus; Grutter, Christian; Pawar, Vijaykumar; Wulfert, Sabine; Rabiller, Matthias; Rauh, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">13286-13296</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Kinase disregulation disrupts the intricate network of intracellular signaling pathways and contributes to the onset of diseases such as cancer.  Although several kinase inhibitors are on the market, inhibitor selectivity and drug resistance mutations persist as fundamental challenges in the development of effective long-term treatments.  Chem. entities binding to less conserved allosteric sites would be expected to offer new opportunities for scaffold development.  Because no high-throughput method was previously available, a fluorescence-based kinase binding assay for identifying and characterizing ligands which stabilize the inactive kinase conformation was developed.  Here, a description of the development and validation of this assay using the serine/threonine kinase p38α is presented.  The covalent attachment of fluorophores to the activation loop of the kinase allowed to detect the conformational changes and measure the Kd, kon, and koff assocd. with the binding and dissocn. of ligands to the allosteric pocket.  The SAR of a synthesized focused library of pyrazolourea derivs., a scaffold known to bind with high affinity to the allosteric pocket of p38α, is also reported.  Addnl., the protein X-ray crystallog. was used together with this assay to examine the binding and dissocn. kinetics to characterize potent quinazoline- and quinoline-based type II inhibitors, which also utilize this binding pocket in p38α.  Last, the b-Raf inhibitor sorafenib was identified as a potent low nanomolar inhibitor of p38α and the protein X-ray crystallog. was used to confirm its unique binding mode to the inactive kinase conformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVNeYPzX2CHbVg90H21EOLACvtfcHk0lj-HblyhQ5XjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXms1ensrk%253D&md5=f56e476572c7cdfb3411eb95b9759fca</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fja902010p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja902010p%26sid%3Dliteratum%253Aachs%26aulast%3DSimard%26aufirst%3DJ.%2BR.%26aulast%3DGetlik%26aufirst%3DM.%26aulast%3DGrutter%26aufirst%3DC.%26aulast%3DPawar%26aufirst%3DV.%26aulast%3DWulfert%26aufirst%3DS.%26aulast%3DRabiller%26aufirst%3DM.%26aulast%3DRauh%26aufirst%3DD.%26atitle%3DDevelopment%2520of%2520a%2520fluorescent-tagged%2520kinase%2520assay%2520system%2520for%2520the%2520detection%2520and%2520characterization%2520of%2520allosteric%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26spage%3D13286%26epage%3D13296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Rational design of inhibitors that bind to inactive kinase conformations</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">358</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm500480k&amp;key=10.1038%2Fnchembio799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm500480k&amp;key=16783341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm500480k&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvFGjs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=358-364&author=Y.+Liuauthor=N.+S.+Gray&title=Rational+design+of+inhibitors+that+bind+to+inactive+kinase+conformations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Rational design of inhibitors that bind to inactive kinase conformations</span></div><div class="casAuthors">Liu, Yi; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">358-364</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The majority of kinase inhibitors, known as type I inhibitors that have been developed so far target the ATP binding site of the kinase in its active conformation, in which the activation loop is phosphorylated.  Recently, crystal structures of inhibitors such as imatinib, BIRB796, and sorafenib (BAY43-9006), known as type II inhibitors, have revealed a new binding mode that exploits an addnl. binding site immediately adjacent to the region occupied by ATP.  This pocket is made accessible by an activation-loop rearrangement that is characteristic of kinases in an inactive conformation.  The examn. of binding features of known type II inhibitors is discussed and a pharmacophore model currently used in the design of a new generation of structurally diverse type II inhibitors is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxahsMPlhgDbVg90H21EOLACvtfcHk0lgLWekw0CZe_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvFGjs7g%253D&md5=4a9347a44a2cf4a412c9741fdcc5696b</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnchembio799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio799%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DRational%2520design%2520of%2520inhibitors%2520that%2520bind%2520to%2520inactive%2520kinase%2520conformations%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2006%26volume%3D2%26spage%3D358%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Miduturu, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwiatkowski, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brault, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwaller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">High-throughput kinase profiling: a more efficient approach toward the discovery of new kinase inhibitors</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">868</span><span class="NLM_x">–</span> <span class="NLM_lpage">879</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm500480k&amp;key=10.1016%2Fj.chembiol.2011.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm500480k&amp;key=21802008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm500480k&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpsFarurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=868-879&author=C.+V.+Miduturuauthor=X.+Dengauthor=N.+Kwiatkowskiauthor=W.+Yangauthor=L.+Braultauthor=P.+Filippakopoulosauthor=E.+Chungauthor=Q.+Yangauthor=J.+Schwallerauthor=S.+Knappauthor=R.+W.+Kingauthor=J.+D.+Leeauthor=S.+Herrgardauthor=P.+Zarrinkarauthor=N.+S.+Gray&title=High-throughput+kinase+profiling%3A+a+more+efficient+approach+toward+the+discovery+of+new+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">High-Throughput Kinase Profiling: A More Efficient Approach toward the Discovery of New Kinase Inhibitors</span></div><div class="casAuthors">Miduturu, Chandrasekhar V.; Deng, Xianming; Kwiatkowski, Nicholas; Yang, Wannian; Brault, Laurent; Filippakopoulos, Panagis; Chung, Eunah; Yang, Qingkai; Schwaller, Juerg; Knapp, Stefan; King, Randall W.; Lee, Jiing-Dwan; Herrgard, Sanna; Zarrinkar, Patrick; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">868-879</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Selective protein kinase inhibitors have only been developed against a small no. of kinase targets.  Here we demonstrate that "high-throughput kinase profiling" is an efficient method for the discovery of lead compds. for established as well as unexplored kinase targets.  We screened a library of 118 compds. constituting two distinct scaffolds (furan-thiazolidinediones and pyrimido-diazepines) against a panel of 353 kinases.  A distinct kinase selectivity profile was obsd. for each scaffold.  Selective inhibitors were identified with submicromolar cellular activity against PIM1, ERK5, ACK1, MPS1, PLK1-3, and Aurora A,B kinases.  In addn., we identified potent inhibitors for so far unexplored kinases such as DRAK1, HIPK2, and DCAMKL1 that await further evaluation.  This inhibitor-centric approach permits comprehensive assessment of a scaffold of interest and represents an efficient and general strategy for identifying new selective kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKLvN9eLNvybVg90H21EOLACvtfcHk0lgLWekw0CZe_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpsFarurw%253D&md5=d62a4771b1215551f3913b93d6eca7ee</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2011.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2011.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DMiduturu%26aufirst%3DC.%2BV.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DKwiatkowski%26aufirst%3DN.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DBrault%26aufirst%3DL.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DChung%26aufirst%3DE.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DSchwaller%26aufirst%3DJ.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DKing%26aufirst%3DR.%2BW.%26aulast%3DLee%26aufirst%3DJ.%2BD.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DZarrinkar%26aufirst%3DP.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DHigh-throughput%2520kinase%2520profiling%253A%2520a%2520more%2520efficient%2520approach%2520toward%2520the%2520discovery%2520of%2520new%2520kinase%2520inhibitors%26jtitle%3DChem.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D868%26epage%3D879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Goldstein, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span> </span><span class="NLM_article-title">High-throughput kinase profiling as a platform for drug discovery</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">391</span><span class="NLM_x">–</span> <span class="NLM_lpage">397</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm500480k&amp;key=10.1038%2Fnrd2541" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm500480k&amp;key=18404149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm500480k&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlt1agtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=391-397&author=D.+M.+Goldsteinauthor=N.+S.+Grayauthor=P.+P.+Zarrinkar&title=High-throughput+kinase+profiling+as+a+platform+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">High-throughput kinase profiling as a platform for drug discovery</span></div><div class="casAuthors">Goldstein, David M.; Gray, Nathanael S.; Zarrinkar, Patrick P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">391-397</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  High-throughput profiling of compd. libraries against large panels of kinases is becoming tech. feasible.  In contrast to the traditional linear, target-centric approach to discovery, this approach may provide a choice of targets to pursue that is guided by the quality of lead compds. available, rather than by target biol. alone, and could thereby significantly improve the productivity of kinase inhibitor discovery.  To fully exploit the potential of kinases as drug targets, novel strategies for the efficient discovery of inhibitors are required.  In contrast to the traditional, linear process of inhibitor discovery, high-throughput kinase profiling enables a parallel approach by interrogating compds. against hundreds of targets in a single screen.  Compd. potency and selectivity are detd. simultaneously, providing a choice of targets to pursue that is guided by the quality of lead compds. available, rather than by target biol. alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwnJ59cVxbJbVg90H21EOLACvtfcHk0lgLWekw0CZe_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlt1agtbs%253D&md5=eaa61fd2958ff04fecf86a993f91833d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrd2541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2541%26sid%3Dliteratum%253Aachs%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DHigh-throughput%2520kinase%2520profiling%2520as%2520a%2520platform%2520for%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26spage%3D391%26epage%3D397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Pauls, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shpiro, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peggie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorcek, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">Essential role for IKKbeta in production of type 1 interferons by plasmacytoid dendritic cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">19216</span><span class="NLM_x">–</span> <span class="NLM_lpage">19228</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=19216-19228&author=E.+Paulsauthor=N.+Shpiroauthor=M.+Peggieauthor=E.+R.+Youngauthor=R.+J.+Sorcekauthor=L.+Tanauthor=H.+G.+Choiauthor=P.+Cohen&title=Essential+role+for+IKKbeta+in+production+of+type+1+interferons+by+plasmacytoid+dendritic+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPauls%26aufirst%3DE.%26aulast%3DShpiro%26aufirst%3DN.%26aulast%3DPeggie%26aufirst%3DM.%26aulast%3DYoung%26aufirst%3DE.%2BR.%26aulast%3DSorcek%26aufirst%3DR.%2BJ.%26aulast%3DTan%26aufirst%3DL.%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DEssential%2520role%2520for%2520IKKbeta%2520in%2520production%2520of%2520type%25201%2520interferons%2520by%2520plasmacytoid%2520dendritic%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D19216%26epage%3D19228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Dzamko, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inesta-Vaquera, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arthur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedrioli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span> </span><span class="NLM_article-title">The IkappaB kinase family phosphorylates the Parkinson’s disease kinase LRRK2 at Ser935 and Ser910 during Toll-like receptor signaling</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e39132</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e39132&author=N.+Dzamkoauthor=F.+Inesta-Vaqueraauthor=J.+Zhangauthor=C.+Xieauthor=H.+Caiauthor=S.+Arthurauthor=L.+Tanauthor=H.+Choiauthor=N.+Grayauthor=P.+Cohenauthor=P.+Pedrioliauthor=K.+Clarkauthor=D.+R.+Alessi&title=The+IkappaB+kinase+family+phosphorylates+the+Parkinson%E2%80%99s+disease+kinase+LRRK2+at+Ser935+and+Ser910+during+Toll-like+receptor+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDzamko%26aufirst%3DN.%26aulast%3DInesta-Vaquera%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DC.%26aulast%3DCai%26aufirst%3DH.%26aulast%3DArthur%26aufirst%3DS.%26aulast%3DTan%26aufirst%3DL.%26aulast%3DChoi%26aufirst%3DH.%26aulast%3DGray%26aufirst%3DN.%26aulast%3DCohen%26aufirst%3DP.%26aulast%3DPedrioli%26aufirst%3DP.%26aulast%3DClark%26aufirst%3DK.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26atitle%3DThe%2520IkappaB%2520kinase%2520family%2520phosphorylates%2520the%2520Parkinson%25E2%2580%2599s%2520disease%2520kinase%2520LRRK2%2520at%2520Ser935%2520and%2520Ser910%2520during%2520Toll-like%2520receptor%2520signaling%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De39132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Sakurai, H.</span><span> </span><span class="NLM_article-title">Targeting of TAK1 in inflammatory disorders and cancer</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">522</span><span class="NLM_x">–</span> <span class="NLM_lpage">530</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=522-530&author=H.+Sakurai&title=Targeting+of+TAK1+in+inflammatory+disorders+and+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSakurai%26aufirst%3DH.%26atitle%3DTargeting%2520of%2520TAK1%2520in%2520inflammatory%2520disorders%2520and%2520cancer%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2012%26volume%3D33%26spage%3D522%26epage%3D530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Dai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aye Thu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, P. C.</span><span> </span><span class="NLM_article-title">TAK1, more than just innate immunity</span> <span class="citation_source-journal">IUBMB Life</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">825</span><span class="NLM_x">–</span> <span class="NLM_lpage">834</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2012&pages=825-834&author=L.+Daiauthor=C.+Aye+Thuauthor=X.+Y.+Liuauthor=J.+Xiauthor=P.+C.+Cheung&title=TAK1%2C+more+than+just+innate+immunity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDai%26aufirst%3DL.%26aulast%3DAye%2BThu%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DX.%2BY.%26aulast%3DXi%26aufirst%3DJ.%26aulast%3DCheung%26aufirst%3DP.%2BC.%26atitle%3DTAK1%252C%2520more%2520than%2520just%2520innate%2520immunity%26jtitle%3DIUBMB%2520Life%26date%3D2012%26volume%3D64%26spage%3D825%26epage%3D834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Buglio, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palakurthi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byth, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vega, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toader, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saeh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neelapu, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Younes, A.</span><span> </span><span class="NLM_article-title">Essential role of TAK1 in regulating mantle cell lymphoma survival</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">355</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2012&pages=347-355&author=D.+Buglioauthor=S.+Palakurthiauthor=K.+Bythauthor=F.+Vegaauthor=D.+Toaderauthor=J.+Saehauthor=S.+S.+Neelapuauthor=A.+Younes&title=Essential+role+of+TAK1+in+regulating+mantle+cell+lymphoma+survival"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBuglio%26aufirst%3DD.%26aulast%3DPalakurthi%26aufirst%3DS.%26aulast%3DByth%26aufirst%3DK.%26aulast%3DVega%26aufirst%3DF.%26aulast%3DToader%26aufirst%3DD.%26aulast%3DSaeh%26aufirst%3DJ.%26aulast%3DNeelapu%26aufirst%3DS.%2BS.%26aulast%3DYounes%26aufirst%3DA.%26atitle%3DEssential%2520role%2520of%2520TAK1%2520in%2520regulating%2520mantle%2520cell%2520lymphoma%2520survival%26jtitle%3DBlood%26date%3D2012%26volume%3D120%26spage%3D347%26epage%3D355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Hornberger, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crew, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleinberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulvihill, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilde, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albertella, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadhim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maresca, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyn, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romashko, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokar, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turton, R.</span><span> </span><span class="NLM_article-title">Discovery of 7-aminofuro[2,3-<i>c</i>]pyridine inhibitors of TAK1: optimization of kinase selectivity and pharmacokinetics</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4511</span><span class="NLM_x">–</span> <span class="NLM_lpage">4516</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4511-4516&author=K.+R.+Hornbergerauthor=X.+Chenauthor=A.+P.+Crewauthor=A.+Kleinbergauthor=L.+Maauthor=M.+J.+Mulvihillauthor=J.+Wangauthor=V.+L.+Wildeauthor=M.+Albertellaauthor=M.+Bittnerauthor=A.+Cookeauthor=S.+Kadhimauthor=J.+Kahlerauthor=P.+Marescaauthor=E.+Mayauthor=P.+Meynauthor=D.+Romashkoauthor=B.+Tokarauthor=R.+Turton&title=Discovery+of+7-aminofuro%5B2%2C3-c%5Dpyridine+inhibitors+of+TAK1%3A+optimization+of+kinase+selectivity+and+pharmacokinetics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHornberger%26aufirst%3DK.%2BR.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCrew%26aufirst%3DA.%2BP.%26aulast%3DKleinberg%26aufirst%3DA.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DMulvihill%26aufirst%3DM.%2BJ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWilde%26aufirst%3DV.%2BL.%26aulast%3DAlbertella%26aufirst%3DM.%26aulast%3DBittner%26aufirst%3DM.%26aulast%3DCooke%26aufirst%3DA.%26aulast%3DKadhim%26aufirst%3DS.%26aulast%3DKahler%26aufirst%3DJ.%26aulast%3DMaresca%26aufirst%3DP.%26aulast%3DMay%26aufirst%3DE.%26aulast%3DMeyn%26aufirst%3DP.%26aulast%3DRomashko%26aufirst%3DD.%26aulast%3DTokar%26aufirst%3DB.%26aulast%3DTurton%26aufirst%3DR.%26atitle%3DDiscovery%2520of%25207-aminofuro%255B2%252C3-c%255Dpyridine%2520inhibitors%2520of%2520TAK1%253A%2520optimization%2520of%2520kinase%2520selectivity%2520and%2520pharmacokinetics%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4511%26epage%3D4516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Hornberger, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crew, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleinberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medeiros, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulvihill, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarrant, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weng, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilde, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albertella, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maresca, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyn, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peick, W.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romashko, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanowitz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokar, B.</span><span> </span><span class="NLM_article-title">Discovery and optimization of 7-aminofuro[2,3-<i>c</i>]pyridine inhibitors of TAK1</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4517</span><span class="NLM_x">–</span> <span class="NLM_lpage">4522</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4517-4522&author=K.+R.+Hornbergerauthor=D.+M.+Bergerauthor=A.+P.+Crewauthor=H.+Dongauthor=A.+Kleinbergauthor=A.+H.+Liauthor=M.+R.+Medeirosauthor=M.+J.+Mulvihillauthor=K.+Siuauthor=J.+Tarrantauthor=J.+Wangauthor=F.+Wengauthor=V.+L.+Wildeauthor=M.+Albertellaauthor=M.+Bittnerauthor=A.+Cookeauthor=M.+J.+Grayauthor=P.+Marescaauthor=E.+Mayauthor=P.+Meynauthor=W.+Peickauthor=D.+Romashkoauthor=M.+Tanowitzauthor=B.+Tokar&title=Discovery+and+optimization+of+7-aminofuro%5B2%2C3-c%5Dpyridine+inhibitors+of+TAK1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHornberger%26aufirst%3DK.%2BR.%26aulast%3DBerger%26aufirst%3DD.%2BM.%26aulast%3DCrew%26aufirst%3DA.%2BP.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DKleinberg%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DA.%2BH.%26aulast%3DMedeiros%26aufirst%3DM.%2BR.%26aulast%3DMulvihill%26aufirst%3DM.%2BJ.%26aulast%3DSiu%26aufirst%3DK.%26aulast%3DTarrant%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWeng%26aufirst%3DF.%26aulast%3DWilde%26aufirst%3DV.%2BL.%26aulast%3DAlbertella%26aufirst%3DM.%26aulast%3DBittner%26aufirst%3DM.%26aulast%3DCooke%26aufirst%3DA.%26aulast%3DGray%26aufirst%3DM.%2BJ.%26aulast%3DMaresca%26aufirst%3DP.%26aulast%3DMay%26aufirst%3DE.%26aulast%3DMeyn%26aufirst%3DP.%26aulast%3DPeick%26aufirst%3DW.%26aulast%3DRomashko%26aufirst%3DD.%26aulast%3DTanowitz%26aufirst%3DM.%26aulast%3DTokar%26aufirst%3DB.%26atitle%3DDiscovery%2520and%2520optimization%2520of%25207-aminofuro%255B2%252C3-c%255Dpyridine%2520inhibitors%2520of%2520TAK1%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4517%26epage%3D4522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Kilty, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryckmans, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Hoorn, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, L. H.</span><span> </span><span class="NLM_article-title">TAK 1 Inhibition in the DFG-out conformation</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">500</span><span class="NLM_x">–</span> <span class="NLM_lpage">505</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm500480k&amp;key=10.1111%2Fcbdd.12169" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm500480k&amp;key=23745990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm500480k&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1ahtLbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2013&pages=500-505&author=I.+Kiltyauthor=M.+P.+Greenauthor=A.+S.+Bellauthor=D.+G.+Brownauthor=P.+G.+Doddauthor=C.+Hewsonauthor=S.+J.+Hughesauthor=C.+Phillipsauthor=T.+Ryckmansauthor=R.+T.+Smithauthor=W.+P.+van+Hoornauthor=P.+Cohenauthor=L.+H.+Jones&title=TAK+1+Inhibition+in+the+DFG-out+conformation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">TAK1 Inhibition in the DFG-Out Conformation</span></div><div class="casAuthors">Kilty, Iain; Green, Martin P.; Bell, Andrew S.; Brown, David G.; Dodd, Peter G.; Hewson, Christopher; Hughes, Samantha J.; Phillips, Christopher; Ryckmans, Thomas; Smith, Robert T.; van Hoorn, Willem P.; Cohen, Philip; Jones, Lyn H.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">500-505</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The first example of an inhibitor of the kinase TAK1 that binds in the DFG-out conformation is disclosed.  These preliminary studies used kinase-targeted screening and structure-based drug design to create a mol. with dual pharmacol. inhibition of p38 and TAK1 that demonstrated significant activity in a cell-based, anti-inflammatory assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr09m3E0JuQAbVg90H21EOLACvtfcHk0ljhriYqpKS0UQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1ahtLbO&md5=685f1ceb03231ae1b421301be95a2885</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1111%2Fcbdd.12169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fcbdd.12169%26sid%3Dliteratum%253Aachs%26aulast%3DKilty%26aufirst%3DI.%26aulast%3DGreen%26aufirst%3DM.%2BP.%26aulast%3DBell%26aufirst%3DA.%2BS.%26aulast%3DBrown%26aufirst%3DD.%2BG.%26aulast%3DDodd%26aufirst%3DP.%2BG.%26aulast%3DHewson%26aufirst%3DC.%26aulast%3DHughes%26aufirst%3DS.%2BJ.%26aulast%3DPhillips%26aufirst%3DC.%26aulast%3DRyckmans%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DR.%2BT.%26aulast%3Dvan%2BHoorn%26aufirst%3DW.%2BP.%26aulast%3DCohen%26aufirst%3DP.%26aulast%3DJones%26aufirst%3DL.%2BH.%26atitle%3DTAK%25201%2520Inhibition%2520in%2520the%2520DFG-out%2520conformation%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2013%26volume%3D82%26spage%3D500%26epage%3D505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Ivanov, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kehrl, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ronai, Z.</span><span> </span><span class="NLM_article-title">Role of TRAF2/GCK in melanoma sensitivity to UV-induced apoptosis</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">933</span><span class="NLM_x">–</span> <span class="NLM_lpage">942</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2000&pages=933-942&author=V.+N.+Ivanovauthor=J.+H.+Kehrlauthor=Z.+Ronai&title=Role+of+TRAF2%2FGCK+in+melanoma+sensitivity+to+UV-induced+apoptosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIvanov%26aufirst%3DV.%2BN.%26aulast%3DKehrl%26aufirst%3DJ.%2BH.%26aulast%3DRonai%26aufirst%3DZ.%26atitle%3DRole%2520of%2520TRAF2%252FGCK%2520in%2520melanoma%2520sensitivity%2520to%2520UV-induced%2520apoptosis%26jtitle%3DOncogene%26date%3D2000%26volume%3D19%26spage%3D933%26epage%3D942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Zhang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inesta-Vaquera, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niepel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ficarro, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machleidt, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marto, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sim, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laughlin, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LoGrasso, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patricelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomanbhoy, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sorger, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Discovery of potent and selective covalent inhibitors of JNK</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">154</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm500480k&amp;key=10.1016%2Fj.chembiol.2011.11.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm500480k&amp;key=22284361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm500480k&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Ghurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=140-154&author=T.+Zhangauthor=F.+Inesta-Vaqueraauthor=M.+Niepelauthor=J.+Zhangauthor=S.+B.+Ficarroauthor=T.+Machleidtauthor=T.+Xieauthor=J.+A.+Martoauthor=N.+Kimauthor=T.+Simauthor=J.+D.+Laughlinauthor=H.+Parkauthor=P.+V.+LoGrassoauthor=M.+Patricelliauthor=T.+K.+Nomanbhoyauthor=P.+K.+Sorgerauthor=D.+R.+Alessiauthor=N.+S.+Gray&title=Discovery+of+potent+and+selective+covalent+inhibitors+of+JNK"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Selective Covalent Inhibitors of JNK</span></div><div class="casAuthors">Zhang, Tinghu; Inesta-Vaquera, Francisco; Niepel, Mario; Zhang, Jianming; Ficarro, Scott B.; Machleidt, Thomas; Xie, Ting; Marto, Jarrod A.; Kim, Nam Doo; Sim, Taebo; Laughlin, John D.; Park, Hajeung; LoGrasso, Philip V.; Patricelli, Matt; Nomanbhoy, Tyzoon K.; Sorger, Peter K.; Alessi, Dario R.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">140-154</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The mitogen-activated kinases JNK1/2/3 are key enzymes in signaling modules that transduce and integrate extracellular stimuli into coordinated cellular response.  Here, we report the discovery of irreversible inhibitors of JNK1/2/3.  We describe two JNK3 cocrystal structures at 2.60 and 2.97 Å resoln. that show the compds. form covalent bonds with a conserved cysteine residue.  JNK-IN-8 is a selective JNK inhibitor that inhibits phosphorylation of c-Jun, a direct substrate of JNK, in cells exposed to submicromolar drug in a manner that depends on covalent modification of the conserved cysteine residue.  Extensive biochem., cellular, and pathway-based profiling establish the selectivity of JNK-IN-8 for JNK and suggests that the compd. will be broadly useful as a pharmacol. probe of JNK-dependent signal transduction.  Potential lead compds. have also been identified for kinases, including IRAK1, PIK3C3, PIP4K2C, and PIP5K3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXs0FY7FSmt7Vg90H21EOLACvtfcHk0lhMlft8c41afA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Ghurw%253D&md5=f7d9647fb2be162c637b1d31a778ceb4</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2011.11.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2011.11.010%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DInesta-Vaquera%26aufirst%3DF.%26aulast%3DNiepel%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DFicarro%26aufirst%3DS.%2BB.%26aulast%3DMachleidt%26aufirst%3DT.%26aulast%3DXie%26aufirst%3DT.%26aulast%3DMarto%26aufirst%3DJ.%2BA.%26aulast%3DKim%26aufirst%3DN.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DLaughlin%26aufirst%3DJ.%2BD.%26aulast%3DPark%26aufirst%3DH.%26aulast%3DLoGrasso%26aufirst%3DP.%2BV.%26aulast%3DPatricelli%26aufirst%3DM.%26aulast%3DNomanbhoy%26aufirst%3DT.%2BK.%26aulast%3DSorger%26aufirst%3DP.%2BK.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520covalent%2520inhibitors%2520of%2520JNK%26jtitle%3DChem.%2520Biol.%26date%3D2012%26volume%3D19%26spage%3D140%26epage%3D154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Sapkota, G. P.</span><span> </span><span class="NLM_article-title">The TGFbeta-induced phosphorylation and activation of p38 mitogen-activated protein kinase is mediated by MAP3K4 and MAP3K10 but not TAK1</span> <span class="citation_source-journal">Open Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">130067</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm500480k&amp;key=10.1098%2Frsob.130067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm500480k&amp;key=23760366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm500480k&amp;key=1%3ACAS%3A280%3ADC%252BC3sjhsFSgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=130067&author=G.+P.+Sapkota&title=The+TGFbeta-induced+phosphorylation+and+activation+of+p38+mitogen-activated+protein+kinase+is+mediated+by+MAP3K4+and+MAP3K10+but+not+TAK1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The TGFβ-induced phosphorylation and activation of p38 mitogen-activated protein kinase is mediated by MAP3K4 and MAP3K10 but not TAK1</span></div><div class="casAuthors">Sapkota Gopal P</div><div class="citationInfo"><span class="NLM_cas:title">Open biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">130067</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The signalling pathways downstream of the transforming growth factor beta (TGFβ) family of cytokines play critical roles in all aspects of cellular homeostasis.  The phosphorylation and activation of p38 mitogen-activated protein kinase (MAPK) has been implicated in TGFβ-induced epithelial-to-mesenchymal transition and apoptosis.  The precise molecular mechanisms by which TGFβ cytokines induce the phosphorylation and activation of p38 MAPK are unclear.  In this study, I demonstrate that TGFβ-activated kinase 1 (TAK1/MAP3K7) does not play a role in the TGFβ-induced phosphorylation and activation of p38 MAPK in MEFs and HaCaT keratinocytes.  Instead, RNAi-mediated depletion of MAP3K4 and MAP3K10 results in the inhibition of the TGFβ-induced p38 MAPK phosphorylation.  Furthermore, the depletion of MAP3K10 from cells homozygously knocked-in with a catalytically inactive mutant of MAP3K4 completely abolishes the TGFβ-induced phosphorylation of p38 MAPK, implying that among MAP3Ks, MAP3K4 and MAP3K10 are sufficient for mediating the TGFβ-induced activation of p38 MAPK.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTjQjrjW36P2lf1XRtfYM0dfW6udTcc2ebWQ-k0mxfFYrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sjhsFSgtw%253D%253D&md5=dd33d804cedf752115dd6a3aab906dc2</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1098%2Frsob.130067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1098%252Frsob.130067%26sid%3Dliteratum%253Aachs%26aulast%3DSapkota%26aufirst%3DG.%2BP.%26atitle%3DThe%2520TGFbeta-induced%2520phosphorylation%2520and%2520activation%2520of%2520p38%2520mitogen-activated%2520protein%2520kinase%2520is%2520mediated%2520by%2520MAP3K4%2520and%2520MAP3K10%2520but%2520not%2520TAK1%26jtitle%3DOpen%2520Biol.%26date%3D2013%26volume%3D3%26spage%3D130067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Patricelli, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szardenings, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liyanage, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomanbhoy, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissig, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aban, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozarich, J. W.</span><span> </span><span class="NLM_article-title">Functional interrogation of the kinome using nucleotide acyl phosphates</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">350</span><span class="NLM_x">–</span> <span class="NLM_lpage">358</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi062142x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm500480k&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhtlaru7rO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=350-358&author=M.+P.+Patricelliauthor=A.+K.+Szardeningsauthor=M.+Liyanageauthor=T.+K.+Nomanbhoyauthor=M.+Wuauthor=H.+Weissigauthor=A.+Abanauthor=D.+Chunauthor=S.+Tannerauthor=J.+W.+Kozarich&title=Functional+interrogation+of+the+kinome+using+nucleotide+acyl+phosphates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Functional Interrogation of the Kinome Using Nucleotide Acyl Phosphates</span></div><div class="casAuthors">Patricelli, Matthew P.; Szardenings, A. Katrin; Liyanage, Marek; Nomanbhoy, Tyzoon K.; Wu, Min; Weissig, Helge; Aban, Arwin; Chun, Doris; Tanner, Stephen; Kozarich, John W.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">350-358</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The central role of protein kinases in signal transduction pathways has generated intense interest in targeting these enzymes for a wide range of therapeutic indications.  Here we report a method for identifying and quantifying protein kinases in any biol. sample or tissue from any species.  The procedure relies on acyl phosphate-contg. nucleotides, prepd. from a biotin deriv. and ATP or ADP.  The acyl phosphate probes react selectively and covalently at the ATP binding sites of at least 75% of the known human protein kinases.  Biotinylated peptide fragments from labeled proteomes are captured and then sequenced and identified using a mass spectrometry-based anal. platform to det. the kinases present and their relative levels.  Further, direct competition between the probes and inhibitors can be assessed to det. inhibitor potency and selectivity against native protein kinases, as well as hundreds of other ATPases.  The ability to broadly profile kinase activities in native proteomes offers an exciting prospect for both target discovery and inhibitor selectivity profiling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiUQQGW0LLn7Vg90H21EOLACvtfcHk0lhMlft8c41afA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhtlaru7rO&md5=a912b834ff5456f09f1c45ddceb15dca</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fbi062142x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi062142x%26sid%3Dliteratum%253Aachs%26aulast%3DPatricelli%26aufirst%3DM.%2BP.%26aulast%3DSzardenings%26aufirst%3DA.%2BK.%26aulast%3DLiyanage%26aufirst%3DM.%26aulast%3DNomanbhoy%26aufirst%3DT.%2BK.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DWeissig%26aufirst%3DH.%26aulast%3DAban%26aufirst%3DA.%26aulast%3DChun%26aufirst%3DD.%26aulast%3DTanner%26aufirst%3DS.%26aulast%3DKozarich%26aufirst%3DJ.%2BW.%26atitle%3DFunctional%2520interrogation%2520of%2520the%2520kinome%2520using%2520nucleotide%2520acyl%2520phosphates%26jtitle%3DBiochemistry%26date%3D2007%26volume%3D46%26spage%3D350%26epage%3D358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Patricelli, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomanbhoy, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagannathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aban, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okerberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herring, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissig, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozarich, J. W.</span><span> </span><span class="NLM_article-title">In situ kinase profiling reveals functionally relevant properties of native kinases</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">699</span><span class="NLM_x">–</span> <span class="NLM_lpage">710</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm500480k&amp;key=10.1016%2Fj.chembiol.2011.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm500480k&amp;key=21700206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm500480k&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotVejtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=699-710&author=M.+P.+Patricelliauthor=T.+K.+Nomanbhoyauthor=J.+Wuauthor=H.+Brownauthor=D.+Zhouauthor=J.+Zhangauthor=S.+Jagannathanauthor=A.+Abanauthor=E.+Okerbergauthor=C.+Herringauthor=B.+Nordinauthor=H.+Weissigauthor=Q.+Yangauthor=J.+D.+Leeauthor=N.+S.+Grayauthor=J.+W.+Kozarich&title=In+situ+kinase+profiling+reveals+functionally+relevant+properties+of+native+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">In Situ Kinase Profiling Reveals Functionally Relevant Properties of Native Kinases</span></div><div class="casAuthors">Patricelli, Matthew P.; Nomanbhoy, Tyzoon K.; Wu, Jiangyue; Brown, Heidi; Zhou, David; Zhang, Jianming; Jagannathan, Subadhra; Aban, Arwin; Okerberg, Eric; Herring, Chris; Nordin, Brian; Weissig, Helge; Yang, Qingkai; Lee, Jiing-Dwan; Gray, Nathanael S.; Kozarich, John W.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">699-710</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Protein kinases are intensely studied mediators of cellular signaling, yet important questions remain regarding their regulation and in vivo properties.  Here, we use a probe-based chemoprotemics platform to profile several well studied kinase inhibitors against >200 kinases in native cell proteomes and reveal biol. targets for some of these inhibitors.  Several striking differences were identified between native and recombinant kinase inhibitory profiles, in particular, for the Raf kinases.  The native kinase binding profiles presented here closely mirror the cellular activity of these inhibitors, even when the inhibition profiles differ dramatically from recombinant assay results.  Addnl., Raf activation events could be detected on live cell treatment with inhibitors.  These studies highlight the complexities of protein kinase behavior in the cellular context and demonstrate that profiling with only recombinant/purified enzymes can be misleading.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopb21npuaC_rVg90H21EOLACvtfcHk0ljW7sCmYnIEHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotVejtbo%253D&md5=dda091b895850c95131f80c3aba9e8c7</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2011.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2011.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DPatricelli%26aufirst%3DM.%2BP.%26aulast%3DNomanbhoy%26aufirst%3DT.%2BK.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DJagannathan%26aufirst%3DS.%26aulast%3DAban%26aufirst%3DA.%26aulast%3DOkerberg%26aufirst%3DE.%26aulast%3DHerring%26aufirst%3DC.%26aulast%3DNordin%26aufirst%3DB.%26aulast%3DWeissig%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DLee%26aufirst%3DJ.%2BD.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DKozarich%26aufirst%3DJ.%2BW.%26atitle%3DIn%2520situ%2520kinase%2520profiling%2520reveals%2520functionally%2520relevant%2520properties%2520of%2520native%2520kinases%26jtitle%3DChem.%2520Biol.%26date%3D2011%26volume%3D18%26spage%3D699%26epage%3D710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Lebakken, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddle, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frazee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eliason, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichling, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogel, K. W.</span><span> </span><span class="NLM_article-title">Development and applications of a broad-coverage, TR-FRET-based kinase binding assay platform</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">924</span><span class="NLM_x">–</span> <span class="NLM_lpage">935</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm500480k&amp;key=10.1177%2F1087057109339207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm500480k&amp;key=19564447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm500480k&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlSjtLnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2009&pages=924-935&author=C.+S.+Lebakkenauthor=S.+M.+Riddleauthor=U.+Singhauthor=W.+J.+Frazeeauthor=H.+C.+Eliasonauthor=Y.+Gaoauthor=L.+J.+Reichlingauthor=B.+D.+Marksauthor=K.+W.+Vogel&title=Development+and+applications+of+a+broad-coverage%2C+TR-FRET-based+kinase+binding+assay+platform"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Development and applications of a broad-coverage, TR-FRET-based kinase binding assay platform</span></div><div class="casAuthors">Lebakken, Connie S.; Riddle, Steven M.; Singh, Upinder; Frazee, W. Jack; Eliason, Hildegard C.; Gao, Yi; Reichling, Laurie J.; Marks, Bryan D.; Vogel, Kurt W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">924-935</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">The expansion of kinase assay technologies over the past decade has mirrored the growing interest in kinases as drug targets.  As a result, there is no shortage of convenient, fluorescence-based methods available to assay targets that span the kinome.  The authors recently reported on the development of a non-activity-based assay to characterize kinase inhibitors that depended on displacement of an Alexa Fluor 647 conjugate of staurosporine (a "tracer") from a particular kinase.  Kinase inhibitors were characterized by a change in fluorescence lifetime of the tracer when it was bound to a kinase relative to when it was displaced by an inhibitor.  Here, the authors report on improvements to this strategy by reconfiguring the assay in a time-resolved fluorescence resonance energy transfer (TR-FRET) format that simplifies instrumentation requirements and allows for the use of a substantially lower concn. of kinase than was required in the fluorescence-lifetime-based format.  The authors use this new assay to demonstrate several aspects of the binding assay format that are advantageous relative to traditional activity-based assays.  The TR-FRET binding format facilitates the assay of compds. against low-activity kinases, allows for the characterization of type II kinase inhibitors either using nonactivated kinases or by monitoring compd. potency over time, and ensures that the signal being detected is specific to the kinase of interest and not a contaminating kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqPbcMF0-PD7Vg90H21EOLACvtfcHk0ljW7sCmYnIEHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlSjtLnM&md5=f8df51adf90d821e480cf706213cc096</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1177%2F1087057109339207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057109339207%26sid%3Dliteratum%253Aachs%26aulast%3DLebakken%26aufirst%3DC.%2BS.%26aulast%3DRiddle%26aufirst%3DS.%2BM.%26aulast%3DSingh%26aufirst%3DU.%26aulast%3DFrazee%26aufirst%3DW.%2BJ.%26aulast%3DEliason%26aufirst%3DH.%2BC.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DReichling%26aufirst%3DL.%2BJ.%26aulast%3DMarks%26aufirst%3DB.%2BD.%26aulast%3DVogel%26aufirst%3DK.%2BW.%26atitle%3DDevelopment%2520and%2520applications%2520of%2520a%2520broad-coverage%252C%2520TR-FRET-based%2520kinase%2520binding%2520assay%2520platform%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2009%26volume%3D14%26spage%3D924%26epage%3D935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Ninomiya-Tsuji, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kajino, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohtomo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mihara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuchiya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, K.</span><span> </span><span class="NLM_article-title">A resorcylic acid lactone, 5<i>Z</i>-7-oxozeaenol, prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">18485</span><span class="NLM_x">–</span> <span class="NLM_lpage">18490</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=18485-18490&author=J.+Ninomiya-Tsujiauthor=T.+Kajinoauthor=K.+Onoauthor=T.+Ohtomoauthor=M.+Matsumotoauthor=M.+Shiinaauthor=M.+Miharaauthor=M.+Tsuchiyaauthor=K.+Matsumoto&title=A+resorcylic+acid+lactone%2C+5Z-7-oxozeaenol%2C+prevents+inflammation+by+inhibiting+the+catalytic+activity+of+TAK1+MAPK+kinase+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNinomiya-Tsuji%26aufirst%3DJ.%26aulast%3DKajino%26aufirst%3DT.%26aulast%3DOno%26aufirst%3DK.%26aulast%3DOhtomo%26aufirst%3DT.%26aulast%3DMatsumoto%26aufirst%3DM.%26aulast%3DShiina%26aufirst%3DM.%26aulast%3DMihara%26aufirst%3DM.%26aulast%3DTsuchiya%26aufirst%3DM.%26aulast%3DMatsumoto%26aufirst%3DK.%26atitle%3DA%2520resorcylic%2520acid%2520lactone%252C%25205Z-7-oxozeaenol%252C%2520prevents%2520inflammation%2520by%2520inhibiting%2520the%2520catalytic%2520activity%2520of%2520TAK1%2520MAPK%2520kinase%2520kinase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D18485%26epage%3D18490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Arana-Argaez, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delgado-Rizo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pizano-Martinez, O. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez-Garcia, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin-Marquez, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munoz-Gomez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petri, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armendariz-Borunda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espinosa-Ramirez, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuniga-Tamayo, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrera-Esparza, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vazquez-Del Mercado, M.</span><span> </span><span class="NLM_article-title">Inhibitors of MAPK pathway ERK1/2 or p38 prevent the IL-1{beta}-induced up-regulation of SRP72 autoantigen in Jurkat cells</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">32824</span><span class="NLM_x">–</span> <span class="NLM_lpage">32833</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=32824-32833&author=V.+E.+Arana-Argaezauthor=V.+Delgado-Rizoauthor=O.+E.+Pizano-Martinezauthor=E.+A.+Martinez-Garciaauthor=B.+T.+Martin-Marquezauthor=A.+Munoz-Gomezauthor=M.+H.+Petriauthor=J.+Armendariz-Borundaauthor=G.+Espinosa-Ramirezauthor=D.+A.+Zuniga-Tamayoauthor=R.+Herrera-Esparzaauthor=M.+Vazquez-Del+Mercado&title=Inhibitors+of+MAPK+pathway+ERK1%2F2+or+p38+prevent+the+IL-1%7Bbeta%7D-induced+up-regulation+of+SRP72+autoantigen+in+Jurkat+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArana-Argaez%26aufirst%3DV.%2BE.%26aulast%3DDelgado-Rizo%26aufirst%3DV.%26aulast%3DPizano-Martinez%26aufirst%3DO.%2BE.%26aulast%3DMartinez-Garcia%26aufirst%3DE.%2BA.%26aulast%3DMartin-Marquez%26aufirst%3DB.%2BT.%26aulast%3DMunoz-Gomez%26aufirst%3DA.%26aulast%3DPetri%26aufirst%3DM.%2BH.%26aulast%3DArmendariz-Borunda%26aufirst%3DJ.%26aulast%3DEspinosa-Ramirez%26aufirst%3DG.%26aulast%3DZuniga-Tamayo%26aufirst%3DD.%2BA.%26aulast%3DHerrera-Esparza%26aufirst%3DR.%26aulast%3DVazquez-Del%2BMercado%26aufirst%3DM.%26atitle%3DInhibitors%2520of%2520MAPK%2520pathway%2520ERK1%252F2%2520or%2520p38%2520prevent%2520the%2520IL-1%257Bbeta%257D-induced%2520up-regulation%2520of%2520SRP72%2520autoantigen%2520in%2520Jurkat%2520cells%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D32824%26epage%3D32833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Pereira, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igea, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canovas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dolado, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nebreda, A. R.</span><span> </span><span class="NLM_article-title">Inhibition of p38 MAPK sensitizes tumour cells to cisplatin-induced apoptosis mediated by reactive oxygen species and JNK</span> <span class="citation_source-journal">EMBO Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1759</span><span class="NLM_x">–</span> <span class="NLM_lpage">1774</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm500480k&amp;key=10.1002%2Femmm.201302732" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm500480k&amp;key=24115572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm500480k&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWms73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=1759-1774&author=L.+Pereiraauthor=A.+Igeaauthor=B.+Canovasauthor=I.+Doladoauthor=A.+R.+Nebreda&title=Inhibition+of+p38+MAPK+sensitizes+tumour+cells+to+cisplatin-induced+apoptosis+mediated+by+reactive+oxygen+species+and+JNK"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of p38 MAPK sensitizes tumour cells to cisplatin-induced apoptosis mediated by reactive oxygen species and JNK</span></div><div class="casAuthors">Pereira, Lorena; Igea, Ana; Canovas, Begona; Dolado, Ignacio; Nebreda, Angel R.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1759-1774</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The p38 MAPK pathway is an important regulator of many cellular responses.  It is well established that p38 MAPK signalling neg. regulates epithelial cell transformation, but enhanced p38 MAPK activity has been also correlated with bad clin. prognosis in some tumor types.  Here, we provide genetic and pharmacol. evidence showing that p38 MAPK inhibition cooperates with the chemotherapeutic agent cisplatin to kill tumor cells.  We show that p38 MAPK inhibition results in ROS upregulation, which in turn activates the JNK pathway via inactivation of phosphatases, sensitizing human tumor cells to cisplatin-induced apoptosis.  Using a mouse model for breast cancer, we confirm that inhibition of p38 MAPK cooperates with cisplatin treatment to reduce tumor size and malignancy in vivo.  Taken together, our results illustrate a new function of p38 MAPK that helps tumor cells to survive chemotherapeutic drug treatments, and reveal that the combination of p38 MAPK inhibitors with cisplatin can be potentially exploited for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7MKSX0-D5tbVg90H21EOLACvtfcHk0liTFSSmodsbHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWms73K&md5=9a4a89c0c5aae156fa159d37833cbb41</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Femmm.201302732&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Femmm.201302732%26sid%3Dliteratum%253Aachs%26aulast%3DPereira%26aufirst%3DL.%26aulast%3DIgea%26aufirst%3DA.%26aulast%3DCanovas%26aufirst%3DB.%26aulast%3DDolado%26aufirst%3DI.%26aulast%3DNebreda%26aufirst%3DA.%2BR.%26atitle%3DInhibition%2520of%2520p38%2520MAPK%2520sensitizes%2520tumour%2520cells%2520to%2520cisplatin-induced%2520apoptosis%2520mediated%2520by%2520reactive%2520oxygen%2520species%2520and%2520JNK%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2013%26volume%3D5%26spage%3D1759%26epage%3D1774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Sato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanjo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ninomiya-Tsuji, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akira, S.</span><span> </span><span class="NLM_article-title">Essential function for the kinase TAK1 in innate and adaptive immune responses</span> <span class="citation_source-journal">Nat. Immunol</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1087</span><span class="NLM_x">–</span> <span class="NLM_lpage">1095</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm500480k&amp;key=10.1038%2Fni1255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm500480k&amp;key=16186825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm500480k&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFamsb7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=1087-1095&author=S.+Satoauthor=H.+Sanjoauthor=K.+Takedaauthor=J.+Ninomiya-Tsujiauthor=M.+Yamamotoauthor=T.+Kawaiauthor=K.+Matsumotoauthor=O.+Takeuchiauthor=S.+Akira&title=Essential+function+for+the+kinase+TAK1+in+innate+and+adaptive+immune+responses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Essential function for the kinase TAK1 in innate and adaptive immune responses</span></div><div class="casAuthors">Sato, Shintaro; Sanjo, Hideki; Takeda, Kiyoshi; Ninomiya-Tsuji, Jun; Yamamoto, Masahiro; Kawai, Taro; Matsumoto, Kunihiro; Takeuchi, Osamu; Akira, Shizuo</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1087-1095</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Transforming growth factor-β-activated kinase 1 (TAK1) has been linked to interleukin 1 receptor and tumor necrosis factor receptor signaling.  Here the authors generated mouse strains with conditional expression of a Map3k7 allele encoding part of TAK1.  TAK1-deficient embryonic fibroblasts demonstrated loss of responses to interleukin 1β and tumor necrosis factor.  Studies of mice with B cell-specific TAK1 deficiency showed that TAK1 was indispensable for cellular responses to Toll-like receptor ligands, CD40 and B cell receptor crosslinking.  In addn., antigen-induced immune responses were considerably impaired in mice with B cell-specific TAK1 deficiency.  TAK1-deficient cells failed to activate transcription factor NF-κB and mitogen-activated protein kinases in response to interleukin 1β, tumor necrosis factor and Toll-like receptor ligands.  However, TAK1-deficient B cells were able to activate NF-κB but not the kinase Jnk in response to B cell receptor stimulation.  These results collectively indicate that TAK1 is key in the cellular response to a variety of stimuli.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrq9Ks8rBWwNbVg90H21EOLACvtfcHk0liTFSSmodsbHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFamsb7K&md5=7d9a7b4799b65cc1c53f4c2ec57c8943</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fni1255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni1255%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DS.%26aulast%3DSanjo%26aufirst%3DH.%26aulast%3DTakeda%26aufirst%3DK.%26aulast%3DNinomiya-Tsuji%26aufirst%3DJ.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DKawai%26aufirst%3DT.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DTakeuchi%26aufirst%3DO.%26aulast%3DAkira%26aufirst%3DS.%26atitle%3DEssential%2520function%2520for%2520the%2520kinase%2520TAK1%2520in%2520innate%2520and%2520adaptive%2520immune%2520responses%26jtitle%3DNat.%2520Immunol%26date%3D2005%26volume%3D6%26spage%3D1087%26epage%3D1095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Schirmer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santi, D. V.</span><span> </span><span class="NLM_article-title">Targeted covalent inactivation of protein kinases by resorcylic acid lactone polyketides</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">4234</span><span class="NLM_x">–</span> <span class="NLM_lpage">4239</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm500480k&amp;key=10.1073%2Fpnas.0600445103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm500480k&amp;key=16537514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm500480k&amp;key=1%3ACAS%3A528%3ADC%252BD28XivFWhsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=4234-4239&author=A.+Schirmerauthor=J.+Kennedyauthor=S.+Murliauthor=R.+Reidauthor=D.+V.+Santi&title=Targeted+covalent+inactivation+of+protein+kinases+by+resorcylic+acid+lactone+polyketides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted covalent inactivation of protein kinases by resorcylic acid lactone polyketides</span></div><div class="casAuthors">Schirmer, Andreas; Kennedy, Jonathan; Murli, Sumati; Reid, Ralph; Santi, Daniel V.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4234-4239</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Resorcylic acid lactones contg. a cis-enone are susceptible to Michael addn. reactions and are potent inhibitors of several protein kinases.  A structural-bioinformatics anal. identified a conserved Cys residue in the ATP-binding site of the kinases reported to be inhibited by cis-enone resorcylic acid lactones but absent in those that are not.  Mining of the kinome database revealed that a subset of some 46 kinases contained this Cys residue.  Screening a panel of 124 kinases with the resorcylic acid lactone hypothemycin showed that 18 of 19 targets contg. the conserved Cys were inhibited.  Kinetic analyses showed time-dependent inhibition, a hallmark of covalent inactivation, and biochem. studies of the interaction of extracellular signal-regulated kinase (ERK)2 with hypothemycin confirmed covalent adduct formation.  Resorcylic acid lactones are unique among kinase inhibitors in that they target mitogen-activated protein (MAP) kinase pathways at four levels: mitogen receptors, MAP kinase kinase (MEK)1/2 and ERK1/2, and certain downstream ERK substrates.  Cell lines dependent on the activation of Tyr kinase mitogen receptor targets of the resorcylic acid lactones were unusually sensitive toward hypothemycin and showed the expected inhibition of kinase phosphorylation due to inhibition of the mitogen receptors and/or MEK1/2 and ERK1/2.  Among cells without mitogen receptor targets, those harboring an ERK pathway-activating B-RAF V600E mutation were selectively and potently inhibited by hypothemycin.  Hypothemycin also prevented stimulated activation of the p38 cascade through inhibition of the Cys-contg. targets MEK3/6 and TGF-β-activated kinase 1 and of the JNK/SAPK (c-Jun N-terminal kinase/stress-activated protein kinase) cascade through inhibition of MEK4/7.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraww22qbwEYLVg90H21EOLACvtfcHk0liTFSSmodsbHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XivFWhsr0%253D&md5=6a4be819f2c2a5a601e5c9cb75faf433</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0600445103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0600445103%26sid%3Dliteratum%253Aachs%26aulast%3DSchirmer%26aufirst%3DA.%26aulast%3DKennedy%26aufirst%3DJ.%26aulast%3DMurli%26aufirst%3DS.%26aulast%3DReid%26aufirst%3DR.%26aulast%3DSanti%26aufirst%3DD.%2BV.%26atitle%3DTargeted%2520covalent%2520inactivation%2520of%2520protein%2520kinases%2520by%2520resorcylic%2520acid%2520lactone%2520polyketides%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D4234%26epage%3D4239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Brown, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vial, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dedi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunster, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheetham, G. M.</span><span> </span><span class="NLM_article-title">Structural basis for the interaction of TAK1 kinase with its activating protein TAB1</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">354</span><span class="NLM_x">, </span> <span class="NLM_fpage">1013</span><span class="NLM_x">–</span> <span class="NLM_lpage">1020</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=354&publication_year=2005&pages=1013-1020&author=K.+Brownauthor=S.+C.+Vialauthor=N.+Dediauthor=J.+M.+Longauthor=N.+J.+Dunsterauthor=G.+M.+Cheetham&title=Structural+basis+for+the+interaction+of+TAK1+kinase+with+its+activating+protein+TAB1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DK.%26aulast%3DVial%26aufirst%3DS.%2BC.%26aulast%3DDedi%26aufirst%3DN.%26aulast%3DLong%26aufirst%3DJ.%2BM.%26aulast%3DDunster%26aufirst%3DN.%2BJ.%26aulast%3DCheetham%26aufirst%3DG.%2BM.%26atitle%3DStructural%2520basis%2520for%2520the%2520interaction%2520of%2520TAK1%2520kinase%2520with%2520its%2520activating%2520protein%2520TAB1%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2005%26volume%3D354%26spage%3D1013%26epage%3D1020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsen, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byth, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toader, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saeh, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span> </span><span class="NLM_article-title">Mechanism and in vitro pharmacology of TAK1 inhibition by (5<i>Z</i>)-7-Oxozeaenol</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">643</span><span class="NLM_x">–</span> <span class="NLM_lpage">650</span></span><div class="citationLinks">[<a href="/doi/10.1021/cb3005897" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=643-650&author=J.+Wuauthor=F.+Powellauthor=N.+A.+Larsenauthor=Z.+Laiauthor=K.+F.+Bythauthor=J.+Readauthor=R.+F.+Guauthor=M.+Rothauthor=D.+Toaderauthor=J.+C.+Saehauthor=H.+Chen&title=Mechanism+and+in+vitro+pharmacology+of+TAK1+inhibition+by+%285Z%29-7-Oxozeaenol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fcb3005897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb3005897%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DPowell%26aufirst%3DF.%26aulast%3DLarsen%26aufirst%3DN.%2BA.%26aulast%3DLai%26aufirst%3DZ.%26aulast%3DByth%26aufirst%3DK.%2BF.%26aulast%3DRead%26aufirst%3DJ.%26aulast%3DGu%26aufirst%3DR.%2BF.%26aulast%3DRoth%26aufirst%3DM.%26aulast%3DToader%26aufirst%3DD.%26aulast%3DSaeh%26aufirst%3DJ.%2BC.%26aulast%3DChen%26aufirst%3DH.%26atitle%3DMechanism%2520and%2520in%2520vitro%2520pharmacology%2520of%2520TAK1%2520inhibition%2520by%2520%25285Z%2529-7-Oxozeaenol%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D643%26epage%3D650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Minor, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cymborowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otwinowski, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chruszcz, M.</span><span> </span><span class="NLM_article-title">HKL-3000: the integration of data reduction and structure solution—from diffraction images to an initial model in minutes</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">859</span><span class="NLM_x">–</span> <span class="NLM_lpage">866</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=859-866&author=W.+Minorauthor=M.+Cymborowskiauthor=Z.+Otwinowskiauthor=M.+Chruszcz&title=HKL-3000%3A+the+integration+of+data+reduction+and+structure+solution%E2%80%94from+diffraction+images+to+an+initial+model+in+minutes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMinor%26aufirst%3DW.%26aulast%3DCymborowski%26aufirst%3DM.%26aulast%3DOtwinowski%26aufirst%3DZ.%26aulast%3DChruszcz%26aufirst%3DM.%26atitle%3DHKL-3000%253A%2520the%2520integration%2520of%2520data%2520reduction%2520and%2520structure%2520solution%25E2%2580%2594from%2520diffraction%2520images%2520to%2520an%2520initial%2520model%2520in%2520minutes%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2006%26volume%3D62%26spage%3D859%26epage%3D866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Collaborative Computational Project, Number 4.</span><span> </span><span class="NLM_article-title">The CCP4 suite: programs for protein crystallography</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">760</span><span class="NLM_x">–</span> <span class="NLM_lpage">763</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm500480k&amp;key=10.1107%2FS0907444994003112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm500480k&amp;key=15299374" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1994&pages=760-763&author=Collaborative+Computational+Project%2C+Number+4.&title=The+CCP4+suite%3A+programs+for+protein+crystallography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1107%2FS0907444994003112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444994003112%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DThe%2520CCP4%2520suite%253A%2520programs%2520for%2520protein%2520crystallography%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1994%26volume%3D50%26spage%3D760%26epage%3D763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Coot: model-building tools for molecular graphics</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2126</span><span class="NLM_x">–</span> <span class="NLM_lpage">2132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm500480k&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm500480k&amp;key=15572765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm500480k&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+model-building+tools+for+molecular+graphics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0ljxBwkmYDMKIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2126%26epage%3D2132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Afonine, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunkoczi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Echols, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Headd, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapral, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriarty, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oeffner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terwilliger, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwart, P. H.</span><span> </span><span class="NLM_article-title">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">221</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm500480k&amp;key=10.1107%2FS0907444909052925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm500480k&amp;key=20124702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm500480k&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=213-221&author=P.+D.+Adamsauthor=P.+V.+Afonineauthor=G.+Bunkocziauthor=V.+B.+Chenauthor=I.+W.+Davisauthor=N.+Echolsauthor=J.+J.+Headdauthor=L.+W.+Hungauthor=G.+J.+Kapralauthor=R.+W.+Grosse-Kunstleveauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+Oeffnerauthor=R.+J.+Readauthor=D.+C.+Richardsonauthor=J.+S.+Richardsonauthor=T.+C.+Terwilligerauthor=P.+H.+Zwart&title=PHENIX%3A+a+comprehensive+Python-based+system+for+macromolecular+structure+solution"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span></div><div class="casAuthors">Adams, Paul D.; Afonine, Pavel V.; Bunkoczi, Gabor; Chen, Vincent B.; Davis, Ian W.; Echols, Nathaniel; Headd, Jeffrey J.; Hung, Li Wei; Kapral, Gary J.; Grosse-Kunstleve, Ralf W.; McCoy, Airlie J.; Moriarty, Nigel W.; Oeffner, Robert; Read, Randy J.; Richardson, David C.; Richardson, Jane S.; Terwilliger, Thomas C.; Zwart, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-221</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  Macromol. X-ray crystallog. is routinely applied to understand biol. processes at a mol. level.  However, significant time and effort are still required to solve and complete many of these structures because of the need for manual interpretation of complex numerical data using many software packages and the repeated use of interactive three-dimensional graphics.  PHENIX has been developed to provide a comprehensive system for macromol. crystallog. structure soln. with an emphasis on the automation of all procedures.  This has relied on the development of algorithms that minimize or eliminate subjective input, the development of algorithms that automate procedures that are traditionally performed by hand and, finally, the development of a framework that allows a tight integration between the algorithms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm_HgKRpa-ObVg90H21EOLACvtfcHk0ljxBwkmYDMKIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D&md5=67b439ff4bd61c659cae37ca4209b7bc</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1107%2FS0907444909052925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909052925%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DBunkoczi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DHung%26aufirst%3DL.%2BW.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DOeffner%26aufirst%3DR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26atitle%3DPHENIX%253A%2520a%2520comprehensive%2520Python-based%2520system%2520for%2520macromolecular%2520structure%2520solution%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D213%26epage%3D221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O91" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O91','PDB','4O91'); return false;">PDB: 4O91</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2YIY" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2YIY','PDB','2YIY'); return false;">PDB: 2YIY</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2EVA" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2EVA','PDB','2EVA'); return false;">PDB: 2EVA</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i27"><a href="/doi/suppl/10.1021/jm500480k">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_02761"></div></div></div></div></div><hr /></hr><p class="last">Figures S1–S5; structures of <b>37</b>–<b>39</b> (Figure S6); Table S1–S4; structures and spectral data of <b>3</b>–<b>26</b>; Ambit profiling data of <b>1</b> and <b>2</b>; ActiveX profiling data of <b>1</b>, <b>2</b>, and <b>17</b>; KinomeScan profiling data and KiNativ assay data in xlsx format. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm500480k/suppl_file/jm500480k_si_001.pdf">jm500480k_si_001.pdf (894.78 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm500480k/suppl_file/jm500480k_si_002.xlsx">jm500480k_si_002.xlsx (25.8 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm500480k/suppl_file/jm500480k_si_003.xlsx">jm500480k_si_003.xlsx (46.76 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm500480k/suppl_file/jm500480k_si_004.xlsx">jm500480k_si_004.xlsx (190.22 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm500480k/suppl_file/jm500480k_si_005.xlsx">jm500480k_si_005.xlsx (19.87 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm500480k/suppl_file/jm500480k_si_006.xlsx">jm500480k_si_006.xlsx (20.2 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">X-ray coordinates and structure factors have been deposited in the Protein Data Bank, accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O91">4O91</a>.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm500480k&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm500480k%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-1%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm500480k" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679939e73dc6d1b7","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
